RemeGen Co. Ltd. CNE1000048G6 07/14/2023 Adoption of Share Incentive Scheme COMPENSATION ISSUER 4397500.000000 0.000000 FOR 4397500.000000 FOR S000002922 RemeGen Co. Ltd. CNE1000048G6 07/14/2023 Board Authorization CORPORATE GOVERNANCE ISSUER 4397500.000000 0.000000 FOR 4397500.000000 FOR S000002922 Shenzhen Mindray Bio-Medical Electronics Co. Ltd. CNE100003G67 07/18/2023 Elect KONG Yu as Independent Director DIRECTOR ELECTIONS ISSUER 965017.000000 0.000000 FOR 965017.000000 FOR S000002922 Shenzhen Mindray Bio-Medical Electronics Co. Ltd. CNE100003G67 07/18/2023 Approve Completion of Raised Funds Investment Project and Use of Excess Raised Funds to Replenish Working Capital CAPITAL STRUCTURE ISSUER 965017.000000 0.000000 FOR 965017.000000 FOR S000002922 Roivant Sciences Ltd. G76279101 09/12/2023 Elect Daniel Gold DIRECTOR ELECTIONS ISSUER 9572139.000000 0.000000 FOR 9572139.000000 FOR S000002922 Roivant Sciences Ltd. G76279101 09/12/2023 Elect Meghan FitzGerald DIRECTOR ELECTIONS ISSUER 9572139.000000 0.000000 FOR 9572139.000000 FOR S000002922 Roivant Sciences Ltd. G76279101 09/12/2023 To ratify the selection by the Audit Committee of the Board of Ernst & Young LLP as Roivant s independent registered public accounting firm for Roivant s fiscal year ending March 31, 2024, to appoint Ernst & Young LLP as auditor for statutory purposes under the Bermuda Companies Act 1981, as amended, for Roivant s fiscal year ending March 31, 2024, and to authorize the Board, through the Audit Committee, to set the remuneration for Ernst & Young LLP as Roivant s auditor for Roivant s fiscal year ending March 31, 2024. AUDIT-RELATED ISSUER 9572139.000000 0.000000 FOR 9572139.000000 FOR S000002922 Novartis AG CH0012005267 09/15/2023 Dividend in Kind to Effect Spin-Off of Sandoz Group AG CAPITAL STRUCTURE ISSUER 22583277.000000 0.000000 FOR 22583277.000000 FOR S000002922 Novartis AG CH0012005267 09/15/2023 Amendment to Par Value CAPITAL STRUCTURE ISSUER 22583277.000000 0.000000 FOR 22583277.000000 FOR S000002922 Novartis AG CH0012005267 09/15/2023 Additional or Amended Proposals CORPORATE GOVERNANCE ISSUER 22583277.000000 0.000000 AGAINST 22583277.000000 NONE S000002922 Hapvida Participacoes Investimento SA BRHAPVACNOR4 09/19/2023 Amendments to Article 6 (Reconciliation of Share Capital) CORPORATE GOVERNANCE ISSUER 8909471.000000 0.000000 FOR 8909471.000000 FOR S000002922 Hapvida Participacoes Investimento SA BRHAPVACNOR4 09/19/2023 Increase in Authorized Capital CAPITAL STRUCTURE ISSUER 8909471.000000 0.000000 FOR 8909471.000000 FOR S000002922 Hapvida Participacoes Investimento SA BRHAPVACNOR4 09/19/2023 Amendments to Article 11 (Shareholders Meeting Quorum) CORPORATE GOVERNANCE ISSUER 8909471.000000 0.000000 FOR 8909471.000000 FOR S000002922 Hapvida Participacoes Investimento SA BRHAPVACNOR4 09/19/2023 Amendments to Article 24 (Regulation) CORPORATE GOVERNANCE ISSUER 8909471.000000 0.000000 FOR 8909471.000000 FOR S000002922 Hapvida Participacoes Investimento SA BRHAPVACNOR4 09/19/2023 Amendments to Articles (Management Board) CORPORATE GOVERNANCE ISSUER 8909471.000000 0.000000 FOR 8909471.000000 FOR S000002922 Hapvida Participacoes Investimento SA BRHAPVACNOR4 09/19/2023 Amendments to Article 30 (Subsidiary) CORPORATE GOVERNANCE ISSUER 8909471.000000 0.000000 FOR 8909471.000000 FOR S000002922 Hapvida Participacoes Investimento SA BRHAPVACNOR4 09/19/2023 Consolidation of Articles CORPORATE GOVERNANCE ISSUER 8909471.000000 0.000000 FOR 8909471.000000 FOR S000002922 Legend Biotech Corporation 52490G102 09/21/2023 To receive the audited consolidated financial statements of the Company for the fiscal year ended December 31,2022. CORPORATE GOVERNANCE ISSUER 1169204.000000 0.000000 FOR 1169204.000000 FOR S000002922 Legend Biotech Corporation 52490G102 09/21/2023 To ratify the appointment of Ernst & Young LLP as independent auditor of the Company (the IndependentAuditor ) for the fiscal year ending December 31, 2023. AUDIT-RELATED ISSUER 1169204.000000 0.000000 FOR 1169204.000000 FOR S000002922 Legend Biotech Corporation 52490G102 09/21/2023 To re-elect Dr. Li Zhu, whose term of office will expire pursuant to article 88(b) of the Company s memorandum of association, to serve as a Class III director of the Company for a full term of three (3) years. DIRECTOR ELECTIONS ISSUER 1169204.000000 0.000000 FOR 1169204.000000 FOR S000002922 Legend Biotech Corporation 52490G102 09/21/2023 To re-elect Dr. Corazon D. Sanders, whose term of office will expire pursuant to article 88(b) of the Company s memorandum of association, to serve as a Class III director of the Company for a full term of three (3) years. DIRECTOR ELECTIONS ISSUER 1169204.000000 0.000000 FOR 1169204.000000 FOR S000002922 Legend Biotech Corporation 52490G102 09/21/2023 To re-elect Dr. Li Mao, whose term of office will expire pursuant to article 88(b) of the Company s memorandum of association, to serve as a Class III director of the Company for a full term of three (3) years. DIRECTOR ELECTIONS ISSUER 1169204.000000 0.000000 FOR 1169204.000000 FOR S000002922 Legend Biotech Corporation 52490G102 09/21/2023 To authorize each of the directors and officers of the Company to take any and every action that might be necessary to effect the foregoing resolutions as such director or officer, in his or her absolute discretion, thinks fit. CORPORATE GOVERNANCE ISSUER 1169204.000000 0.000000 FOR 1169204.000000 FOR S000002922 ASAHI INTECC CO., LTD. JP3110650003 09/28/2023 Allocation of Profits/Dividends CAPITAL STRUCTURE ISSUER 2023500.000000 0.000000 FOR 2023500.000000 FOR S000002922 ASAHI INTECC CO., LTD. JP3110650003 09/28/2023 Amendments to Articles CORPORATE GOVERNANCE ISSUER 2023500.000000 0.000000 FOR 2023500.000000 FOR S000002922 ASAHI INTECC CO., LTD. JP3110650003 09/28/2023 Elect Masahiko Miyata DIRECTOR ELECTIONS ISSUER 2023500.000000 0.000000 FOR 2023500.000000 FOR S000002922 ASAHI INTECC CO., LTD. JP3110650003 09/28/2023 Elect Kenji Miyata DIRECTOR ELECTIONS ISSUER 2023500.000000 0.000000 FOR 2023500.000000 FOR S000002922 ASAHI INTECC CO., LTD. JP3110650003 09/28/2023 Elect Tadakazu Kato DIRECTOR ELECTIONS ISSUER 2023500.000000 0.000000 FOR 2023500.000000 FOR S000002922 ASAHI INTECC CO., LTD. JP3110650003 09/28/2023 Elect Munechika Matsumoto DIRECTOR ELECTIONS ISSUER 2023500.000000 0.000000 FOR 2023500.000000 FOR S000002922 ASAHI INTECC CO., LTD. JP3110650003 09/28/2023 Elect Yoshinori Terai DIRECTOR ELECTIONS ISSUER 2023500.000000 0.000000 FOR 2023500.000000 FOR S000002922 ASAHI INTECC CO., LTD. JP3110650003 09/28/2023 Elect Mizuho Ito DIRECTOR ELECTIONS ISSUER 2023500.000000 0.000000 FOR 2023500.000000 FOR S000002922 ASAHI INTECC CO., LTD. JP3110650003 09/28/2023 Elect Makoto Nishiuchi DIRECTOR ELECTIONS ISSUER 2023500.000000 0.000000 FOR 2023500.000000 FOR S000002922 ASAHI INTECC CO., LTD. JP3110650003 09/28/2023 Elect Kiyomichi Ito DIRECTOR ELECTIONS ISSUER 2023500.000000 0.000000 FOR 2023500.000000 FOR S000002922 ASAHI INTECC CO., LTD. JP3110650003 09/28/2023 Elect Takahiro Kusakari DIRECTOR ELECTIONS ISSUER 2023500.000000 0.000000 FOR 2023500.000000 FOR S000002922 ASAHI INTECC CO., LTD. JP3110650003 09/28/2023 Elect Akihiro Taguchi DIRECTOR ELECTIONS ISSUER 2023500.000000 0.000000 FOR 2023500.000000 FOR S000002922 Shandong Weigao Group Medical Polymer Company Limited CNE100000171 10/13/2023 Issuance of Domestic Shares CAPITAL STRUCTURE ISSUER 49706791.000000 0.000000 FOR 49706791.000000 FOR S000002922 Shandong Weigao Group Medical Polymer Company Limited CNE100000171 10/13/2023 Grant of Share Awards to Core Employees COMPENSATION ISSUER 49706791.000000 0.000000 FOR 49706791.000000 FOR S000002922 Shandong Weigao Group Medical Polymer Company Limited CNE100000171 10/13/2023 Grant of Share Awards to Connected Grantees COMPENSATION ISSUER 49706791.000000 0.000000 FOR 49706791.000000 FOR S000002922 Shandong Weigao Group Medical Polymer Company Limited CNE100000171 10/13/2023 Grant of Share Awards to Mr. Long Jing (Exceeding 0.1% of the Issued Share of Company) COMPENSATION ISSUER 49706791.000000 0.000000 FOR 49706791.000000 FOR S000002922 Shandong Weigao Group Medical Polymer Company Limited CNE100000171 10/13/2023 Grant of Share Awards to Mr. Cong Rinan (Exceeding 0.1% of the Issued Share of Company) COMPENSATION ISSUER 49706791.000000 0.000000 FOR 49706791.000000 FOR S000002922 Shandong Weigao Group Medical Polymer Company Limited CNE100000171 10/13/2023 Grant of Share Awards to Mr. Chen Lin (Exceeding 0.1% of the Issued Share of Company) COMPENSATION ISSUER 49706791.000000 0.000000 FOR 49706791.000000 FOR S000002922 Shandong Weigao Group Medical Polymer Company Limited CNE100000171 10/13/2023 Board Authorization To Handle Matters In Connection With The Allotment of Shares CORPORATE GOVERNANCE ISSUER 49706791.000000 0.000000 FOR 49706791.000000 FOR S000002922 Shandong Weigao Group Medical Polymer Company Limited CNE100000171 10/13/2023 Amendments to Articles of Association CORPORATE GOVERNANCE ISSUER 49706791.000000 0.000000 FOR 49706791.000000 FOR S000002922 Shandong Weigao Group Medical Polymer Company Limited CNE100000171 10/13/2023 Interim Dividends CAPITAL STRUCTURE ISSUER 49706791.000000 0.000000 FOR 49706791.000000 FOR S000002922 Shandong Weigao Group Medical Polymer Company Limited CNE100000171 10/13/2023 Authority to Issue Shares w/o Preemptive Rights CAPITAL STRUCTURE ISSUER 49706791.000000 0.000000 FOR 49706791.000000 FOR S000002922 Shandong Weigao Group Medical Polymer Company Limited CNE100000171 10/13/2023 Purchase Framework Agreement EXTRAORDINARY TRANSACTIONS ISSUER 49706791.000000 0.000000 FOR 49706791.000000 FOR S000002922 Shandong Weigao Group Medical Polymer Company Limited CNE100000171 10/13/2023 Logistic Support Services Framework Agreement EXTRAORDINARY TRANSACTIONS ISSUER 49706791.000000 0.000000 FOR 49706791.000000 FOR S000002922 Revolution Medicines, Inc. 76155X100 11/08/2023 To approve the issuance of shares of Revolution Medicines common stock (including securities convertible into or exercisable for shares of Revolution Medicines common stock) to certain equityholders of EQRx, Inc., which is referred to as EQRx, pursuant to the Agreement and Plan of Merger, dated as of July 31, 2023 (as it may be amended from time to time), by and among Revolution Medicines, Equinox Merger Sub I, Inc., Equinox Merger Sub II LLC, and EQRx, which proposal is referred to as the Revolution Medicines share issuance proposal. EXTRAORDINARY TRANSACTIONS ISSUER 4702802.000000 0.000000 AGAINST 4702802.000000 AGAINST S000002922 Revolution Medicines, Inc. 76155X100 11/08/2023 To approve the adjournment of the Revolution Medicines special meeting, to a later date or dates, if necessary or appropriate, to solicit additional proxies if there are not sufficient votes at the time of the Revolution Medicines special meeting to approve the Revolution Medicines share issuance proposal. CORPORATE GOVERNANCE ISSUER 4702802.000000 0.000000 FOR 4702802.000000 FOR S000002922 Genus plc GB0002074580 11/22/2023 Accounts and Reports CORPORATE GOVERNANCE ISSUER 1791160.000000 0.000000 FOR 1791160.000000 FOR S000002922 Genus plc GB0002074580 11/22/2023 Remuneration Report COMPENSATION ISSUER 1791160.000000 0.000000 FOR 1791160.000000 FOR S000002922 Genus plc GB0002074580 11/22/2023 Final Dividend CAPITAL STRUCTURE ISSUER 1791160.000000 0.000000 FOR 1791160.000000 FOR S000002922 Genus plc GB0002074580 11/22/2023 Elect Jorgen Kokke DIRECTOR ELECTIONS ISSUER 1791160.000000 0.000000 FOR 1791160.000000 FOR S000002922 Genus plc GB0002074580 11/22/2023 Elect Iain G.T. Ferguson DIRECTOR ELECTIONS ISSUER 1791160.000000 0.000000 FOR 1791160.000000 FOR S000002922 Genus plc GB0002074580 11/22/2023 Elect Alison Henriksen DIRECTOR ELECTIONS ISSUER 1791160.000000 0.000000 FOR 1791160.000000 FOR S000002922 Genus plc GB0002074580 11/22/2023 Elect Lysanne Gray DIRECTOR ELECTIONS ISSUER 1791160.000000 0.000000 FOR 1791160.000000 FOR S000002922 Genus plc GB0002074580 11/22/2023 Elect Lesley Knox DIRECTOR ELECTIONS ISSUER 1791160.000000 0.000000 FOR 1791160.000000 FOR S000002922 Genus plc GB0002074580 11/22/2023 Elect Jason Chin DIRECTOR ELECTIONS ISSUER 1791160.000000 0.000000 FOR 1791160.000000 FOR S000002922 Genus plc GB0002074580 11/22/2023 Appointment of Auditor AUDIT-RELATED ISSUER 1791160.000000 0.000000 FOR 1791160.000000 FOR S000002922 Genus plc GB0002074580 11/22/2023 Authority to Set Auditor's Fees AUDIT-RELATED ISSUER 1791160.000000 0.000000 FOR 1791160.000000 FOR S000002922 Genus plc GB0002074580 11/22/2023 Authority to Issue Shares Pursuant to Buy-Out Awards CAPITAL STRUCTURE ISSUER 1791160.000000 0.000000 FOR 1791160.000000 FOR S000002922 Genus plc GB0002074580 11/22/2023 Amendment to Performance Share Plan COMPENSATION ISSUER 1791160.000000 0.000000 FOR 1791160.000000 FOR S000002922 Genus plc GB0002074580 11/22/2023 Recruitment Grant COMPENSATION ISSUER 1791160.000000 0.000000 FOR 1791160.000000 FOR S000002922 Genus plc GB0002074580 11/22/2023 Authority to Issue Shares w/ Preemptive Rights CAPITAL STRUCTURE ISSUER 1791160.000000 0.000000 FOR 1791160.000000 FOR S000002922 Genus plc GB0002074580 11/22/2023 Authority to Issue Shares w/o Preemptive Rights CAPITAL STRUCTURE ISSUER 1791160.000000 0.000000 FOR 1791160.000000 FOR S000002922 Genus plc GB0002074580 11/22/2023 Authority to Issue Shares w/o Preemptive Rights (Specified Capital Investment) CAPITAL STRUCTURE ISSUER 1791160.000000 0.000000 FOR 1791160.000000 FOR S000002922 Genus plc GB0002074580 11/22/2023 Authority to Repurchase Shares CAPITAL STRUCTURE ISSUER 1791160.000000 0.000000 FOR 1791160.000000 FOR S000002922 Genus plc GB0002074580 11/22/2023 Authority to Set General Meeting Notice Period at 14 Days CORPORATE GOVERNANCE ISSUER 1791160.000000 0.000000 FOR 1791160.000000 FOR S000002922 Wuxi AppTec Co. Ltd. CNE1000031K4 01/05/2024 Direct Repurchase of H Shares in relation to the 2023 H Share Award and Trust Scheme and Cancellation of H Shares CAPITAL STRUCTURE ISSUER 8827300.000000 0.000000 FOR 8827300.000000 FOR S000002922 Wuxi AppTec Co. Ltd. CNE100003F19 01/05/2024 Direct Repurchase of H Shares in relation to the 2023 H Share Award and Trust Scheme and Cancellation of H Shares CAPITAL STRUCTURE ISSUER 19.000000 0.000000 FOR 19.000000 FOR S000002922 Wuxi AppTec Co. Ltd. CNE100003F19 01/05/2024 Direct Repurchase of H Shares in relation to the 2023 H Share Award and Trust Scheme and Cancellation of H Shares CAPITAL STRUCTURE ISSUER 19.000000 0.000000 FOR 19.000000 FOR S000002922 Wuxi AppTec Co. Ltd. CNE1000031K4 01/05/2024 Direct Repurchase of H Shares in relation to the 2023 H Share Award and Trust Scheme and Cancellation of H Shares CAPITAL STRUCTURE ISSUER 8827300.000000 0.000000 FOR 8827300.000000 FOR S000002922 Sage Therapeutics, Inc. 78667J108 01/31/2024 To approve a one-time stock option exchange program for non- executive officer employees of Sage (the Option Exchange Proposal ). COMPENSATION ISSUER 4304671.000000 0.000000 FOR 4304671.000000 FOR S000002922 Sage Therapeutics, Inc. 78667J108 01/31/2024 To approve a proposal to adjourn the Special Meeting to a later date or dates, if necessary or appropriate, to permit further solicitation and vote of proxies in the event that there are insufficient votes for, or otherwise in connection with, the approval of the Option Exchange Proposal. CORPORATE GOVERNANCE ISSUER 4304671.000000 0.000000 FOR 4304671.000000 FOR S000002922 Novartis AG CH0012005267 03/05/2024 Accounts and Reports CORPORATE GOVERNANCE ISSUER 20565879.000000 0.000000 FOR 20565879.000000 FOR S000002922 Novartis AG CH0012005267 03/05/2024 Approval of Non-Financial Statement Reports CORPORATE GOVERNANCE ISSUER 20565879.000000 0.000000 FOR 20565879.000000 FOR S000002922 Novartis AG CH0012005267 03/05/2024 Ratification of Board and Management Acts CORPORATE GOVERNANCE ISSUER 20565879.000000 0.000000 FOR 20565879.000000 FOR S000002922 Novartis AG CH0012005267 03/05/2024 Allocation of Dividends CAPITAL STRUCTURE ISSUER 20565879.000000 0.000000 FOR 20565879.000000 FOR S000002922 Novartis AG CH0012005267 03/05/2024 Cancellation of Shares and Reduction in Share Capital CAPITAL STRUCTURE ISSUER 20565879.000000 0.000000 FOR 20565879.000000 FOR S000002922 Novartis AG CH0012005267 03/05/2024 Board Compensation COMPENSATION ISSUER 20565879.000000 0.000000 FOR 20565879.000000 FOR S000002922 Novartis AG CH0012005267 03/05/2024 Executive Compensation (Total) COMPENSATION ISSUER 20565879.000000 0.000000 FOR 20565879.000000 FOR S000002922 Novartis AG CH0012005267 03/05/2024 Compensation Report COMPENSATION ISSUER 20565879.000000 0.000000 FOR 20565879.000000 FOR S000002922 Novartis AG CH0012005267 03/05/2024 Elect Jorg Reinhardt as Board Chair DIRECTOR ELECTIONS ISSUER 20565879.000000 0.000000 FOR 20565879.000000 FOR S000002922 Novartis AG CH0012005267 03/05/2024 Elect Nancy C. Andrews DIRECTOR ELECTIONS ISSUER 20565879.000000 0.000000 FOR 20565879.000000 FOR S000002922 Novartis AG CH0012005267 03/05/2024 Elect Ton Buchner DIRECTOR ELECTIONS ISSUER 20565879.000000 0.000000 AGAINST 20565879.000000 AGAINST S000002922 Novartis AG CH0012005267 03/05/2024 Elect Patrice Bula DIRECTOR ELECTIONS ISSUER 20565879.000000 0.000000 FOR 20565879.000000 FOR S000002922 Novartis AG CH0012005267 03/05/2024 Elect Elizabeth Doherty DIRECTOR ELECTIONS ISSUER 20565879.000000 0.000000 AGAINST 20565879.000000 AGAINST S000002922 Novartis AG CH0012005267 03/05/2024 Elect Bridgette P. Heller DIRECTOR ELECTIONS ISSUER 20565879.000000 0.000000 FOR 20565879.000000 FOR S000002922 Novartis AG CH0012005267 03/05/2024 Elect Daniel Hochstrasser DIRECTOR ELECTIONS ISSUER 20565879.000000 0.000000 FOR 20565879.000000 FOR S000002922 Novartis AG CH0012005267 03/05/2024 Elect Frans van Houten DIRECTOR ELECTIONS ISSUER 20565879.000000 0.000000 FOR 20565879.000000 FOR S000002922 Novartis AG CH0012005267 03/05/2024 Elect Simon Moroney DIRECTOR ELECTIONS ISSUER 20565879.000000 0.000000 FOR 20565879.000000 FOR S000002922 Novartis AG CH0012005267 03/05/2024 Elect Ana de Pro Gonzalo DIRECTOR ELECTIONS ISSUER 20565879.000000 0.000000 FOR 20565879.000000 FOR S000002922 Novartis AG CH0012005267 03/05/2024 Elect Charles L. Sawyers DIRECTOR ELECTIONS ISSUER 20565879.000000 0.000000 FOR 20565879.000000 FOR S000002922 Novartis AG CH0012005267 03/05/2024 Elect William T. Winters DIRECTOR ELECTIONS ISSUER 20565879.000000 0.000000 FOR 20565879.000000 FOR S000002922 Novartis AG CH0012005267 03/05/2024 Elect John D. Young DIRECTOR ELECTIONS ISSUER 20565879.000000 0.000000 FOR 20565879.000000 FOR S000002922 Novartis AG CH0012005267 03/05/2024 Elect Patrice Bula as Compensation Committee Member CORPORATE GOVERNANCE ISSUER 20565879.000000 0.000000 FOR 20565879.000000 FOR S000002922 Novartis AG CH0012005267 03/05/2024 Elect Bridgette P. Heller as Compensation Committee Member CORPORATE GOVERNANCE ISSUER 20565879.000000 0.000000 FOR 20565879.000000 FOR S000002922 Novartis AG CH0012005267 03/05/2024 Elect Simon Moroney as Compensation Committee Chair CORPORATE GOVERNANCE ISSUER 20565879.000000 0.000000 FOR 20565879.000000 FOR S000002922 Novartis AG CH0012005267 03/05/2024 Elect William T. Winters as Compensation Committee Member CORPORATE GOVERNANCE ISSUER 20565879.000000 0.000000 FOR 20565879.000000 FOR S000002922 Novartis AG CH0012005267 03/05/2024 Appointment of Auditor AUDIT-RELATED ISSUER 20565879.000000 0.000000 FOR 20565879.000000 FOR S000002922 Novartis AG CH0012005267 03/05/2024 Appointment of Independent Proxy CORPORATE GOVERNANCE ISSUER 20565879.000000 0.000000 FOR 20565879.000000 FOR S000002922 Novartis AG CH0012005267 03/05/2024 Transaction of Other Business CORPORATE GOVERNANCE ISSUER 20565879.000000 0.000000 AGAINST 20565879.000000 NONE S000002922 Cencora, Inc. 03073E105 03/12/2024 Election of Director: Ornella Barra DIRECTOR ELECTIONS ISSUER 1245570.000000 0.000000 FOR 1245570.000000 FOR S000002922 Cencora, Inc. 03073E105 03/12/2024 Election of Director: Werner Baumann DIRECTOR ELECTIONS ISSUER 1245570.000000 0.000000 FOR 1245570.000000 FOR S000002922 Cencora, Inc. 03073E105 03/12/2024 Election of Director: Steven H. Collis DIRECTOR ELECTIONS ISSUER 1245570.000000 0.000000 FOR 1245570.000000 FOR S000002922 Cencora, Inc. 03073E105 03/12/2024 Election of Director: D. Mark Durcan DIRECTOR ELECTIONS ISSUER 1245570.000000 0.000000 FOR 1245570.000000 FOR S000002922 Cencora, Inc. 03073E105 03/12/2024 Election of Director: Richard W. Gochnauer DIRECTOR ELECTIONS ISSUER 1245570.000000 0.000000 FOR 1245570.000000 FOR S000002922 Cencora, Inc. 03073E105 03/12/2024 Election of Director: Lon R. Greenberg DIRECTOR ELECTIONS ISSUER 1245570.000000 0.000000 FOR 1245570.000000 FOR S000002922 Cencora, Inc. 03073E105 03/12/2024 Election of Director: Kathleen W. Hyle DIRECTOR ELECTIONS ISSUER 1245570.000000 0.000000 FOR 1245570.000000 FOR S000002922 Cencora, Inc. 03073E105 03/12/2024 Election of Director: Lorence H. Kim, M.D. DIRECTOR ELECTIONS ISSUER 1245570.000000 0.000000 FOR 1245570.000000 FOR S000002922 Cencora, Inc. 03073E105 03/12/2024 Election of Director: Redonda G. Miller, M.D. DIRECTOR ELECTIONS ISSUER 1245570.000000 0.000000 FOR 1245570.000000 FOR S000002922 Cencora, Inc. 03073E105 03/12/2024 Election of Director: Dennis M. Nally DIRECTOR ELECTIONS ISSUER 1245570.000000 0.000000 FOR 1245570.000000 FOR S000002922 Cencora, Inc. 03073E105 03/12/2024 Election of Director: Lauren M. Tyler DIRECTOR ELECTIONS ISSUER 1245570.000000 0.000000 FOR 1245570.000000 FOR S000002922 Cencora, Inc. 03073E105 03/12/2024 Advisory vote to approve the compensation of the Company s named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1245570.000000 0.000000 FOR 1245570.000000 FOR S000002922 Cencora, Inc. 03073E105 03/12/2024 Advisory vote to approve the compensation of the Company s named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1245570.000000 0.000000 FOR 1245570.000000 FOR 1 S000002922 Cencora, Inc. 03073E105 03/12/2024 Ratification of Ernst & Young LLP as the Company s independent registered public accounting firm for fiscal year 2024. AUDIT-RELATED ISSUER 1245570.000000 0.000000 FOR 1245570.000000 FOR S000002922 Cencora, Inc. 03073E105 03/12/2024 Approval of an amendment of the certificate of incorporation to provide for the exculpation of officers as permitted by Delaware law. CORPORATE GOVERNANCE ISSUER 1245570.000000 0.000000 FOR 1245570.000000 FOR S000002922 Cencora, Inc. 03073E105 03/12/2024 Approval of miscellaneous amendments to the certificate of incorporation. CORPORATE GOVERNANCE ISSUER 1245570.000000 0.000000 FOR 1245570.000000 FOR S000002922 Cencora, Inc. 03073E105 03/12/2024 Shareholder proposal regarding voting standard for election of directors. SHAREHOLDER RIGHTS AND DEFENSES SECURITY HOLDER 1245570.000000 0.000000 AGAINST 1245570.000000 FOR S000002922 Karuna Therapeutics, Inc. 48576A100 03/12/2024 To adopt the Agreement and Plan of Merger, dated as of December 22, 2023 (the merger agreement ), among Karuna Therapeutics, Inc. ( Karuna ), Bristol-Myers Squibb Company ( Bristol-Myers Squibb ), and Miramar Merger Sub Inc., a wholly owned subsidiary of Bristol-Myers Squibb Company ( Merger Sub ), pursuant to which, subject to the terms and conditions set forth therein, Merger Sub will be merged with and into Karuna, and Karuna will survive the merger as a wholly owned subsidiary of Bristol-Myers Squibb. EXTRAORDINARY TRANSACTIONS ISSUER 423693.000000 0.000000 FOR 423693.000000 FOR S000002922 Karuna Therapeutics, Inc. 48576A100 03/12/2024 To approve, on an advisory, non-binding basis, certain compensation that will or may be paid by Karuna to its named executive officers that is based on or otherwise relates to the merger of Merger Sub with and into Karuna pursuant to the merger agreement. SECTION 14A SAY-ON-PAY VOTES ISSUER 423693.000000 0.000000 FOR 423693.000000 FOR S000002922 Karuna Therapeutics, Inc. 48576A100 03/12/2024 To approve, on an advisory, non-binding basis, certain compensation that will or may be paid by Karuna to its named executive officers that is based on or otherwise relates to the merger of Merger Sub with and into Karuna pursuant to the merger agreement. SECTION 14A SAY-ON-PAY VOTES ISSUER 423693.000000 0.000000 FOR 423693.000000 FOR 1 S000002922 Karuna Therapeutics, Inc. 48576A100 03/12/2024 To adjourn the special meeting from time to time, if necessary or appropriate, as determined in good faith by the board of directors of Karuna including for the purpose of soliciting additional votes for the approval of the proposal to adopt the merger agreement if there are insufficient votes at the time of the special meeting to approve the proposal to adopt the merger agreement. CORPORATE GOVERNANCE ISSUER 423693.000000 0.000000 FOR 423693.000000 FOR S000002922 Genmab A/S DK0010272202 03/13/2024 Accounts and Reports; Ratification of Board and Management Acts CORPORATE GOVERNANCE ISSUER 2088852.000000 0.000000 FOR 2088852.000000 FOR S000002922 Genmab A/S DK0010272202 03/13/2024 Allocation of Profits/Dividends CAPITAL STRUCTURE ISSUER 2088852.000000 0.000000 FOR 2088852.000000 FOR S000002922 Genmab A/S DK0010272202 03/13/2024 Remuneration Report COMPENSATION ISSUER 2088852.000000 0.000000 FOR 2088852.000000 FOR S000002922 Genmab A/S DK0010272202 03/13/2024 Elect Deirdre P. Connelly DIRECTOR ELECTIONS ISSUER 2088852.000000 0.000000 FOR 2088852.000000 FOR S000002922 Genmab A/S DK0010272202 03/13/2024 Elect Pernille Erenbjerg DIRECTOR ELECTIONS ISSUER 2088852.000000 0.000000 AGAINST 2088852.000000 AGAINST S000002922 Genmab A/S DK0010272202 03/13/2024 Elect Rolf Hoffman DIRECTOR ELECTIONS ISSUER 2088852.000000 0.000000 FOR 2088852.000000 FOR S000002922 Genmab A/S DK0010272202 03/13/2024 Elect Elizabeth O'Farrell DIRECTOR ELECTIONS ISSUER 2088852.000000 0.000000 FOR 2088852.000000 FOR S000002922 Genmab A/S DK0010272202 03/13/2024 Elect Paolo Paoletti DIRECTOR ELECTIONS ISSUER 2088852.000000 0.000000 FOR 2088852.000000 FOR S000002922 Genmab A/S DK0010272202 03/13/2024 Elect Anders Gersel Pedersen DIRECTOR ELECTIONS ISSUER 2088852.000000 0.000000 AGAINST 2088852.000000 AGAINST S000002922 Genmab A/S DK0010272202 03/13/2024 Appointment of Auditor AUDIT-RELATED ISSUER 2088852.000000 0.000000 FOR 2088852.000000 FOR S000002922 Genmab A/S DK0010272202 03/13/2024 Directors' Fees COMPENSATION ISSUER 2088852.000000 0.000000 FOR 2088852.000000 FOR S000002922 Genmab A/S DK0010272202 03/13/2024 Indemnification of Directors CORPORATE GOVERNANCE ISSUER 2088852.000000 0.000000 FOR 2088852.000000 FOR S000002922 Genmab A/S DK0010272202 03/13/2024 Amendments to Articles (Indemnification of Directors) CORPORATE GOVERNANCE ISSUER 2088852.000000 0.000000 FOR 2088852.000000 FOR S000002922 Genmab A/S DK0010272202 03/13/2024 Remuneration Policy COMPENSATION ISSUER 2088852.000000 0.000000 FOR 2088852.000000 FOR S000002922 Genmab A/S DK0010272202 03/13/2024 Authority to Issue Shares and Convertible Debt w/o Preemptive Rights CAPITAL STRUCTURE ISSUER 2088852.000000 0.000000 FOR 2088852.000000 FOR S000002922 Genmab A/S DK0010272202 03/13/2024 Issuance of Warrants w/o Preemptive Rights CAPITAL STRUCTURE ISSUER 2088852.000000 0.000000 FOR 2088852.000000 FOR S000002922 Genmab A/S DK0010272202 03/13/2024 Authority to Repurchase Shares CAPITAL STRUCTURE ISSUER 2088852.000000 0.000000 FOR 2088852.000000 FOR S000002922 Genmab A/S DK0010272202 03/13/2024 Authorization of Legal Formalities CORPORATE GOVERNANCE ISSUER 2088852.000000 0.000000 FOR 2088852.000000 FOR S000002922 Genmab A/S 372303206 03/13/2024 Accounts and Reports; Ratification of Board and Management Acts CORPORATE GOVERNANCE ISSUER 2285855.000000 0.000000 FOR 2285855.000000 FOR S000002922 Genmab A/S 372303206 03/13/2024 Allocation of Profits/Dividends CAPITAL STRUCTURE ISSUER 2285855.000000 0.000000 FOR 2285855.000000 FOR S000002922 Genmab A/S 372303206 03/13/2024 Remuneration Report COMPENSATION ISSUER 2285855.000000 0.000000 FOR 2285855.000000 FOR S000002922 Genmab A/S 372303206 03/13/2024 Elect Deirdre P. Connelly DIRECTOR ELECTIONS ISSUER 2285855.000000 0.000000 FOR 2285855.000000 FOR S000002922 Genmab A/S 372303206 03/13/2024 Elect Pernille Erenbjerg DIRECTOR ELECTIONS ISSUER 2285855.000000 0.000000 ABSTAIN 2285855.000000 AGAINST S000002922 Genmab A/S 372303206 03/13/2024 Elect Rolf Hoffman DIRECTOR ELECTIONS ISSUER 2285855.000000 0.000000 FOR 2285855.000000 FOR S000002922 Genmab A/S 372303206 03/13/2024 Elect Elizabeth O'Farrell DIRECTOR ELECTIONS ISSUER 2285855.000000 0.000000 FOR 2285855.000000 FOR S000002922 Genmab A/S 372303206 03/13/2024 Elect Paolo Paoletti DIRECTOR ELECTIONS ISSUER 2285855.000000 0.000000 FOR 2285855.000000 FOR S000002922 Genmab A/S 372303206 03/13/2024 Elect Anders Gersel Pedersen DIRECTOR ELECTIONS ISSUER 2285855.000000 0.000000 ABSTAIN 2285855.000000 AGAINST S000002922 Genmab A/S 372303206 03/13/2024 Appointment of Auditor AUDIT-RELATED ISSUER 2285855.000000 0.000000 FOR 2285855.000000 FOR S000002922 Genmab A/S 372303206 03/13/2024 Directors' Fees COMPENSATION ISSUER 2285855.000000 0.000000 FOR 2285855.000000 FOR S000002922 Genmab A/S 372303206 03/13/2024 Indemnification of Directors CORPORATE GOVERNANCE ISSUER 2285855.000000 0.000000 FOR 2285855.000000 FOR S000002922 Genmab A/S 372303206 03/13/2024 Amendments to Articles (Indemnification of Directors) CORPORATE GOVERNANCE ISSUER 2285855.000000 0.000000 FOR 2285855.000000 FOR S000002922 Genmab A/S 372303206 03/13/2024 Remuneration Policy COMPENSATION ISSUER 2285855.000000 0.000000 FOR 2285855.000000 FOR S000002922 Genmab A/S 372303206 03/13/2024 Authority to Issue Shares and Convertible Debt w/o Preemptive Rights CAPITAL STRUCTURE ISSUER 2285855.000000 0.000000 FOR 2285855.000000 FOR S000002922 Genmab A/S 372303206 03/13/2024 Issuance of Warrants w/o Preemptive Rights CAPITAL STRUCTURE ISSUER 2285855.000000 0.000000 FOR 2285855.000000 FOR S000002922 Genmab A/S 372303206 03/13/2024 Authority to Repurchase Shares CAPITAL STRUCTURE ISSUER 2285855.000000 0.000000 FOR 2285855.000000 FOR S000002922 Genmab A/S 372303206 03/13/2024 Authorization of Legal Formalities CORPORATE GOVERNANCE ISSUER 2285855.000000 0.000000 FOR 2285855.000000 FOR S000002922 Agilent Technologies, Inc. 00846U101 03/14/2024 Election of Directors: To elect four directors to a three-year term. At the annual meeting, the Board of Directors intends to present the following nominees for election as directors: Mala Anand DIRECTOR ELECTIONS ISSUER 3576445.000000 0.000000 FOR 3576445.000000 FOR S000002922 Agilent Technologies, Inc. 00846U101 03/14/2024 Election of Directors: To elect four directors to a three-year term. At the annual meeting, the Board of Directors intends to present the following nominees for election as directors: Koh Boon Hwee DIRECTOR ELECTIONS ISSUER 3576445.000000 0.000000 FOR 3576445.000000 FOR S000002922 Agilent Technologies, Inc. 00846U101 03/14/2024 Election of Directors: To elect four directors to a three-year term. At the annual meeting, the Board of Directors intends to present the following nominees for election as directors: Michael R. McMullen DIRECTOR ELECTIONS ISSUER 3576445.000000 0.000000 FOR 3576445.000000 FOR S000002922 Agilent Technologies, Inc. 00846U101 03/14/2024 Election of Directors: To elect four directors to a three-year term. At the annual meeting, the Board of Directors intends to present the following nominees for election as directors: Daniel K. Podolsky, M.D. DIRECTOR ELECTIONS ISSUER 3576445.000000 0.000000 FOR 3576445.000000 FOR S000002922 Agilent Technologies, Inc. 00846U101 03/14/2024 To approve, on a non-binding advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 3576445.000000 0.000000 FOR 3576445.000000 FOR S000002922 Agilent Technologies, Inc. 00846U101 03/14/2024 To approve, on a non-binding advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 3576445.000000 0.000000 FOR 3576445.000000 FOR 1 S000002922 Agilent Technologies, Inc. 00846U101 03/14/2024 To ratify the Audit and Finance Committee's appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm. AUDIT-RELATED ISSUER 3576445.000000 0.000000 FOR 3576445.000000 FOR S000002922 Agilent Technologies, Inc. 00846U101 03/14/2024 To vote on a shareholder proposal regarding simple majority vote, if properly presented at the meeting. SHAREHOLDER RIGHTS AND DEFENSES SECURITY HOLDER 3576445.000000 0.000000 FOR 3576445.000000 NONE S000002922 Novo Nordisk A/S DK0062498333 03/21/2024 Accounts and Reports CORPORATE GOVERNANCE ISSUER 4946683.000000 0.000000 FOR 4946683.000000 FOR S000002922 Novo Nordisk A/S DK0062498333 03/21/2024 Allocation of Profits/Dividends CAPITAL STRUCTURE ISSUER 4946683.000000 0.000000 FOR 4946683.000000 FOR S000002922 Novo Nordisk A/S DK0062498333 03/21/2024 Remuneration Report COMPENSATION ISSUER 4946683.000000 0.000000 FOR 4946683.000000 FOR S000002922 Novo Nordisk A/S DK0062498333 03/21/2024 Directors' Fees COMPENSATION ISSUER 4946683.000000 0.000000 FOR 4946683.000000 FOR S000002922 Novo Nordisk A/S DK0062498333 03/21/2024 Indemnification of the Board of Directors CORPORATE GOVERNANCE ISSUER 4946683.000000 0.000000 FOR 4946683.000000 FOR S000002922 Novo Nordisk A/S DK0062498333 03/21/2024 Indemnification of the Executive Management CORPORATE GOVERNANCE ISSUER 4946683.000000 0.000000 FOR 4946683.000000 FOR S000002922 Novo Nordisk A/S DK0062498333 03/21/2024 Amendments to Articles CORPORATE GOVERNANCE ISSUER 4946683.000000 0.000000 FOR 4946683.000000 FOR S000002922 Novo Nordisk A/S DK0062498333 03/21/2024 Remuneration Policy COMPENSATION ISSUER 4946683.000000 0.000000 FOR 4946683.000000 FOR S000002922 Novo Nordisk A/S DK0062498333 03/21/2024 Election of Helge Lund as Chair DIRECTOR ELECTIONS ISSUER 4946683.000000 0.000000 FOR 4946683.000000 FOR S000002922 Novo Nordisk A/S DK0062498333 03/21/2024 Election of Henrik Poulsen as Vice Chair DIRECTOR ELECTIONS ISSUER 4946683.000000 0.000000 FOR 4946683.000000 FOR S000002922 Novo Nordisk A/S DK0062498333 03/21/2024 Elect Laurence Debroux DIRECTOR ELECTIONS ISSUER 4946683.000000 0.000000 FOR 4946683.000000 FOR S000002922 Novo Nordisk A/S DK0062498333 03/21/2024 Elect Andreas Fibig DIRECTOR ELECTIONS ISSUER 4946683.000000 0.000000 FOR 4946683.000000 FOR S000002922 Novo Nordisk A/S DK0062498333 03/21/2024 Elect Sylvie Gregoire DIRECTOR ELECTIONS ISSUER 4946683.000000 0.000000 FOR 4946683.000000 FOR S000002922 Novo Nordisk A/S DK0062498333 03/21/2024 Elect Kasim Kutay DIRECTOR ELECTIONS ISSUER 4946683.000000 0.000000 FOR 4946683.000000 FOR S000002922 Novo Nordisk A/S DK0062498333 03/21/2024 Elect Christina Choi Lai Law DIRECTOR ELECTIONS ISSUER 4946683.000000 0.000000 FOR 4946683.000000 FOR S000002922 Novo Nordisk A/S DK0062498333 03/21/2024 Elect Martin Mackay DIRECTOR ELECTIONS ISSUER 4946683.000000 0.000000 FOR 4946683.000000 FOR S000002922 Novo Nordisk A/S DK0062498333 03/21/2024 Appointment of Auditor AUDIT-RELATED ISSUER 4946683.000000 0.000000 FOR 4946683.000000 FOR S000002922 Novo Nordisk A/S DK0062498333 03/21/2024 Cancellation of Shares CAPITAL STRUCTURE ISSUER 4946683.000000 0.000000 FOR 4946683.000000 FOR S000002922 Novo Nordisk A/S DK0062498333 03/21/2024 Authority to Repurchase Shares CAPITAL STRUCTURE ISSUER 4946683.000000 0.000000 FOR 4946683.000000 FOR S000002922 Novo Nordisk A/S DK0062498333 03/21/2024 Authority to Issue Shares w/ or w/o Preemptive Rights CAPITAL STRUCTURE ISSUER 4946683.000000 0.000000 FOR 4946683.000000 FOR S000002922 CHUGAI PHARMACEUTICAL CO.,LTD. JP3519400000 03/28/2024 Allocation of Profits/Dividends CAPITAL STRUCTURE ISSUER 22219500.000000 0.000000 FOR 22219500.000000 FOR S000002922 CHUGAI PHARMACEUTICAL CO.,LTD. JP3519400000 03/28/2024 Amendments to Articles CORPORATE GOVERNANCE ISSUER 22219500.000000 0.000000 FOR 22219500.000000 FOR S000002922 CHUGAI PHARMACEUTICAL CO.,LTD. JP3519400000 03/28/2024 Elect Osamu Okuda DIRECTOR ELECTIONS ISSUER 22219500.000000 0.000000 FOR 22219500.000000 FOR S000002922 CHUGAI PHARMACEUTICAL CO.,LTD. JP3519400000 03/28/2024 Elect Iwaaki Taniguchi DIRECTOR ELECTIONS ISSUER 22219500.000000 0.000000 FOR 22219500.000000 FOR S000002922 CHUGAI PHARMACEUTICAL CO.,LTD. JP3519400000 03/28/2024 Elect Hitoshi Iikura DIRECTOR ELECTIONS ISSUER 22219500.000000 0.000000 FOR 22219500.000000 FOR S000002922 CHUGAI PHARMACEUTICAL CO.,LTD. JP3519400000 03/28/2024 Elect Mariko Momoi DIRECTOR ELECTIONS ISSUER 22219500.000000 0.000000 FOR 22219500.000000 FOR S000002922 CHUGAI PHARMACEUTICAL CO.,LTD. JP3519400000 03/28/2024 Elect Fumio Tateishi DIRECTOR ELECTIONS ISSUER 22219500.000000 0.000000 FOR 22219500.000000 FOR S000002922 CHUGAI PHARMACEUTICAL CO.,LTD. JP3519400000 03/28/2024 Elect Hideo Teramoto DIRECTOR ELECTIONS ISSUER 22219500.000000 0.000000 FOR 22219500.000000 FOR S000002922 CHUGAI PHARMACEUTICAL CO.,LTD. JP3519400000 03/28/2024 Elect Christoph Franz DIRECTOR ELECTIONS ISSUER 22219500.000000 0.000000 FOR 22219500.000000 FOR S000002922 CHUGAI PHARMACEUTICAL CO.,LTD. JP3519400000 03/28/2024 Elect James H. Sabry DIRECTOR ELECTIONS ISSUER 22219500.000000 0.000000 FOR 22219500.000000 FOR S000002922 CHUGAI PHARMACEUTICAL CO.,LTD. JP3519400000 03/28/2024 Elect Teresa A. Graham DIRECTOR ELECTIONS ISSUER 22219500.000000 0.000000 FOR 22219500.000000 FOR S000002922 CHUGAI PHARMACEUTICAL CO.,LTD. JP3519400000 03/28/2024 Elect Kenichi Masuda DIRECTOR ELECTIONS ISSUER 22219500.000000 0.000000 FOR 22219500.000000 FOR S000002922 CHUGAI PHARMACEUTICAL CO.,LTD. JP3519400000 03/28/2024 Elect Mami Yunoki @ Mami Kato DIRECTOR ELECTIONS ISSUER 22219500.000000 0.000000 FOR 22219500.000000 FOR S000002922 CHUGAI PHARMACEUTICAL CO.,LTD. JP3519400000 03/28/2024 Statutory Auditors' Fees COMPENSATION ISSUER 22219500.000000 0.000000 FOR 22219500.000000 FOR S000002922 Otsuka Holdings Co., Ltd. JP3188220002 03/28/2024 Elect Ichiro Otsuka DIRECTOR ELECTIONS ISSUER 7660100.000000 0.000000 FOR 7660100.000000 FOR S000002922 Otsuka Holdings Co., Ltd. JP3188220002 03/28/2024 Elect Tatsuo Higuchi DIRECTOR ELECTIONS ISSUER 7660100.000000 0.000000 FOR 7660100.000000 FOR S000002922 Otsuka Holdings Co., Ltd. JP3188220002 03/28/2024 Elect Makoto Inoue DIRECTOR ELECTIONS ISSUER 7660100.000000 0.000000 FOR 7660100.000000 FOR S000002922 Otsuka Holdings Co., Ltd. JP3188220002 03/28/2024 Elect Yoshiro Matsuo DIRECTOR ELECTIONS ISSUER 7660100.000000 0.000000 FOR 7660100.000000 FOR S000002922 Otsuka Holdings Co., Ltd. JP3188220002 03/28/2024 Elect Yuko Makino DIRECTOR ELECTIONS ISSUER 7660100.000000 0.000000 FOR 7660100.000000 FOR S000002922 Otsuka Holdings Co., Ltd. JP3188220002 03/28/2024 Elect Shuichi Takagi DIRECTOR ELECTIONS ISSUER 7660100.000000 0.000000 FOR 7660100.000000 FOR S000002922 Otsuka Holdings Co., Ltd. JP3188220002 03/28/2024 Elect Masayuki Kobayashi DIRECTOR ELECTIONS ISSUER 7660100.000000 0.000000 FOR 7660100.000000 FOR S000002922 Otsuka Holdings Co., Ltd. JP3188220002 03/28/2024 Elect Noriko Tojo DIRECTOR ELECTIONS ISSUER 7660100.000000 0.000000 FOR 7660100.000000 FOR S000002922 Otsuka Holdings Co., Ltd. JP3188220002 03/28/2024 Elect Yukio Matsutani DIRECTOR ELECTIONS ISSUER 7660100.000000 0.000000 FOR 7660100.000000 FOR S000002922 Otsuka Holdings Co., Ltd. JP3188220002 03/28/2024 Elect Ko Sekiguchi DIRECTOR ELECTIONS ISSUER 7660100.000000 0.000000 FOR 7660100.000000 FOR S000002922 Otsuka Holdings Co., Ltd. JP3188220002 03/28/2024 Elect Yoshihisa Aoki DIRECTOR ELECTIONS ISSUER 7660100.000000 0.000000 FOR 7660100.000000 FOR S000002922 Otsuka Holdings Co., Ltd. JP3188220002 03/28/2024 Elect Mayo Mita @ Mayo Nakatsuka DIRECTOR ELECTIONS ISSUER 7660100.000000 0.000000 FOR 7660100.000000 FOR S000002922 Otsuka Holdings Co., Ltd. JP3188220002 03/28/2024 Elect Tatsuaki Kitachi DIRECTOR ELECTIONS ISSUER 7660100.000000 0.000000 FOR 7660100.000000 FOR S000002922 Otsuka Holdings Co., Ltd. JP3188220002 03/28/2024 Amendment to the Restricted Stock Plan COMPENSATION ISSUER 7660100.000000 0.000000 FOR 7660100.000000 FOR S000002922 AstraZeneca plc GB0009895292 04/11/2024 Accounts and Reports CORPORATE GOVERNANCE ISSUER 18553764.000000 0.000000 FOR 18553764.000000 FOR S000002922 AstraZeneca plc GB0009895292 04/11/2024 Allocation of Profits/Dividends CAPITAL STRUCTURE ISSUER 18553764.000000 0.000000 FOR 18553764.000000 FOR S000002922 AstraZeneca plc GB0009895292 04/11/2024 Appointment of Auditor AUDIT-RELATED ISSUER 18553764.000000 0.000000 FOR 18553764.000000 FOR S000002922 AstraZeneca plc GB0009895292 04/11/2024 Authority to Set Auditor's Fees AUDIT-RELATED ISSUER 18553764.000000 0.000000 FOR 18553764.000000 FOR S000002922 AstraZeneca plc GB0009895292 04/11/2024 Elect Michel Demare DIRECTOR ELECTIONS ISSUER 18553764.000000 0.000000 FOR 18553764.000000 FOR S000002922 AstraZeneca plc GB0009895292 04/11/2024 Elect Pascal Soriot DIRECTOR ELECTIONS ISSUER 18553764.000000 0.000000 FOR 18553764.000000 FOR S000002922 AstraZeneca plc GB0009895292 04/11/2024 Elect Aradhana Sarin DIRECTOR ELECTIONS ISSUER 18553764.000000 0.000000 FOR 18553764.000000 FOR S000002922 AstraZeneca plc GB0009895292 04/11/2024 Elect Philip Broadley DIRECTOR ELECTIONS ISSUER 18553764.000000 0.000000 FOR 18553764.000000 FOR S000002922 AstraZeneca plc GB0009895292 04/11/2024 Elect Euan Ashley DIRECTOR ELECTIONS ISSUER 18553764.000000 0.000000 FOR 18553764.000000 FOR S000002922 AstraZeneca plc GB0009895292 04/11/2024 Elect Deborah DiSanzo DIRECTOR ELECTIONS ISSUER 18553764.000000 0.000000 FOR 18553764.000000 FOR S000002922 AstraZeneca plc GB0009895292 04/11/2024 Elect Diana Layfield DIRECTOR ELECTIONS ISSUER 18553764.000000 0.000000 FOR 18553764.000000 FOR S000002922 AstraZeneca plc GB0009895292 04/11/2024 Elect Anna Manz DIRECTOR ELECTIONS ISSUER 18553764.000000 0.000000 FOR 18553764.000000 FOR S000002922 AstraZeneca plc GB0009895292 04/11/2024 Elect Sherilyn S. McCoy DIRECTOR ELECTIONS ISSUER 18553764.000000 0.000000 FOR 18553764.000000 FOR S000002922 AstraZeneca plc GB0009895292 04/11/2024 Elect Tony Mok DIRECTOR ELECTIONS ISSUER 18553764.000000 0.000000 FOR 18553764.000000 FOR S000002922 AstraZeneca plc GB0009895292 04/11/2024 Elect Nazneen Rahman DIRECTOR ELECTIONS ISSUER 18553764.000000 0.000000 FOR 18553764.000000 FOR S000002922 AstraZeneca plc GB0009895292 04/11/2024 Elect Andreas Rummelt DIRECTOR ELECTIONS ISSUER 18553764.000000 0.000000 FOR 18553764.000000 FOR S000002922 AstraZeneca plc GB0009895292 04/11/2024 Elect Marcus Wallenberg DIRECTOR ELECTIONS ISSUER 18553764.000000 0.000000 AGAINST 18553764.000000 AGAINST S000002922 AstraZeneca plc GB0009895292 04/11/2024 Remuneration Report COMPENSATION ISSUER 18553764.000000 0.000000 FOR 18553764.000000 FOR S000002922 AstraZeneca plc GB0009895292 04/11/2024 Remuneration Policy COMPENSATION ISSUER 18553764.000000 0.000000 FOR 18553764.000000 FOR S000002922 AstraZeneca plc GB0009895292 04/11/2024 Amendment to Performance Share Plan COMPENSATION ISSUER 18553764.000000 0.000000 FOR 18553764.000000 FOR S000002922 AstraZeneca plc GB0009895292 04/11/2024 Authorisation of Political Donations OTHER SOCIAL ISSUES ISSUER 18553764.000000 0.000000 FOR 18553764.000000 FOR S000002922 AstraZeneca plc GB0009895292 04/11/2024 Authority to Issue Shares w/ Preemptive Rights CAPITAL STRUCTURE ISSUER 18553764.000000 0.000000 FOR 18553764.000000 FOR S000002922 AstraZeneca plc GB0009895292 04/11/2024 Authority to Issue Shares w/o Preemptive Rights CAPITAL STRUCTURE ISSUER 18553764.000000 0.000000 FOR 18553764.000000 FOR S000002922 AstraZeneca plc GB0009895292 04/11/2024 Authority to Issue Shares w/o Preemptive Rights (Specified Capital Investment) CAPITAL STRUCTURE ISSUER 18553764.000000 0.000000 FOR 18553764.000000 FOR S000002922 AstraZeneca plc GB0009895292 04/11/2024 Authority to Repurchase Shares CAPITAL STRUCTURE ISSUER 18553764.000000 0.000000 FOR 18553764.000000 FOR S000002922 AstraZeneca plc GB0009895292 04/11/2024 Authority to Set General Meeting Notice Period at 14 Days CORPORATE GOVERNANCE ISSUER 18553764.000000 0.000000 FOR 18553764.000000 FOR S000002922 IQVIA Holdings Inc. 46266C105 04/16/2024 The election of six directors: Ari Bousbib DIRECTOR ELECTIONS ISSUER 1696452.000000 0.000000 FOR 1696452.000000 FOR S000002922 IQVIA Holdings Inc. 46266C105 04/16/2024 The election of six directors: Carol J. Burt DIRECTOR ELECTIONS ISSUER 1696452.000000 0.000000 FOR 1696452.000000 FOR S000002922 IQVIA Holdings Inc. 46266C105 04/16/2024 The election of six directors: Colleen A. Goggins DIRECTOR ELECTIONS ISSUER 1696452.000000 0.000000 FOR 1696452.000000 FOR S000002922 IQVIA Holdings Inc. 46266C105 04/16/2024 The election of six directors: John M. Leonard DIRECTOR ELECTIONS ISSUER 1696452.000000 0.000000 FOR 1696452.000000 FOR S000002922 IQVIA Holdings Inc. 46266C105 04/16/2024 The election of six directors: Todd B. Sisitsky DIRECTOR ELECTIONS ISSUER 1696452.000000 0.000000 FOR 1696452.000000 FOR S000002922 IQVIA Holdings Inc. 46266C105 04/16/2024 The election of six directors: Sheila A. Stamps DIRECTOR ELECTIONS ISSUER 1696452.000000 0.000000 FOR 1696452.000000 FOR S000002922 IQVIA Holdings Inc. 46266C105 04/16/2024 Approve an advisory (non-binding) resolution to approve IQVIA's executive compensation (say-on-pay). SECTION 14A SAY-ON-PAY VOTES ISSUER 1696452.000000 0.000000 FOR 1696452.000000 FOR S000002922 IQVIA Holdings Inc. 46266C105 04/16/2024 Approve an advisory (non-binding) resolution to approve IQVIA's executive compensation (say-on-pay). SECTION 14A SAY-ON-PAY VOTES ISSUER 1696452.000000 0.000000 FOR 1696452.000000 FOR 1 S000002922 IQVIA Holdings Inc. 46266C105 04/16/2024 If properly presented, a stockholder proposal concerning political spending. OTHER SOCIAL ISSUES SECURITY HOLDER 1696452.000000 0.000000 AGAINST 1696452.000000 FOR S000002922 IQVIA Holdings Inc. 46266C105 04/16/2024 Ratification of the appointment of PricewaterhouseCoopers LLP as IQVIA's independent registered public accounting firm for 2024. AUDIT-RELATED ISSUER 1696452.000000 0.000000 FOR 1696452.000000 FOR S000002922 Humana Inc. 444859102 04/18/2024 Election of Director: Raquel C. Bono, M.D. DIRECTOR ELECTIONS ISSUER 2411897.000000 0.000000 FOR 2411897.000000 FOR S000002922 Humana Inc. 444859102 04/18/2024 Election of Director: Bruce D. Broussard DIRECTOR ELECTIONS ISSUER 2411897.000000 0.000000 FOR 2411897.000000 FOR S000002922 Humana Inc. 444859102 04/18/2024 Election of Director: Frank A. D'Amelio DIRECTOR ELECTIONS ISSUER 2411897.000000 0.000000 FOR 2411897.000000 FOR S000002922 Humana Inc. 444859102 04/18/2024 Election of Director: David T. Feinberg, M.D. DIRECTOR ELECTIONS ISSUER 2411897.000000 0.000000 FOR 2411897.000000 FOR S000002922 Humana Inc. 444859102 04/18/2024 Election of Director: Wayne A. I. Frederick, M.D. DIRECTOR ELECTIONS ISSUER 2411897.000000 0.000000 FOR 2411897.000000 FOR S000002922 Humana Inc. 444859102 04/18/2024 Election of Director: John W. Garratt DIRECTOR ELECTIONS ISSUER 2411897.000000 0.000000 FOR 2411897.000000 FOR S000002922 Humana Inc. 444859102 04/18/2024 Election of Director: Kurt J. Hilzinger DIRECTOR ELECTIONS ISSUER 2411897.000000 0.000000 FOR 2411897.000000 FOR S000002922 Humana Inc. 444859102 04/18/2024 Election of Director: Karen W. Katz DIRECTOR ELECTIONS ISSUER 2411897.000000 0.000000 FOR 2411897.000000 FOR S000002922 Humana Inc. 444859102 04/18/2024 Election of Director: Marcy S. Klevorn DIRECTOR ELECTIONS ISSUER 2411897.000000 0.000000 FOR 2411897.000000 FOR S000002922 Humana Inc. 444859102 04/18/2024 Election of Director: Jorge S. Mesquita DIRECTOR ELECTIONS ISSUER 2411897.000000 0.000000 FOR 2411897.000000 FOR S000002922 Humana Inc. 444859102 04/18/2024 Election of Director: Brad D. Smith DIRECTOR ELECTIONS ISSUER 2411897.000000 0.000000 FOR 2411897.000000 FOR S000002922 Humana Inc. 444859102 04/18/2024 The ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm. AUDIT-RELATED ISSUER 2411897.000000 0.000000 FOR 2411897.000000 FOR S000002922 Humana Inc. 444859102 04/18/2024 Non-binding advisory vote for the approval of the compensation of the named executive officers as disclosed in the 2024 proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 2411897.000000 0.000000 FOR 2411897.000000 FOR S000002922 Humana Inc. 444859102 04/18/2024 Non-binding advisory vote for the approval of the compensation of the named executive officers as disclosed in the 2024 proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 2411897.000000 0.000000 FOR 2411897.000000 FOR 1 S000002922 Humana Inc. 444859102 04/18/2024 The approval of the amendment to the Company's Restated Certificate of Incorporation to limit the liability of certain officers of the Company as permitted by Delaware law. CORPORATE GOVERNANCE ISSUER 2411897.000000 0.000000 FOR 2411897.000000 FOR S000002922 Humana Inc. 444859102 04/18/2024 The approval of the amendment to the Company's Restated Certificate of Incorporation to eliminate supermajority voting requirement in connection with certain transactions. SHAREHOLDER RIGHTS AND DEFENSES ISSUER 2411897.000000 0.000000 FOR 2411897.000000 FOR S000002922 Humana Inc. 444859102 04/18/2024 The stockholder proposal on simple majority vote, if properly presented at the meeting. SHAREHOLDER RIGHTS AND DEFENSES SECURITY HOLDER 2411897.000000 0.000000 AGAINST 2411897.000000 FOR S000002922 Tecan Group AG CH0012100191 04/18/2024 Accounts and Reports CORPORATE GOVERNANCE ISSUER 236453.000000 0.000000 TAKENOACTION 236453.000000 NONE S000002922 Tecan Group AG CH0012100191 04/18/2024 Report on Non-Financial Matters CORPORATE GOVERNANCE ISSUER 236453.000000 0.000000 TAKENOACTION 236453.000000 NONE S000002922 Tecan Group AG CH0012100191 04/18/2024 Allocation of Profits CAPITAL STRUCTURE ISSUER 236453.000000 0.000000 TAKENOACTION 236453.000000 NONE S000002922 Tecan Group AG CH0012100191 04/18/2024 Dividend from Reserves CAPITAL STRUCTURE ISSUER 236453.000000 0.000000 TAKENOACTION 236453.000000 NONE S000002922 Tecan Group AG CH0012100191 04/18/2024 Ratification of Board and Management Acts CORPORATE GOVERNANCE ISSUER 236453.000000 0.000000 TAKENOACTION 236453.000000 NONE S000002922 Tecan Group AG CH0012100191 04/18/2024 Amendments to Articles (Company Purpose) CORPORATE GOVERNANCE ISSUER 236453.000000 0.000000 TAKENOACTION 236453.000000 NONE S000002922 Tecan Group AG CH0012100191 04/18/2024 Amendments to Articles (General Meeting and Shareholder Rights) CORPORATE GOVERNANCE ISSUER 236453.000000 0.000000 TAKENOACTION 236453.000000 NONE S000002922 Tecan Group AG CH0012100191 04/18/2024 Amendments to Articles (Virtual Meeting) CORPORATE GOVERNANCE ISSUER 236453.000000 0.000000 TAKENOACTION 236453.000000 NONE S000002922 Tecan Group AG CH0012100191 04/18/2024 Increase in Board Size CORPORATE GOVERNANCE ISSUER 236453.000000 0.000000 TAKENOACTION 236453.000000 NONE S000002922 Tecan Group AG CH0012100191 04/18/2024 Amendments to Articles (Miscellaneous) CORPORATE GOVERNANCE ISSUER 236453.000000 0.000000 TAKENOACTION 236453.000000 NONE S000002922 Tecan Group AG CH0012100191 04/18/2024 Elect Monica Manotas DIRECTOR ELECTIONS ISSUER 236453.000000 0.000000 TAKENOACTION 236453.000000 NONE S000002922 Tecan Group AG CH0012100191 04/18/2024 Elect Lukas Braunschweiler DIRECTOR ELECTIONS ISSUER 236453.000000 0.000000 TAKENOACTION 236453.000000 NONE S000002922 Tecan Group AG CH0012100191 04/18/2024 Elect Myra Eskes DIRECTOR ELECTIONS ISSUER 236453.000000 0.000000 TAKENOACTION 236453.000000 NONE S000002922 Tecan Group AG CH0012100191 04/18/2024 Elect Oliver S. Fetzer DIRECTOR ELECTIONS ISSUER 236453.000000 0.000000 TAKENOACTION 236453.000000 NONE S000002922 Tecan Group AG CH0012100191 04/18/2024 Elect Matthias Gillner DIRECTOR ELECTIONS ISSUER 236453.000000 0.000000 TAKENOACTION 236453.000000 NONE S000002922 Tecan Group AG CH0012100191 04/18/2024 Elect Karen Hubscher DIRECTOR ELECTIONS ISSUER 236453.000000 0.000000 TAKENOACTION 236453.000000 NONE S000002922 Tecan Group AG CH0012100191 04/18/2024 Elect Christa Kreuzburg DIRECTOR ELECTIONS ISSUER 236453.000000 0.000000 TAKENOACTION 236453.000000 NONE S000002922 Tecan Group AG CH0012100191 04/18/2024 Elect Daniel R. Marshak DIRECTOR ELECTIONS ISSUER 236453.000000 0.000000 TAKENOACTION 236453.000000 NONE S000002922 Tecan Group AG CH0012100191 04/18/2024 Appoint Lukas Braunschweiler as Board Chair CORPORATE GOVERNANCE ISSUER 236453.000000 0.000000 TAKENOACTION 236453.000000 NONE S000002922 Tecan Group AG CH0012100191 04/18/2024 Elect Myra Eskes as Compensation Committee Member CORPORATE GOVERNANCE ISSUER 236453.000000 0.000000 TAKENOACTION 236453.000000 NONE S000002922 Tecan Group AG CH0012100191 04/18/2024 Elect Oliver S. Fetzer as Compensation Committee Member CORPORATE GOVERNANCE ISSUER 236453.000000 0.000000 TAKENOACTION 236453.000000 NONE S000002922 Tecan Group AG CH0012100191 04/18/2024 Elect Christa Kreuzburg as Compensation Committee Member CORPORATE GOVERNANCE ISSUER 236453.000000 0.000000 TAKENOACTION 236453.000000 NONE S000002922 Tecan Group AG CH0012100191 04/18/2024 Elect Daniel R. Marshak as Compensation Committee Member CORPORATE GOVERNANCE ISSUER 236453.000000 0.000000 TAKENOACTION 236453.000000 NONE S000002922 Tecan Group AG CH0012100191 04/18/2024 Appointment of Auditor AUDIT-RELATED ISSUER 236453.000000 0.000000 TAKENOACTION 236453.000000 NONE S000002922 Tecan Group AG CH0012100191 04/18/2024 Appointment of Independent Proxy CORPORATE GOVERNANCE ISSUER 236453.000000 0.000000 TAKENOACTION 236453.000000 NONE S000002922 Tecan Group AG CH0012100191 04/18/2024 Compensation Report COMPENSATION ISSUER 236453.000000 0.000000 TAKENOACTION 236453.000000 NONE S000002922 Tecan Group AG CH0012100191 04/18/2024 Board Compensation COMPENSATION ISSUER 236453.000000 0.000000 TAKENOACTION 236453.000000 NONE S000002922 Tecan Group AG CH0012100191 04/18/2024 Executive Compensation (Total) COMPENSATION ISSUER 236453.000000 0.000000 TAKENOACTION 236453.000000 NONE S000002922 Tecan Group AG CH0012100191 04/18/2024 Transaction of Other Business CORPORATE GOVERNANCE ISSUER 236453.000000 0.000000 TAKENOACTION 236453.000000 NONE S000002922 DiaSorin S.p.A. IT0003492391 04/24/2024 Accounts and Reports CORPORATE GOVERNANCE ISSUER 552359.000000 0.000000 FOR 552359.000000 FOR S000002922 DiaSorin S.p.A. IT0003492391 04/24/2024 Allocation of Dividends CAPITAL STRUCTURE ISSUER 552359.000000 0.000000 FOR 552359.000000 FOR S000002922 DiaSorin S.p.A. IT0003492391 04/24/2024 Remuneration Policy COMPENSATION ISSUER 552359.000000 0.000000 AGAINST 552359.000000 AGAINST S000002922 DiaSorin S.p.A. IT0003492391 04/24/2024 Remuneration Report COMPENSATION ISSUER 552359.000000 0.000000 FOR 552359.000000 FOR S000002922 DiaSorin S.p.A. IT0003492391 04/24/2024 Appointment of Auditor and Authority to Set Fees AUDIT-RELATED ISSUER 552359.000000 0.000000 FOR 552359.000000 FOR S000002922 HCA Healthcare, Inc. 40412C101 04/25/2024 Election of Director: Thomas F. Frist III DIRECTOR ELECTIONS ISSUER 2719849.000000 0.000000 FOR 2719849.000000 FOR S000002922 HCA Healthcare, Inc. 40412C101 04/25/2024 Election of Director: Samuel N. Hazen DIRECTOR ELECTIONS ISSUER 2719849.000000 0.000000 FOR 2719849.000000 FOR S000002922 HCA Healthcare, Inc. 40412C101 04/25/2024 Election of Director: Meg G. Crofton DIRECTOR ELECTIONS ISSUER 2719849.000000 0.000000 FOR 2719849.000000 FOR S000002922 HCA Healthcare, Inc. 40412C101 04/25/2024 Election of Director: Robert J. Dennis DIRECTOR ELECTIONS ISSUER 2719849.000000 0.000000 FOR 2719849.000000 FOR S000002922 HCA Healthcare, Inc. 40412C101 04/25/2024 Election of Director: Nancy-Ann DeParle DIRECTOR ELECTIONS ISSUER 2719849.000000 0.000000 FOR 2719849.000000 FOR S000002922 HCA Healthcare, Inc. 40412C101 04/25/2024 Election of Director: William R. Frist DIRECTOR ELECTIONS ISSUER 2719849.000000 0.000000 FOR 2719849.000000 FOR S000002922 HCA Healthcare, Inc. 40412C101 04/25/2024 Election of Director: Hugh F. Johnston DIRECTOR ELECTIONS ISSUER 2719849.000000 0.000000 AGAINST 2719849.000000 AGAINST S000002922 HCA Healthcare, Inc. 40412C101 04/25/2024 Election of Director: Michael W. Michelson DIRECTOR ELECTIONS ISSUER 2719849.000000 0.000000 FOR 2719849.000000 FOR S000002922 HCA Healthcare, Inc. 40412C101 04/25/2024 Election of Director: Wayne J. Riley, M.D. DIRECTOR ELECTIONS ISSUER 2719849.000000 0.000000 FOR 2719849.000000 FOR S000002922 HCA Healthcare, Inc. 40412C101 04/25/2024 Election of Director: Andrea B. Smith DIRECTOR ELECTIONS ISSUER 2719849.000000 0.000000 FOR 2719849.000000 FOR S000002922 HCA Healthcare, Inc. 40412C101 04/25/2024 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2024. AUDIT-RELATED ISSUER 2719849.000000 0.000000 FOR 2719849.000000 FOR S000002922 HCA Healthcare, Inc. 40412C101 04/25/2024 Advisory vote to approve named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 2719849.000000 0.000000 FOR 2719849.000000 FOR S000002922 HCA Healthcare, Inc. 40412C101 04/25/2024 Advisory vote to approve named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 2719849.000000 0.000000 FOR 2719849.000000 FOR 1 S000002922 HCA Healthcare, Inc. 40412C101 04/25/2024 Advisory vote to approve the frequency of future advisory votes to approve named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 2719849.000000 0.000000 ONE YEAR 2719849.000000 FOR S000002922 HCA Healthcare, Inc. 40412C101 04/25/2024 Advisory vote to approve the frequency of future advisory votes to approve named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 2719849.000000 0.000000 ONE YEAR 2719849.000000 FOR 1 S000002922 HCA Healthcare, Inc. 40412C101 04/25/2024 Stockholder proposal, if properly presented at the meeting, regarding report on risk mitigation regarding state restrictions for emergency abortions. OTHER SOCIAL ISSUES SECURITY HOLDER 2719849.000000 0.000000 AGAINST 2719849.000000 FOR S000002922 HCA Healthcare, Inc. 40412C101 04/25/2024 Stockholder proposal, if properly presented at the meeting, regarding report on patient feedback regarding quality of care. OTHER SOCIAL ISSUES SECURITY HOLDER 2719849.000000 0.000000 AGAINST 2719849.000000 FOR S000002922 HCA Healthcare, Inc. 40412C101 04/25/2024 Stockholder proposal, if properly presented at the meeting, regarding report on maternal health outcomes. OTHER SOCIAL ISSUES SECURITY HOLDER 2719849.000000 0.000000 AGAINST 2719849.000000 FOR S000002922 Pfizer Inc. 717081103 04/25/2024 Election of Director: Ronald E. Blaylock DIRECTOR ELECTIONS ISSUER 48436030.000000 0.000000 FOR 48436030.000000 FOR S000002922 Pfizer Inc. 717081103 04/25/2024 Election of Director: Albert Bourla DIRECTOR ELECTIONS ISSUER 48436030.000000 0.000000 FOR 48436030.000000 FOR S000002922 Pfizer Inc. 717081103 04/25/2024 Election of Director: Susan Desmond-Hellmann DIRECTOR ELECTIONS ISSUER 48436030.000000 0.000000 FOR 48436030.000000 FOR S000002922 Pfizer Inc. 717081103 04/25/2024 Election of Director: Joseph J. Echevarria DIRECTOR ELECTIONS ISSUER 48436030.000000 0.000000 FOR 48436030.000000 FOR S000002922 Pfizer Inc. 717081103 04/25/2024 Election of Director: Scott Gottlieb DIRECTOR ELECTIONS ISSUER 48436030.000000 0.000000 FOR 48436030.000000 FOR S000002922 Pfizer Inc. 717081103 04/25/2024 Election of Director: Helen H. Hobbs DIRECTOR ELECTIONS ISSUER 48436030.000000 0.000000 FOR 48436030.000000 FOR S000002922 Pfizer Inc. 717081103 04/25/2024 Election of Director: Susan Hockfield DIRECTOR ELECTIONS ISSUER 48436030.000000 0.000000 FOR 48436030.000000 FOR S000002922 Pfizer Inc. 717081103 04/25/2024 Election of Director: Dan R. Littman DIRECTOR ELECTIONS ISSUER 48436030.000000 0.000000 FOR 48436030.000000 FOR S000002922 Pfizer Inc. 717081103 04/25/2024 Election of Director: Shantanu Narayen DIRECTOR ELECTIONS ISSUER 48436030.000000 0.000000 FOR 48436030.000000 FOR S000002922 Pfizer Inc. 717081103 04/25/2024 Election of Director: Suzanne Nora Johnson DIRECTOR ELECTIONS ISSUER 48436030.000000 0.000000 FOR 48436030.000000 FOR S000002922 Pfizer Inc. 717081103 04/25/2024 Election of Director: James Quincey DIRECTOR ELECTIONS ISSUER 48436030.000000 0.000000 FOR 48436030.000000 FOR S000002922 Pfizer Inc. 717081103 04/25/2024 Election of Director: James C. Smith DIRECTOR ELECTIONS ISSUER 48436030.000000 0.000000 FOR 48436030.000000 FOR S000002922 Pfizer Inc. 717081103 04/25/2024 Ratify the selection of KPMG LLP as independent registered public accounting firm for 2024 AUDIT-RELATED ISSUER 48436030.000000 0.000000 FOR 48436030.000000 FOR S000002922 Pfizer Inc. 717081103 04/25/2024 Approval of the Amended and Restated Pfizer Inc. 2019 Stock Plan COMPENSATION ISSUER 48436030.000000 0.000000 FOR 48436030.000000 FOR S000002922 Pfizer Inc. 717081103 04/25/2024 2024 advisory approval of executive compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 48436030.000000 0.000000 FOR 48436030.000000 FOR S000002922 Pfizer Inc. 717081103 04/25/2024 2024 advisory approval of executive compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 48436030.000000 0.000000 FOR 48436030.000000 FOR 1 S000002922 Pfizer Inc. 717081103 04/25/2024 Adopt an Independent Board Chair Policy CORPORATE GOVERNANCE SECURITY HOLDER 48436030.000000 0.000000 FOR 48436030.000000 AGAINST S000002922 Pfizer Inc. 717081103 04/25/2024 Publish a Congruency Report on Political, Lobbying, Electioneering Expenditures OTHER SOCIAL ISSUES SECURITY HOLDER 48436030.000000 0.000000 AGAINST 48436030.000000 FOR S000002922 Pfizer Inc. 717081103 04/25/2024 Amend Director Resignation Processes SHAREHOLDER RIGHTS AND DEFENSES SECURITY HOLDER 48436030.000000 0.000000 AGAINST 48436030.000000 FOR S000002922 Pfizer Inc. 717081103 04/25/2024 Publish a Report on Corporate Contributions OTHER SOCIAL ISSUES SECURITY HOLDER 48436030.000000 0.000000 AGAINST 48436030.000000 FOR S000002922 UCB SA BE0003739530 04/25/2024 Accounts and Reports; Allocation of Dividends CAPITAL STRUCTURE ISSUER 8103270.000000 0.000000 FOR 8103270.000000 FOR S000002922 UCB SA BE0003739530 04/25/2024 Remuneration Report COMPENSATION ISSUER 8103270.000000 0.000000 FOR 8103270.000000 FOR S000002922 UCB SA BE0003739530 04/25/2024 Remuneration Policy COMPENSATION ISSUER 8103270.000000 0.000000 FOR 8103270.000000 FOR S000002922 UCB SA BE0003739530 04/25/2024 Ratification of Board Acts CORPORATE GOVERNANCE ISSUER 8103270.000000 0.000000 FOR 8103270.000000 FOR S000002922 UCB SA BE0003739530 04/25/2024 Ratification of Auditor's Acts CORPORATE GOVERNANCE ISSUER 8103270.000000 0.000000 FOR 8103270.000000 FOR S000002922 UCB SA BE0003739530 04/25/2024 Elect Pierre Gurdjian to the Board of Directors DIRECTOR ELECTIONS ISSUER 8103270.000000 0.000000 FOR 8103270.000000 FOR S000002922 UCB SA BE0003739530 04/25/2024 Ratification of Independence of Pierre Gurdjian CORPORATE GOVERNANCE ISSUER 8103270.000000 0.000000 FOR 8103270.000000 FOR S000002922 UCB SA BE0003739530 04/25/2024 Elect Ulf Wiinberg to the Board of Directors DIRECTOR ELECTIONS ISSUER 8103270.000000 0.000000 FOR 8103270.000000 FOR S000002922 UCB SA BE0003739530 04/25/2024 Ratification of Independence of Ulf Wiinberg CORPORATE GOVERNANCE ISSUER 8103270.000000 0.000000 FOR 8103270.000000 FOR S000002922 UCB SA BE0003739530 04/25/2024 Elect Charles Antoine Janssen to the Board of Directors DIRECTOR ELECTIONS ISSUER 8103270.000000 0.000000 FOR 8103270.000000 FOR S000002922 UCB SA BE0003739530 04/25/2024 Elect Nefertiti Greene to the Board of Directors DIRECTOR ELECTIONS ISSUER 8103270.000000 0.000000 FOR 8103270.000000 FOR S000002922 UCB SA BE0003739530 04/25/2024 Ratification of Independence of Nefertiti Greene CORPORATE GOVERNANCE ISSUER 8103270.000000 0.000000 FOR 8103270.000000 FOR S000002922 UCB SA BE0003739530 04/25/2024 Elect Dolca Thomas to the Board of Directors DIRECTOR ELECTIONS ISSUER 8103270.000000 0.000000 FOR 8103270.000000 FOR S000002922 UCB SA BE0003739530 04/25/2024 Ratification of Independence of Dolca Thomas CORPORATE GOVERNANCE ISSUER 8103270.000000 0.000000 FOR 8103270.000000 FOR S000002922 UCB SA BE0003739530 04/25/2024 Elect Rodolfo J Savitzky to the Board of Directors DIRECTOR ELECTIONS ISSUER 8103270.000000 0.000000 FOR 8103270.000000 FOR S000002922 UCB SA BE0003739530 04/25/2024 Ratification of Independence of Rodolfo J Savitzky CORPORATE GOVERNANCE ISSUER 8103270.000000 0.000000 FOR 8103270.000000 FOR S000002922 UCB SA BE0003739530 04/25/2024 Appointment of Auditor for Annual Accounts, Sustainability Reporting, and Authority to Set Fees AUDIT-RELATED ISSUER 8103270.000000 0.000000 FOR 8103270.000000 FOR S000002922 UCB SA BE0003739530 04/25/2024 Long Term Incentive Plan (Free Allocation of Shares) COMPENSATION ISSUER 8103270.000000 0.000000 FOR 8103270.000000 FOR S000002922 UCB SA BE0003739530 04/25/2024 Change in Control Clause (EMTN Program) SHAREHOLDER RIGHTS AND DEFENSES ISSUER 8103270.000000 0.000000 FOR 8103270.000000 FOR S000002922 UCB SA BE0003739530 04/25/2024 Change in Control Clause (Schuldschein loan agreement) SHAREHOLDER RIGHTS AND DEFENSES ISSUER 8103270.000000 0.000000 FOR 8103270.000000 FOR S000002922 UCB SA BE0003739530 04/25/2024 Increase in Authorised Capital CAPITAL STRUCTURE ISSUER 8103270.000000 0.000000 FOR 8103270.000000 FOR S000002922 UCB SA BE0003739530 04/25/2024 Authority to Repurchase Shares CAPITAL STRUCTURE ISSUER 8103270.000000 0.000000 FOR 8103270.000000 FOR S000002922 Abbott Laboratories 002824100 04/26/2024 Election of 12 Directors: R. J. Alpern DIRECTOR ELECTIONS ISSUER 8584207.000000 0.000000 FOR 8584207.000000 FOR S000002922 Abbott Laboratories 002824100 04/26/2024 Election of 12 Directors: C. Babineaux-Fontenot DIRECTOR ELECTIONS ISSUER 8584207.000000 0.000000 FOR 8584207.000000 FOR S000002922 Abbott Laboratories 002824100 04/26/2024 Election of 12 Directors: S. E. Blount DIRECTOR ELECTIONS ISSUER 8584207.000000 0.000000 FOR 8584207.000000 FOR S000002922 Abbott Laboratories 002824100 04/26/2024 Election of 12 Directors: R. B. Ford DIRECTOR ELECTIONS ISSUER 8584207.000000 0.000000 FOR 8584207.000000 FOR S000002922 Abbott Laboratories 002824100 04/26/2024 Election of 12 Directors: P. Gonzalez DIRECTOR ELECTIONS ISSUER 8584207.000000 0.000000 FOR 8584207.000000 FOR S000002922 Abbott Laboratories 002824100 04/26/2024 Election of 12 Directors: M. A. Kumbier DIRECTOR ELECTIONS ISSUER 8584207.000000 0.000000 FOR 8584207.000000 FOR S000002922 Abbott Laboratories 002824100 04/26/2024 Election of 12 Directors: D. W. McDew DIRECTOR ELECTIONS ISSUER 8584207.000000 0.000000 FOR 8584207.000000 FOR S000002922 Abbott Laboratories 002824100 04/26/2024 Election of 12 Directors: N. McKinstry DIRECTOR ELECTIONS ISSUER 8584207.000000 0.000000 FOR 8584207.000000 FOR S000002922 Abbott Laboratories 002824100 04/26/2024 Election of 12 Directors: M. G. O'Grady DIRECTOR ELECTIONS ISSUER 8584207.000000 0.000000 FOR 8584207.000000 FOR S000002922 Abbott Laboratories 002824100 04/26/2024 Election of 12 Directors: M. F. Roman DIRECTOR ELECTIONS ISSUER 8584207.000000 0.000000 FOR 8584207.000000 FOR S000002922 Abbott Laboratories 002824100 04/26/2024 Election of 12 Directors: D. J. Starks DIRECTOR ELECTIONS ISSUER 8584207.000000 0.000000 FOR 8584207.000000 FOR S000002922 Abbott Laboratories 002824100 04/26/2024 Election of 12 Directors: J. G. Stratton DIRECTOR ELECTIONS ISSUER 8584207.000000 0.000000 FOR 8584207.000000 FOR S000002922 Abbott Laboratories 002824100 04/26/2024 Ratification of Ernst & Young LLP As Auditors AUDIT-RELATED ISSUER 8584207.000000 0.000000 FOR 8584207.000000 FOR S000002922 Abbott Laboratories 002824100 04/26/2024 Say on Pay - An Advisory Vote on the Approval of Executive Compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 8584207.000000 0.000000 FOR 8584207.000000 FOR S000002922 Abbott Laboratories 002824100 04/26/2024 Say on Pay - An Advisory Vote on the Approval of Executive Compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 8584207.000000 0.000000 FOR 8584207.000000 FOR 1 S000002922 Verona Pharma plc 925050106 04/26/2024 To re-elect Lisa Deschamps as a director of the Company. DIRECTOR ELECTIONS ISSUER 1160032.000000 0.000000 FOR 1160032.000000 FOR S000002922 Verona Pharma plc 925050106 04/26/2024 To re-elect Martin Edwards as a director of the Company. DIRECTOR ELECTIONS ISSUER 1160032.000000 0.000000 FOR 1160032.000000 FOR S000002922 Verona Pharma plc 925050106 04/26/2024 To re-elect Sven Anders Ullman as a director of the Company. DIRECTOR ELECTIONS ISSUER 1160032.000000 0.000000 FOR 1160032.000000 FOR S000002922 Verona Pharma plc 925050106 04/26/2024 To re-elect Christina Ackermann as a director of the Company. DIRECTOR ELECTIONS ISSUER 1160032.000000 0.000000 FOR 1160032.000000 FOR S000002922 Verona Pharma plc 925050106 04/26/2024 To re-elect Michael Austwick as a director of the Company. DIRECTOR ELECTIONS ISSUER 1160032.000000 0.000000 FOR 1160032.000000 FOR S000002922 Verona Pharma plc 925050106 04/26/2024 To receive and adopt the U.K. statutory annual accounts and Directors report for the year ended 31 December 2023. CORPORATE GOVERNANCE ISSUER 1160032.000000 0.000000 FOR 1160032.000000 FOR S000002922 Verona Pharma plc 925050106 04/26/2024 To receive and approve, as a nonbinding advisory resolution, the U.K. statutory Directors Remuneration Report for the year ended 31 December 2023. COMPENSATION ISSUER 1160032.000000 0.000000 FOR 1160032.000000 FOR S000002922 Verona Pharma plc 925050106 04/26/2024 To receive and approve the U.K. Directors Remuneration Policy. COMPENSATION ISSUER 1160032.000000 0.000000 FOR 1160032.000000 FOR S000002922 Verona Pharma plc 925050106 04/26/2024 To approve an increase in the maximum aggregate level of NonExecutive Director annual remuneration (by way of fee) in accordance with Article 21.4 of the Companys Articles of Association to 750,000 per annum on an ongoing basis. COMPENSATION ISSUER 1160032.000000 0.000000 FOR 1160032.000000 FOR S000002922 Verona Pharma plc 925050106 04/26/2024 To appoint Ernst & Young LLP as the Companys auditors, to hold office until the conclusion of the next annual general meeting of shareholders. AUDIT-RELATED ISSUER 1160032.000000 0.000000 FOR 1160032.000000 FOR S000002922 Verona Pharma plc 925050106 04/26/2024 To authorize the Audit and Risk Committee to determine the auditors remuneration for the year ending December 31, 2024. AUDIT-RELATED ISSUER 1160032.000000 0.000000 FOR 1160032.000000 FOR S000002922 Verona Pharma plc 925050106 04/26/2024 To approve, on an advisory (nonbinding) basis, the compensation of the Companys named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1160032.000000 0.000000 FOR 1160032.000000 FOR S000002922 Verona Pharma plc 925050106 04/26/2024 To approve, on an advisory (nonbinding) basis, the compensation of the Companys named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1160032.000000 0.000000 FOR 1160032.000000 FOR 1 S000002922 Verona Pharma plc 925050106 04/26/2024 To authorize the Board of Directors to exercise all the powers of the Company to allot shares in the Company or grant rights to subscribe for or to convert any security into shares in the Company up to an aggregate nominal amount of 8,345,745 (being up to a maximum of 166,914,908 shares representing 25% of the Companys existing ordinary share capital as at the close of business on March 13, 2024 (being the latest practicable date prior to publication of this document)). CAPITAL STRUCTURE ISSUER 1160032.000000 0.000000 FOR 1160032.000000 FOR S000002922 Verona Pharma plc 925050106 04/26/2024 To authorize the Board of Directors to allot equity securities for cash and/or to sell ordinary shares held by the Company as treasury shares for cash as if Section 561(1) of the Companies Act does not apply to any such allotment. CAPITAL STRUCTURE ISSUER 1160032.000000 0.000000 FOR 1160032.000000 FOR S000002922 Galapagos NV BE0003818359 04/30/2024 Increase in Authorised Capital (Subsequent Gilead Warrant B) CAPITAL STRUCTURE ISSUER 1175458.000000 0.000000 FOR 1175458.000000 FOR S000002922 Galapagos NV BE0003818359 04/30/2024 Increase in Authorised Capital CAPITAL STRUCTURE ISSUER 1175458.000000 0.000000 FOR 1175458.000000 FOR S000002922 Galapagos NV BE0003818359 04/30/2024 Authority to Coordinate Articles CORPORATE GOVERNANCE ISSUER 1175458.000000 0.000000 FOR 1175458.000000 FOR S000002922 Galapagos NV BE0003818359 04/30/2024 Authorization of Legal Formalities (Power of attorney) CORPORATE GOVERNANCE ISSUER 1175458.000000 0.000000 FOR 1175458.000000 FOR S000002922 Galapagos NV BE0003818359 04/30/2024 Authorization of Legal Formalities CORPORATE GOVERNANCE ISSUER 1175458.000000 0.000000 FOR 1175458.000000 FOR S000002922 Galapagos NV BE0003818359 04/30/2024 Accounts and Reports; Allocation of Profits CAPITAL STRUCTURE ISSUER 1175458.000000 0.000000 FOR 1175458.000000 FOR S000002922 Galapagos NV BE0003818359 04/30/2024 Remuneration Report COMPENSATION ISSUER 1175458.000000 0.000000 AGAINST 1175458.000000 AGAINST S000002922 Galapagos NV BE0003818359 04/30/2024 Remuneration Policy COMPENSATION ISSUER 1175458.000000 0.000000 FOR 1175458.000000 FOR S000002922 Galapagos NV BE0003818359 04/30/2024 Ratification of Board and Auditors' Acts CORPORATE GOVERNANCE ISSUER 1175458.000000 0.000000 FOR 1175458.000000 FOR S000002922 Galapagos NV BE0003818359 04/30/2024 Directors' Fees COMPENSATION ISSUER 1175458.000000 0.000000 FOR 1175458.000000 FOR S000002922 Galapagos NV BE0003818359 04/30/2024 Elect Elisabeth Svanberg to the Board of Directors DIRECTOR ELECTIONS ISSUER 1175458.000000 0.000000 FOR 1175458.000000 FOR S000002922 Galapagos NV BE0003818359 04/30/2024 Elect Dr Susanne Schaffert to the Board of Directors DIRECTOR ELECTIONS ISSUER 1175458.000000 0.000000 FOR 1175458.000000 FOR S000002922 Galapagos NV BE0003818359 04/30/2024 Elect Simon Sturge to the Board of Directors DIRECTOR ELECTIONS ISSUER 1175458.000000 0.000000 FOR 1175458.000000 FOR S000002922 Galapagos NV BE0003818359 04/30/2024 Elect Andrew Dickinson to the Board of Directors DIRECTOR ELECTIONS ISSUER 1175458.000000 0.000000 FOR 1175458.000000 FOR S000002922 Galapagos NV BE0003818359 04/30/2024 Appointment of Auditor for Sustainability Reporting AUDIT-RELATED ISSUER 1175458.000000 0.000000 FOR 1175458.000000 FOR S000002922 Hapvida Participacoes Investimento SA BRHAPVACNOR4 04/30/2024 Board Size CORPORATE GOVERNANCE ISSUER 8909471.000000 0.000000 FOR 8909471.000000 FOR S000002922 Hapvida Participacoes Investimento SA BRHAPVACNOR4 04/30/2024 Request Cumulative Voting DIRECTOR ELECTIONS ISSUER 8909471.000000 0.000000 AGAINST 8909471.000000 NONE S000002922 Hapvida Participacoes Investimento SA BRHAPVACNOR4 04/30/2024 Election of Directors DIRECTOR ELECTIONS ISSUER 8909471.000000 0.000000 AGAINST 8909471.000000 AGAINST S000002922 Hapvida Participacoes Investimento SA BRHAPVACNOR4 04/30/2024 Approve Recasting of Votes for Amended Slate CORPORATE GOVERNANCE ISSUER 8909471.000000 0.000000 AGAINST 8909471.000000 NONE S000002922 Hapvida Participacoes Investimento SA BRHAPVACNOR4 04/30/2024 Proportional Allocation of Cumulative Votes DIRECTOR ELECTIONS ISSUER 8909471.000000 0.000000 FOR 8909471.000000 NONE S000002922 Hapvida Participacoes Investimento SA BRHAPVACNOR4 04/30/2024 Allocate Cumulative Votes to Candido Pinheiro Koren de Lima DIRECTOR ELECTIONS ISSUER 8909471.000000 0.000000 ABSTAIN 8909471.000000 NONE S000002922 Hapvida Participacoes Investimento SA BRHAPVACNOR4 04/30/2024 Allocate Cumulative Votes to Candido Pinheiro Koren de Lima Junior DIRECTOR ELECTIONS ISSUER 8909471.000000 0.000000 ABSTAIN 8909471.000000 NONE S000002922 Hapvida Participacoes Investimento SA BRHAPVACNOR4 04/30/2024 Allocate Cumulative Votes to Jorge Fontoura Pinheiro Koren de Lima DIRECTOR ELECTIONS ISSUER 8909471.000000 0.000000 ABSTAIN 8909471.000000 NONE S000002922 Hapvida Participacoes Investimento SA BRHAPVACNOR4 04/30/2024 Allocate Cumulative Votes to Carlos Augusto Leone Piani DIRECTOR ELECTIONS ISSUER 8909471.000000 0.000000 FOR 8909471.000000 NONE S000002922 Hapvida Participacoes Investimento SA BRHAPVACNOR4 04/30/2024 Allocate Cumulative Votes to Jose Luis Camargo Junior DIRECTOR ELECTIONS ISSUER 8909471.000000 0.000000 FOR 8909471.000000 NONE S000002922 Hapvida Participacoes Investimento SA BRHAPVACNOR4 04/30/2024 Allocate Cumulative Votes to Alberto Serrentino DIRECTOR ELECTIONS ISSUER 8909471.000000 0.000000 ABSTAIN 8909471.000000 NONE S000002922 Hapvida Participacoes Investimento SA BRHAPVACNOR4 04/30/2024 Allocate Cumulative Votes to Nicola Calicchio Neto DIRECTOR ELECTIONS ISSUER 8909471.000000 0.000000 FOR 8909471.000000 NONE S000002922 Hapvida Participacoes Investimento SA BRHAPVACNOR4 04/30/2024 Allocate Cumulative Votes to Maria Paula Soares Aranha DIRECTOR ELECTIONS ISSUER 8909471.000000 0.000000 FOR 8909471.000000 NONE S000002922 Hapvida Participacoes Investimento SA BRHAPVACNOR4 04/30/2024 Allocate Cumulative Votes to Mauricio Fernandes Teixeira DIRECTOR ELECTIONS ISSUER 8909471.000000 0.000000 ABSTAIN 8909471.000000 NONE S000002922 Hapvida Participacoes Investimento SA BRHAPVACNOR4 04/30/2024 Request Separate Election for Board Member/s DIRECTOR ELECTIONS ISSUER 8909471.000000 0.000000 ABSTAIN 8909471.000000 NONE S000002922 Hapvida Participacoes Investimento SA BRHAPVACNOR4 04/30/2024 Elect Candido Pinheiro Koren de Lima as Chair CORPORATE GOVERNANCE ISSUER 8909471.000000 0.000000 AGAINST 8909471.000000 AGAINST S000002922 Hapvida Participacoes Investimento SA BRHAPVACNOR4 04/30/2024 Ratify Carlos Augusto Leone Piani Independence Status CORPORATE GOVERNANCE ISSUER 8909471.000000 0.000000 FOR 8909471.000000 FOR S000002922 Hapvida Participacoes Investimento SA BRHAPVACNOR4 04/30/2024 Ratify Jose Luis Camargo Junior Independence Status CORPORATE GOVERNANCE ISSUER 8909471.000000 0.000000 FOR 8909471.000000 FOR S000002922 Hapvida Participacoes Investimento SA BRHAPVACNOR4 04/30/2024 Ratify Nicola Calicchio Neto Independence Status CORPORATE GOVERNANCE ISSUER 8909471.000000 0.000000 FOR 8909471.000000 FOR S000002922 Hapvida Participacoes Investimento SA BRHAPVACNOR4 04/30/2024 Ratify Maria Paula Soares Aranha Independence Status CORPORATE GOVERNANCE ISSUER 8909471.000000 0.000000 FOR 8909471.000000 FOR S000002922 Hapvida Participacoes Investimento SA BRHAPVACNOR4 04/30/2024 Remuneration Policy COMPENSATION ISSUER 8909471.000000 0.000000 FOR 8909471.000000 FOR S000002922 Hapvida Participacoes Investimento SA BRHAPVACNOR4 04/30/2024 Request Establishment of Supervisory Council DIRECTOR ELECTIONS ISSUER 8909471.000000 0.000000 FOR 8909471.000000 NONE S000002922 Molina Healthcare, Inc. 60855R100 05/01/2024 Election of Director to serve until the 2025 Annual meeting: Barbara L. Brasier DIRECTOR ELECTIONS ISSUER 849274.000000 0.000000 FOR 849274.000000 FOR S000002922 Molina Healthcare, Inc. 60855R100 05/01/2024 Election of Director to serve until the 2025 Annual meeting: Daniel Cooperman DIRECTOR ELECTIONS ISSUER 849274.000000 0.000000 FOR 849274.000000 FOR S000002922 Molina Healthcare, Inc. 60855R100 05/01/2024 Election of Director to serve until the 2025 Annual meeting: Stephen H. Lockhart DIRECTOR ELECTIONS ISSUER 849274.000000 0.000000 FOR 849274.000000 FOR S000002922 Molina Healthcare, Inc. 60855R100 05/01/2024 Election of Director to serve until the 2025 Annual meeting: Steven J. Orlando DIRECTOR ELECTIONS ISSUER 849274.000000 0.000000 FOR 849274.000000 FOR S000002922 Molina Healthcare, Inc. 60855R100 05/01/2024 Election of Director to serve until the 2025 Annual meeting: Ronna E. Romney DIRECTOR ELECTIONS ISSUER 849274.000000 0.000000 FOR 849274.000000 FOR S000002922 Molina Healthcare, Inc. 60855R100 05/01/2024 Election of Director to serve until the 2025 Annual meeting: Richard M. Schapiro DIRECTOR ELECTIONS ISSUER 849274.000000 0.000000 FOR 849274.000000 FOR S000002922 Molina Healthcare, Inc. 60855R100 05/01/2024 Election of Director to serve until the 2025 Annual meeting: Dale B. Wolf DIRECTOR ELECTIONS ISSUER 849274.000000 0.000000 FOR 849274.000000 FOR S000002922 Molina Healthcare, Inc. 60855R100 05/01/2024 Election of Director to serve until the 2025 Annual meeting: Richard C. Zoretic DIRECTOR ELECTIONS ISSUER 849274.000000 0.000000 FOR 849274.000000 FOR S000002922 Molina Healthcare, Inc. 60855R100 05/01/2024 Election of Director to serve until the 2025 Annual meeting: Joseph M. Zubretsky DIRECTOR ELECTIONS ISSUER 849274.000000 0.000000 FOR 849274.000000 FOR S000002922 Molina Healthcare, Inc. 60855R100 05/01/2024 To consider and approve, on a non-binding, advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 849274.000000 0.000000 FOR 849274.000000 FOR S000002922 Molina Healthcare, Inc. 60855R100 05/01/2024 To consider and approve, on a non-binding, advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 849274.000000 0.000000 FOR 849274.000000 FOR 1 S000002922 Molina Healthcare, Inc. 60855R100 05/01/2024 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for 2024. AUDIT-RELATED ISSUER 849274.000000 0.000000 FOR 849274.000000 FOR S000002922 Molina Healthcare, Inc. 60855R100 05/01/2024 Shareholder proposal regarding simple majority voting, if properly presented. SHAREHOLDER RIGHTS AND DEFENSES SECURITY HOLDER 849274.000000 0.000000 AGAINST 849274.000000 FOR S000002922 Boston Scientific Corporation 101137107 05/02/2024 Proposal to elect nine Directors: Charles J. Dockendorff DIRECTOR ELECTIONS ISSUER 14731695.000000 0.000000 AGAINST 14731695.000000 AGAINST S000002922 Boston Scientific Corporation 101137107 05/02/2024 Proposal to elect nine Directors: Yoshiaki Fujimori DIRECTOR ELECTIONS ISSUER 14731695.000000 0.000000 FOR 14731695.000000 FOR S000002922 Boston Scientific Corporation 101137107 05/02/2024 Proposal to elect nine Directors: Edward J. Ludwig DIRECTOR ELECTIONS ISSUER 14731695.000000 0.000000 FOR 14731695.000000 FOR S000002922 Boston Scientific Corporation 101137107 05/02/2024 Proposal to elect nine Directors: Michael F. Mahoney DIRECTOR ELECTIONS ISSUER 14731695.000000 0.000000 FOR 14731695.000000 FOR S000002922 Boston Scientific Corporation 101137107 05/02/2024 Proposal to elect nine Directors: Jessica L. Mega DIRECTOR ELECTIONS ISSUER 14731695.000000 0.000000 FOR 14731695.000000 FOR S000002922 Boston Scientific Corporation 101137107 05/02/2024 Proposal to elect nine Directors: Susan E. Morano DIRECTOR ELECTIONS ISSUER 14731695.000000 0.000000 FOR 14731695.000000 FOR S000002922 Boston Scientific Corporation 101137107 05/02/2024 Proposal to elect nine Directors: John E. Sununu DIRECTOR ELECTIONS ISSUER 14731695.000000 0.000000 FOR 14731695.000000 FOR S000002922 Boston Scientific Corporation 101137107 05/02/2024 Proposal to elect nine Directors: David S. Wichmann DIRECTOR ELECTIONS ISSUER 14731695.000000 0.000000 FOR 14731695.000000 FOR S000002922 Boston Scientific Corporation 101137107 05/02/2024 Proposal to elect nine Directors: Ellen M. Zane DIRECTOR ELECTIONS ISSUER 14731695.000000 0.000000 FOR 14731695.000000 FOR S000002922 Boston Scientific Corporation 101137107 05/02/2024 To approve, on a non-binding, advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 14731695.000000 0.000000 FOR 14731695.000000 FOR S000002922 Boston Scientific Corporation 101137107 05/02/2024 To approve, on a non-binding, advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 14731695.000000 0.000000 FOR 14731695.000000 FOR 1 S000002922 Boston Scientific Corporation 101137107 05/02/2024 To approve an amendment and restatement of our By-Laws to provide for advance notice and universal proxy rule updates. SHAREHOLDER RIGHTS AND DEFENSES ISSUER 14731695.000000 0.000000 FOR 14731695.000000 FOR S000002922 Boston Scientific Corporation 101137107 05/02/2024 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the 2024 fiscal year. AUDIT-RELATED ISSUER 14731695.000000 0.000000 FOR 14731695.000000 FOR S000002922 Encompass Health Corporation 29261A100 05/02/2024 Election of ten nominees to the Board of Directors to serve until our 2025 Annual Meeting of Stockholders: Greg D. Carmichael DIRECTOR ELECTIONS ISSUER 2095873.000000 0.000000 FOR 2095873.000000 FOR S000002922 Encompass Health Corporation 29261A100 05/02/2024 Election of ten nominees to the Board of Directors to serve until our 2025 Annual Meeting of Stockholders: Edward M. Christie III DIRECTOR ELECTIONS ISSUER 2095873.000000 0.000000 FOR 2095873.000000 FOR S000002922 Encompass Health Corporation 29261A100 05/02/2024 Election of ten nominees to the Board of Directors to serve until our 2025 Annual Meeting of Stockholders: Joan E. Herman DIRECTOR ELECTIONS ISSUER 2095873.000000 0.000000 FOR 2095873.000000 FOR S000002922 Encompass Health Corporation 29261A100 05/02/2024 Election of ten nominees to the Board of Directors to serve until our 2025 Annual Meeting of Stockholders: Leslye G. Katz DIRECTOR ELECTIONS ISSUER 2095873.000000 0.000000 FOR 2095873.000000 FOR S000002922 Encompass Health Corporation 29261A100 05/02/2024 Election of ten nominees to the Board of Directors to serve until our 2025 Annual Meeting of Stockholders: Patricia A. Maryland DIRECTOR ELECTIONS ISSUER 2095873.000000 0.000000 FOR 2095873.000000 FOR S000002922 Encompass Health Corporation 29261A100 05/02/2024 Election of ten nominees to the Board of Directors to serve until our 2025 Annual Meeting of Stockholders: Kevin J. O'Connor DIRECTOR ELECTIONS ISSUER 2095873.000000 0.000000 FOR 2095873.000000 FOR S000002922 Encompass Health Corporation 29261A100 05/02/2024 Election of ten nominees to the Board of Directors to serve until our 2025 Annual Meeting of Stockholders: Christopher R. Reidy DIRECTOR ELECTIONS ISSUER 2095873.000000 0.000000 FOR 2095873.000000 FOR S000002922 Encompass Health Corporation 29261A100 05/02/2024 Election of ten nominees to the Board of Directors to serve until our 2025 Annual Meeting of Stockholders: Nancy M. Schlichting DIRECTOR ELECTIONS ISSUER 2095873.000000 0.000000 FOR 2095873.000000 FOR S000002922 Encompass Health Corporation 29261A100 05/02/2024 Election of ten nominees to the Board of Directors to serve until our 2025 Annual Meeting of Stockholders: Mark J. Tarr DIRECTOR ELECTIONS ISSUER 2095873.000000 0.000000 FOR 2095873.000000 FOR S000002922 Encompass Health Corporation 29261A100 05/02/2024 Election of ten nominees to the Board of Directors to serve until our 2025 Annual Meeting of Stockholders: Terrance Williams DIRECTOR ELECTIONS ISSUER 2095873.000000 0.000000 FOR 2095873.000000 FOR S000002922 Encompass Health Corporation 29261A100 05/02/2024 Ratification of the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for 2024. AUDIT-RELATED ISSUER 2095873.000000 0.000000 FOR 2095873.000000 FOR S000002922 Encompass Health Corporation 29261A100 05/02/2024 An advisory vote to approve executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 2095873.000000 0.000000 FOR 2095873.000000 FOR S000002922 Encompass Health Corporation 29261A100 05/02/2024 An advisory vote to approve executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 2095873.000000 0.000000 FOR 2095873.000000 FOR 1 S000002922 Encompass Health Corporation 29261A100 05/02/2024 A vote on a resolution requesting a report on the effectiveness of the Company's diversity, equity, and inclusion efforts. DIVERSITY, EQUITY, AND INCLUSION SECURITY HOLDER 2095873.000000 0.000000 AGAINST 2095873.000000 FOR S000002922 Teleflex Incorporated 879369106 05/03/2024 Election of Directors: Candace H. Duncan DIRECTOR ELECTIONS ISSUER 1217493.000000 0.000000 FOR 1217493.000000 FOR S000002922 Teleflex Incorporated 879369106 05/03/2024 Election of Directors: Gretchen R. Haggerty DIRECTOR ELECTIONS ISSUER 1217493.000000 0.000000 FOR 1217493.000000 FOR S000002922 Teleflex Incorporated 879369106 05/03/2024 Election of Directors: Liam J. Kelly DIRECTOR ELECTIONS ISSUER 1217493.000000 0.000000 FOR 1217493.000000 FOR S000002922 Teleflex Incorporated 879369106 05/03/2024 Election of Directors: Stephen K. Klasko DIRECTOR ELECTIONS ISSUER 1217493.000000 0.000000 FOR 1217493.000000 FOR S000002922 Teleflex Incorporated 879369106 05/03/2024 Election of Directors: Stuart A. Randle DIRECTOR ELECTIONS ISSUER 1217493.000000 0.000000 FOR 1217493.000000 FOR S000002922 Teleflex Incorporated 879369106 05/03/2024 Election of Directors: Jaewon Ryu DIRECTOR ELECTIONS ISSUER 1217493.000000 0.000000 FOR 1217493.000000 FOR S000002922 Teleflex Incorporated 879369106 05/03/2024 Approval, on an advisory basis, of named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 1217493.000000 0.000000 FOR 1217493.000000 FOR S000002922 Teleflex Incorporated 879369106 05/03/2024 Approval, on an advisory basis, of named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 1217493.000000 0.000000 FOR 1217493.000000 FOR 1 S000002922 Teleflex Incorporated 879369106 05/03/2024 Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for 2024. AUDIT-RELATED ISSUER 1217493.000000 0.000000 FOR 1217493.000000 FOR S000002922 Teleflex Incorporated 879369106 05/03/2024 Stockholder proposal, if properly presented at the Annual Meeting, to reduce the ownership threshold to call a special stockholder meeting. SHAREHOLDER RIGHTS AND DEFENSES SECURITY HOLDER 1217493.000000 0.000000 AGAINST 1217493.000000 FOR S000002922 Eli Lilly and Company 532457108 05/06/2024 Election of the following directors, each to serve a three-year term: Katherine Baicker, Ph.D. DIRECTOR ELECTIONS ISSUER 5387346.000000 0.000000 FOR 5387346.000000 FOR S000002922 Eli Lilly and Company 532457108 05/06/2024 Election of the following directors, each to serve a three-year term: J. Erik Fyrwald DIRECTOR ELECTIONS ISSUER 5387346.000000 0.000000 AGAINST 5387346.000000 AGAINST S000002922 Eli Lilly and Company 532457108 05/06/2024 Election of the following directors, each to serve a three-year term: Jamere Jackson DIRECTOR ELECTIONS ISSUER 5387346.000000 0.000000 FOR 5387346.000000 FOR S000002922 Eli Lilly and Company 532457108 05/06/2024 Election of the following directors, each to serve a three-year term: Gabrielle Sulzberger DIRECTOR ELECTIONS ISSUER 5387346.000000 0.000000 FOR 5387346.000000 FOR S000002922 Eli Lilly and Company 532457108 05/06/2024 Approval, on an advisory basis, of the compensation paid to the company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 5387346.000000 0.000000 FOR 5387346.000000 FOR S000002922 Eli Lilly and Company 532457108 05/06/2024 Approval, on an advisory basis, of the compensation paid to the company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 5387346.000000 0.000000 FOR 5387346.000000 FOR 1 S000002922 Eli Lilly and Company 532457108 05/06/2024 Ratification of the appointment of Ernst & Young LLP as the independent auditor for 2024. AUDIT-RELATED ISSUER 5387346.000000 0.000000 FOR 5387346.000000 FOR S000002922 Eli Lilly and Company 532457108 05/06/2024 Approval of amendments to the company's Articles of Incorporation to eliminate the classified board structure. SHAREHOLDER RIGHTS AND DEFENSES ISSUER 5387346.000000 0.000000 FOR 5387346.000000 FOR S000002922 Eli Lilly and Company 532457108 05/06/2024 Approval of amendments to the company's Articles of Incorporation to eliminate supermajority voting provisions. SHAREHOLDER RIGHTS AND DEFENSES ISSUER 5387346.000000 0.000000 FOR 5387346.000000 FOR S000002922 Eli Lilly and Company 532457108 05/06/2024 Shareholder proposal to publish an annual report disclosing lobbying activities. OTHER SOCIAL ISSUES SECURITY HOLDER 5387346.000000 0.000000 FOR 5387346.000000 AGAINST S000002922 Eli Lilly and Company 532457108 05/06/2024 Shareholder proposal to report on effectiveness of the company s diversity, equity, and inclusion efforts. DIVERSITY, EQUITY, AND INCLUSION SECURITY HOLDER 5387346.000000 0.000000 AGAINST 5387346.000000 FOR S000002922 Eli Lilly and Company 532457108 05/06/2024 Shareholder proposal to establish and report on a process by which the impact of extended patent exclusivities on product access would be considered in deciding whether to apply for secondary and tertiary patents. OTHER SOCIAL ISSUES SECURITY HOLDER 5387346.000000 0.000000 AGAINST 5387346.000000 FOR S000002922 Eli Lilly and Company 532457108 05/06/2024 Shareholder proposal to adopt a comprehensive human rights policy. HUMAN RIGHTS OR HUMAN CAPITAL/WORKFORCE SECURITY HOLDER 5387346.000000 0.000000 AGAINST 5387346.000000 FOR S000002922 Moderna, Inc. 60770K107 05/06/2024 To elect three Class III director nominees set forth in the proxy statement, each to serve for a three-year term expiring at the 2027 annual meeting of shareholders and until his or her other respective successor is duly elected and qualified or such director's earlier death, resignation or removal: Robert Langer DIRECTOR ELECTIONS ISSUER 6521472.000000 0.000000 FOR 6521472.000000 FOR S000002922 Moderna, Inc. 60770K107 05/06/2024 To elect three Class III director nominees set forth in the proxy statement, each to serve for a three-year term expiring at the 2027 annual meeting of shareholders and until his or her other respective successor is duly elected and qualified or such director's earlier death, resignation or removal: Elizabeth Nabel, M.D. DIRECTOR ELECTIONS ISSUER 6521472.000000 0.000000 FOR 6521472.000000 FOR S000002922 Moderna, Inc. 60770K107 05/06/2024 To elect three Class III director nominees set forth in the proxy statement, each to serve for a three-year term expiring at the 2027 annual meeting of shareholders and until his or her other respective successor is duly elected and qualified or such director's earlier death, resignation or removal: Elizabeth Tallett DIRECTOR ELECTIONS ISSUER 6521472.000000 0.000000 AGAINST 6521472.000000 AGAINST S000002922 Moderna, Inc. 60770K107 05/06/2024 To approve, on a non-binding, advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 6521472.000000 0.000000 FOR 6521472.000000 FOR S000002922 Moderna, Inc. 60770K107 05/06/2024 To approve, on a non-binding, advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 6521472.000000 0.000000 FOR 6521472.000000 FOR 1 S000002922 Moderna, Inc. 60770K107 05/06/2024 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2024. AUDIT-RELATED ISSUER 6521472.000000 0.000000 FOR 6521472.000000 FOR S000002922 Moderna, Inc. 60770K107 05/06/2024 To approve an amendment to the Amended and Restated Certificate of Incorporation to provide shareholders the right to call a special meeting. SHAREHOLDER RIGHTS AND DEFENSES ISSUER 6521472.000000 0.000000 FOR 6521472.000000 FOR S000002922 Moderna, Inc. 60770K107 05/06/2024 To approve an amendment to the Amended and Restated Certificate of Incorporation to reflect new Delaware law provisions regarding officer exculpation. CORPORATE GOVERNANCE ISSUER 6521472.000000 0.000000 FOR 6521472.000000 FOR S000002922 argenx SE NL0010832176 05/07/2024 Remuneration Report COMPENSATION ISSUER 1367795.000000 0.000000 AGAINST 1367795.000000 AGAINST S000002922 argenx SE NL0010832176 05/07/2024 Accounts and Reports CORPORATE GOVERNANCE ISSUER 1367795.000000 0.000000 FOR 1367795.000000 FOR S000002922 argenx SE NL0010832176 05/07/2024 Allocation of Losses CAPITAL STRUCTURE ISSUER 1367795.000000 0.000000 FOR 1367795.000000 FOR S000002922 argenx SE NL0010832176 05/07/2024 Ratification of Board Acts CORPORATE GOVERNANCE ISSUER 1367795.000000 0.000000 FOR 1367795.000000 FOR S000002922 argenx SE NL0010832176 05/07/2024 Remuneration Policy COMPENSATION ISSUER 1367795.000000 0.000000 FOR 1367795.000000 FOR S000002922 argenx SE NL0010832176 05/07/2024 Elect Brian L. Kotzin to the Board of Directors DIRECTOR ELECTIONS ISSUER 1367795.000000 0.000000 FOR 1367795.000000 FOR S000002922 argenx SE NL0010832176 05/07/2024 Elect Peter K.M. Verhaeghe to the Board of Directors DIRECTOR ELECTIONS ISSUER 1367795.000000 0.000000 FOR 1367795.000000 FOR S000002922 argenx SE NL0010832176 05/07/2024 Elect Pamela Klein to the Board of Directors DIRECTOR ELECTIONS ISSUER 1367795.000000 0.000000 FOR 1367795.000000 FOR S000002922 argenx SE NL0010832176 05/07/2024 Authority to Issue Shares w/ or w/o Preemptive Rights CAPITAL STRUCTURE ISSUER 1367795.000000 0.000000 FOR 1367795.000000 FOR S000002922 argenx SE NL0010832176 05/07/2024 Amendments to Articles CORPORATE GOVERNANCE ISSUER 1367795.000000 0.000000 FOR 1367795.000000 FOR S000002922 argenx SE NL0010832176 05/07/2024 Appointment of Auditor (FY2024) AUDIT-RELATED ISSUER 1367795.000000 0.000000 FOR 1367795.000000 FOR S000002922 argenx SE NL0010832176 05/07/2024 Appointment of Auditor (FY2025) AUDIT-RELATED ISSUER 1367795.000000 0.000000 FOR 1367795.000000 FOR S000002922 Danaher Corporation 235851102 05/07/2024 To elect the thirteen directors named in the attached Proxy Statement to hold office until the 2025 Annual Meeting of Shareholders and until their successors are elected and qualified: Rainer M. Blair DIRECTOR ELECTIONS ISSUER 5113563.000000 0.000000 FOR 5113563.000000 FOR S000002922 Danaher Corporation 235851102 05/07/2024 To elect the thirteen directors named in the attached Proxy Statement to hold office until the 2025 Annual Meeting of Shareholders and until their successors are elected and qualified: Feroz Dewan DIRECTOR ELECTIONS ISSUER 5113563.000000 0.000000 FOR 5113563.000000 FOR S000002922 Danaher Corporation 235851102 05/07/2024 To elect the thirteen directors named in the attached Proxy Statement to hold office until the 2025 Annual Meeting of Shareholders and until their successors are elected and qualified: Linda Filler DIRECTOR ELECTIONS ISSUER 5113563.000000 0.000000 FOR 5113563.000000 FOR S000002922 Danaher Corporation 235851102 05/07/2024 To elect the thirteen directors named in the attached Proxy Statement to hold office until the 2025 Annual Meeting of Shareholders and until their successors are elected and qualified: Teri List DIRECTOR ELECTIONS ISSUER 5113563.000000 0.000000 FOR 5113563.000000 FOR S000002922 Danaher Corporation 235851102 05/07/2024 To elect the thirteen directors named in the attached Proxy Statement to hold office until the 2025 Annual Meeting of Shareholders and until their successors are elected and qualified: Jessica L. Mega, MD, MPH DIRECTOR ELECTIONS ISSUER 5113563.000000 0.000000 FOR 5113563.000000 FOR S000002922 Danaher Corporation 235851102 05/07/2024 To elect the thirteen directors named in the attached Proxy Statement to hold office until the 2025 Annual Meeting of Shareholders and until their successors are elected and qualified: Mitchell P. Rales DIRECTOR ELECTIONS ISSUER 5113563.000000 0.000000 FOR 5113563.000000 FOR S000002922 Danaher Corporation 235851102 05/07/2024 To elect the thirteen directors named in the attached Proxy Statement to hold office until the 2025 Annual Meeting of Shareholders and until their successors are elected and qualified: Steven M. Rales DIRECTOR ELECTIONS ISSUER 5113563.000000 0.000000 FOR 5113563.000000 FOR S000002922 Danaher Corporation 235851102 05/07/2024 To elect the thirteen directors named in the attached Proxy Statement to hold office until the 2025 Annual Meeting of Shareholders and until their successors are elected and qualified: Pardis C. Sabeti, MD, D. PHIL DIRECTOR ELECTIONS ISSUER 5113563.000000 0.000000 FOR 5113563.000000 FOR S000002922 Danaher Corporation 235851102 05/07/2024 To elect the thirteen directors named in the attached Proxy Statement to hold office until the 2025 Annual Meeting of Shareholders and until their successors are elected and qualified: A. Shane Sanders DIRECTOR ELECTIONS ISSUER 5113563.000000 0.000000 FOR 5113563.000000 FOR S000002922 Danaher Corporation 235851102 05/07/2024 To elect the thirteen directors named in the attached Proxy Statement to hold office until the 2025 Annual Meeting of Shareholders and until their successors are elected and qualified: John T. Schwieters DIRECTOR ELECTIONS ISSUER 5113563.000000 0.000000 FOR 5113563.000000 FOR S000002922 Danaher Corporation 235851102 05/07/2024 To elect the thirteen directors named in the attached Proxy Statement to hold office until the 2025 Annual Meeting of Shareholders and until their successors are elected and qualified: Alan G. Spoon DIRECTOR ELECTIONS ISSUER 5113563.000000 0.000000 AGAINST 5113563.000000 AGAINST S000002922 Danaher Corporation 235851102 05/07/2024 To elect the thirteen directors named in the attached Proxy Statement to hold office until the 2025 Annual Meeting of Shareholders and until their successors are elected and qualified: Raymond C. Stevens, Ph.D DIRECTOR ELECTIONS ISSUER 5113563.000000 0.000000 FOR 5113563.000000 FOR S000002922 Danaher Corporation 235851102 05/07/2024 To elect the thirteen directors named in the attached Proxy Statement to hold office until the 2025 Annual Meeting of Shareholders and until their successors are elected and qualified: Elias A. Zerhouni, MD DIRECTOR ELECTIONS ISSUER 5113563.000000 0.000000 FOR 5113563.000000 FOR S000002922 Danaher Corporation 235851102 05/07/2024 To ratify the selection of Ernst & Young LLP as Danaher's independent registered public accounting firm for the year ending December 31, 2024. AUDIT-RELATED ISSUER 5113563.000000 0.000000 FOR 5113563.000000 FOR S000002922 Danaher Corporation 235851102 05/07/2024 To approve on an advisory basis the Company's named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 5113563.000000 0.000000 FOR 5113563.000000 FOR S000002922 Danaher Corporation 235851102 05/07/2024 To approve on an advisory basis the Company's named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 5113563.000000 0.000000 FOR 5113563.000000 FOR 1 S000002922 Danaher Corporation 235851102 05/07/2024 To act upon a shareholder proposal requesting that Danaher amend its governing documents to reduce the percentage of shares required for shareholders to call a special meeting of shareholders from 25% to 15%. SHAREHOLDER RIGHTS AND DEFENSES SECURITY HOLDER 5113563.000000 0.000000 FOR 5113563.000000 AGAINST S000002922 Danaher Corporation 235851102 05/07/2024 To act upon a shareholder proposal requesting a report to shareholders on the effectiveness of the Company's diversity, equity and inclusion efforts. DIVERSITY, EQUITY, AND INCLUSION SECURITY HOLDER 5113563.000000 0.000000 AGAINST 5113563.000000 FOR S000002922 Edwards Lifesciences Corporation 28176E108 05/07/2024 Election of Directors: Leslie C. Davis DIRECTOR ELECTIONS ISSUER 9386095.000000 0.000000 FOR 9386095.000000 FOR S000002922 Edwards Lifesciences Corporation 28176E108 05/07/2024 Election of Directors: Kieran T. Gallahue DIRECTOR ELECTIONS ISSUER 9386095.000000 0.000000 FOR 9386095.000000 FOR S000002922 Edwards Lifesciences Corporation 28176E108 05/07/2024 Election of Directors: Leslie S. Heisz DIRECTOR ELECTIONS ISSUER 9386095.000000 0.000000 FOR 9386095.000000 FOR S000002922 Edwards Lifesciences Corporation 28176E108 05/07/2024 Election of Directors: Paul A. LaViolette DIRECTOR ELECTIONS ISSUER 9386095.000000 0.000000 FOR 9386095.000000 FOR S000002922 Edwards Lifesciences Corporation 28176E108 05/07/2024 Election of Directors: Steven R. Loranger DIRECTOR ELECTIONS ISSUER 9386095.000000 0.000000 FOR 9386095.000000 FOR S000002922 Edwards Lifesciences Corporation 28176E108 05/07/2024 Election of Directors: Ramona Sequeira DIRECTOR ELECTIONS ISSUER 9386095.000000 0.000000 FOR 9386095.000000 FOR S000002922 Edwards Lifesciences Corporation 28176E108 05/07/2024 Election of Directors: Nicholas J. Valeriani DIRECTOR ELECTIONS ISSUER 9386095.000000 0.000000 FOR 9386095.000000 FOR S000002922 Edwards Lifesciences Corporation 28176E108 05/07/2024 Election of Directors: Bernard J. Zovighian DIRECTOR ELECTIONS ISSUER 9386095.000000 0.000000 FOR 9386095.000000 FOR S000002922 Edwards Lifesciences Corporation 28176E108 05/07/2024 Advisory Vote to Approve Named Executive Officer Compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 9386095.000000 0.000000 FOR 9386095.000000 FOR S000002922 Edwards Lifesciences Corporation 28176E108 05/07/2024 Advisory Vote to Approve Named Executive Officer Compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 9386095.000000 0.000000 FOR 9386095.000000 FOR 1 S000002922 Edwards Lifesciences Corporation 28176E108 05/07/2024 Ratification of Appointment of Independent Registered Public Accounting Firm AUDIT-RELATED ISSUER 9386095.000000 0.000000 FOR 9386095.000000 FOR S000002922 Edwards Lifesciences Corporation 28176E108 05/07/2024 Approval of the Amended and Restated Long-Term Stock Incentive Compensation COMPENSATION ISSUER 9386095.000000 0.000000 FOR 9386095.000000 FOR S000002922 Alcon AG CH0432492467 05/08/2024 Accounts and Reports CORPORATE GOVERNANCE ISSUER 2660263.000000 0.000000 TAKENOACTION 2660263.000000 NONE S000002922 Alcon AG CH0432492467 05/08/2024 Ratification of Board and Management Acts CORPORATE GOVERNANCE ISSUER 2660263.000000 0.000000 TAKENOACTION 2660263.000000 NONE S000002922 Alcon AG CH0432492467 05/08/2024 Allocation of Dividends CAPITAL STRUCTURE ISSUER 2660263.000000 0.000000 TAKENOACTION 2660263.000000 NONE S000002922 Alcon AG CH0432492467 05/08/2024 Report on Non-Financial Matters CORPORATE GOVERNANCE ISSUER 2660263.000000 0.000000 TAKENOACTION 2660263.000000 NONE S000002922 Alcon AG CH0432492467 05/08/2024 Compensation Report COMPENSATION ISSUER 2660263.000000 0.000000 TAKENOACTION 2660263.000000 NONE S000002922 Alcon AG CH0432492467 05/08/2024 Board Compensation COMPENSATION ISSUER 2660263.000000 0.000000 TAKENOACTION 2660263.000000 NONE S000002922 Alcon AG CH0432492467 05/08/2024 Executive Compensation (Total) COMPENSATION ISSUER 2660263.000000 0.000000 TAKENOACTION 2660263.000000 NONE S000002922 Alcon AG CH0432492467 05/08/2024 Elect F. Michael Ball as Board Chair DIRECTOR ELECTIONS ISSUER 2660263.000000 0.000000 TAKENOACTION 2660263.000000 NONE S000002922 Alcon AG CH0432492467 05/08/2024 Elect Lynn Dorsey Bleil DIRECTOR ELECTIONS ISSUER 2660263.000000 0.000000 TAKENOACTION 2660263.000000 NONE S000002922 Alcon AG CH0432492467 05/08/2024 Elect Raquel C. Bono DIRECTOR ELECTIONS ISSUER 2660263.000000 0.000000 TAKENOACTION 2660263.000000 NONE S000002922 Alcon AG CH0432492467 05/08/2024 Elect Arthur Cummings DIRECTOR ELECTIONS ISSUER 2660263.000000 0.000000 TAKENOACTION 2660263.000000 NONE S000002922 Alcon AG CH0432492467 05/08/2024 Elect David J. Endicott DIRECTOR ELECTIONS ISSUER 2660263.000000 0.000000 TAKENOACTION 2660263.000000 NONE S000002922 Alcon AG CH0432492467 05/08/2024 Elect Thomas Glanzmann DIRECTOR ELECTIONS ISSUER 2660263.000000 0.000000 TAKENOACTION 2660263.000000 NONE S000002922 Alcon AG CH0432492467 05/08/2024 Elect D. Keith Grossman DIRECTOR ELECTIONS ISSUER 2660263.000000 0.000000 TAKENOACTION 2660263.000000 NONE S000002922 Alcon AG CH0432492467 05/08/2024 Elect Scott H. Maw DIRECTOR ELECTIONS ISSUER 2660263.000000 0.000000 TAKENOACTION 2660263.000000 NONE S000002922 Alcon AG CH0432492467 05/08/2024 Elect Karen J. May DIRECTOR ELECTIONS ISSUER 2660263.000000 0.000000 TAKENOACTION 2660263.000000 NONE S000002922 Alcon AG CH0432492467 05/08/2024 Elect Ines Poschel DIRECTOR ELECTIONS ISSUER 2660263.000000 0.000000 TAKENOACTION 2660263.000000 NONE S000002922 Alcon AG CH0432492467 05/08/2024 Elect Dieter Spalti DIRECTOR ELECTIONS ISSUER 2660263.000000 0.000000 TAKENOACTION 2660263.000000 NONE S000002922 Alcon AG CH0432492467 05/08/2024 Elect Thomas Glanzmann CORPORATE GOVERNANCE ISSUER 2660263.000000 0.000000 TAKENOACTION 2660263.000000 NONE S000002922 Alcon AG CH0432492467 05/08/2024 Elect Scott H. Maw CORPORATE GOVERNANCE ISSUER 2660263.000000 0.000000 TAKENOACTION 2660263.000000 NONE S000002922 Alcon AG CH0432492467 05/08/2024 Elect Karen J. May CORPORATE GOVERNANCE ISSUER 2660263.000000 0.000000 TAKENOACTION 2660263.000000 NONE S000002922 Alcon AG CH0432492467 05/08/2024 Elect Ines Poschel CORPORATE GOVERNANCE ISSUER 2660263.000000 0.000000 TAKENOACTION 2660263.000000 NONE S000002922 Alcon AG CH0432492467 05/08/2024 Appointment of Independent Proxy CORPORATE GOVERNANCE ISSUER 2660263.000000 0.000000 TAKENOACTION 2660263.000000 NONE S000002922 Alcon AG CH0432492467 05/08/2024 Appointment of Auditor AUDIT-RELATED ISSUER 2660263.000000 0.000000 TAKENOACTION 2660263.000000 NONE S000002922 Alcon AG CH0432492467 05/08/2024 Additional or Amended Proposals CORPORATE GOVERNANCE ISSUER 2660263.000000 0.000000 TAKENOACTION 2660263.000000 NONE S000002922 GSK plc GB00BN7SWP63 05/08/2024 Accounts and Reports CORPORATE GOVERNANCE ISSUER 31901977.000000 0.000000 FOR 31901977.000000 FOR S000002922 GSK plc GB00BN7SWP63 05/08/2024 Remuneration Report COMPENSATION ISSUER 31901977.000000 0.000000 FOR 31901977.000000 FOR S000002922 GSK plc GB00BN7SWP63 05/08/2024 Elect Wendy Becker DIRECTOR ELECTIONS ISSUER 31901977.000000 0.000000 FOR 31901977.000000 FOR S000002922 GSK plc GB00BN7SWP63 05/08/2024 Elect Jeannie Lee DIRECTOR ELECTIONS ISSUER 31901977.000000 0.000000 FOR 31901977.000000 FOR S000002922 GSK plc GB00BN7SWP63 05/08/2024 Elect Sir Jonathan R. Symonds DIRECTOR ELECTIONS ISSUER 31901977.000000 0.000000 FOR 31901977.000000 FOR S000002922 GSK plc GB00BN7SWP63 05/08/2024 Elect Emma N. Walmsley DIRECTOR ELECTIONS ISSUER 31901977.000000 0.000000 FOR 31901977.000000 FOR S000002922 GSK plc GB00BN7SWP63 05/08/2024 Elect Julie Brown DIRECTOR ELECTIONS ISSUER 31901977.000000 0.000000 FOR 31901977.000000 FOR S000002922 GSK plc GB00BN7SWP63 05/08/2024 Elect Elizabeth McKee Anderson DIRECTOR ELECTIONS ISSUER 31901977.000000 0.000000 FOR 31901977.000000 FOR S000002922 GSK plc GB00BN7SWP63 05/08/2024 Elect Charles A. Bancroft DIRECTOR ELECTIONS ISSUER 31901977.000000 0.000000 FOR 31901977.000000 FOR S000002922 GSK plc GB00BN7SWP63 05/08/2024 Elect Hal V. Barron DIRECTOR ELECTIONS ISSUER 31901977.000000 0.000000 FOR 31901977.000000 FOR S000002922 GSK plc GB00BN7SWP63 05/08/2024 Elect Anne Beal DIRECTOR ELECTIONS ISSUER 31901977.000000 0.000000 FOR 31901977.000000 FOR S000002922 GSK plc GB00BN7SWP63 05/08/2024 Elect Harry Dietz DIRECTOR ELECTIONS ISSUER 31901977.000000 0.000000 FOR 31901977.000000 FOR S000002922 GSK plc GB00BN7SWP63 05/08/2024 Elect Jesse Goodman DIRECTOR ELECTIONS ISSUER 31901977.000000 0.000000 FOR 31901977.000000 FOR S000002922 GSK plc GB00BN7SWP63 05/08/2024 Elect Vishal Sikka DIRECTOR ELECTIONS ISSUER 31901977.000000 0.000000 FOR 31901977.000000 FOR S000002922 GSK plc GB00BN7SWP63 05/08/2024 Appointment of Auditor AUDIT-RELATED ISSUER 31901977.000000 0.000000 FOR 31901977.000000 FOR S000002922 GSK plc GB00BN7SWP63 05/08/2024 Authority to Set Auditor's Fees AUDIT-RELATED ISSUER 31901977.000000 0.000000 FOR 31901977.000000 FOR S000002922 GSK plc GB00BN7SWP63 05/08/2024 Authorisation of Political Donations OTHER SOCIAL ISSUES ISSUER 31901977.000000 0.000000 FOR 31901977.000000 FOR S000002922 GSK plc GB00BN7SWP63 05/08/2024 Authority to Issue Shares w/ Preemptive Rights CAPITAL STRUCTURE ISSUER 31901977.000000 0.000000 FOR 31901977.000000 FOR S000002922 GSK plc GB00BN7SWP63 05/08/2024 Authority to Issue Shares w/o Preemptive Rights CAPITAL STRUCTURE ISSUER 31901977.000000 0.000000 FOR 31901977.000000 FOR S000002922 GSK plc GB00BN7SWP63 05/08/2024 Authority to Issue Shares w/o Preemptive Rights (Specified Capital Investment) CAPITAL STRUCTURE ISSUER 31901977.000000 0.000000 FOR 31901977.000000 FOR S000002922 GSK plc GB00BN7SWP63 05/08/2024 Authority to Repurchase Shares CAPITAL STRUCTURE ISSUER 31901977.000000 0.000000 FOR 31901977.000000 FOR S000002922 GSK plc GB00BN7SWP63 05/08/2024 Approve Exemption from Statement of the Senior Statutory Auditor's name in published Auditors' Reports CORPORATE GOVERNANCE ISSUER 31901977.000000 0.000000 FOR 31901977.000000 FOR S000002922 GSK plc GB00BN7SWP63 05/08/2024 Authority to Set General Meeting Notice Period at 14 Days CORPORATE GOVERNANCE ISSUER 31901977.000000 0.000000 FOR 31901977.000000 FOR S000002922 Stryker Corporation 863667101 05/09/2024 Election of Ten Directors: Mary K. Brainerd DIRECTOR ELECTIONS ISSUER 2022549.000000 0.000000 FOR 2022549.000000 FOR S000002922 Stryker Corporation 863667101 05/09/2024 Election of Ten Directors: Giovanni Caforio, M.D. DIRECTOR ELECTIONS ISSUER 2022549.000000 0.000000 FOR 2022549.000000 FOR S000002922 Stryker Corporation 863667101 05/09/2024 Election of Ten Directors: Allan C. Golston DIRECTOR ELECTIONS ISSUER 2022549.000000 0.000000 FOR 2022549.000000 FOR S000002922 Stryker Corporation 863667101 05/09/2024 Election of Ten Directors: Kevin A. Lobo (Chair of the Board, Chief Executive Officer and President) DIRECTOR ELECTIONS ISSUER 2022549.000000 0.000000 FOR 2022549.000000 FOR S000002922 Stryker Corporation 863667101 05/09/2024 Election of Ten Directors: Sherilyn S. McCoy (Lead Independent Director) DIRECTOR ELECTIONS ISSUER 2022549.000000 0.000000 FOR 2022549.000000 FOR S000002922 Stryker Corporation 863667101 05/09/2024 Election of Ten Directors: Rachel Ruggeri DIRECTOR ELECTIONS ISSUER 2022549.000000 0.000000 FOR 2022549.000000 FOR S000002922 Stryker Corporation 863667101 05/09/2024 Election of Ten Directors: Andrew K. Silvernail DIRECTOR ELECTIONS ISSUER 2022549.000000 0.000000 FOR 2022549.000000 FOR S000002922 Stryker Corporation 863667101 05/09/2024 Election of Ten Directors: Lisa M. Skeete Tatum DIRECTOR ELECTIONS ISSUER 2022549.000000 0.000000 FOR 2022549.000000 FOR S000002922 Stryker Corporation 863667101 05/09/2024 Election of Ten Directors: Ronda E. Stryker DIRECTOR ELECTIONS ISSUER 2022549.000000 0.000000 FOR 2022549.000000 FOR S000002922 Stryker Corporation 863667101 05/09/2024 Election of Ten Directors: Rajeev Suri DIRECTOR ELECTIONS ISSUER 2022549.000000 0.000000 FOR 2022549.000000 FOR S000002922 Stryker Corporation 863667101 05/09/2024 Ratification of Appointment of Ernst & Young LLP as Our Independent Registered Public Accounting Firm for 2024. AUDIT-RELATED ISSUER 2022549.000000 0.000000 FOR 2022549.000000 FOR S000002922 Stryker Corporation 863667101 05/09/2024 Advisory Vote to Approve Named Executive Officer Compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 2022549.000000 0.000000 FOR 2022549.000000 FOR S000002922 Stryker Corporation 863667101 05/09/2024 Advisory Vote to Approve Named Executive Officer Compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 2022549.000000 0.000000 FOR 2022549.000000 FOR 1 S000002922 Stryker Corporation 863667101 05/09/2024 Shareholder Proposal on Transparency in Political Spending. OTHER SOCIAL ISSUES SECURITY HOLDER 2022549.000000 0.000000 AGAINST 2022549.000000 FOR S000002922 Centene Corporation 15135B101 05/14/2024 Election of Directors: Jessica L. Blume DIRECTOR ELECTIONS ISSUER 8607919.000000 0.000000 FOR 8607919.000000 FOR S000002922 Centene Corporation 15135B101 05/14/2024 Election of Directors: Kenneth A. Burdick DIRECTOR ELECTIONS ISSUER 8607919.000000 0.000000 FOR 8607919.000000 FOR S000002922 Centene Corporation 15135B101 05/14/2024 Election of Directors: Christopher J. Coughlin DIRECTOR ELECTIONS ISSUER 8607919.000000 0.000000 FOR 8607919.000000 FOR S000002922 Centene Corporation 15135B101 05/14/2024 Election of Directors: H. James Dallas DIRECTOR ELECTIONS ISSUER 8607919.000000 0.000000 FOR 8607919.000000 FOR S000002922 Centene Corporation 15135B101 05/14/2024 Election of Directors: Wayne S. DeVeydt DIRECTOR ELECTIONS ISSUER 8607919.000000 0.000000 FOR 8607919.000000 FOR S000002922 Centene Corporation 15135B101 05/14/2024 Election of Directors: Frederick H. Eppinger DIRECTOR ELECTIONS ISSUER 8607919.000000 0.000000 FOR 8607919.000000 FOR S000002922 Centene Corporation 15135B101 05/14/2024 Election of Directors: Monte E. Ford DIRECTOR ELECTIONS ISSUER 8607919.000000 0.000000 FOR 8607919.000000 FOR S000002922 Centene Corporation 15135B101 05/14/2024 Election of Directors: Sarah M. London DIRECTOR ELECTIONS ISSUER 8607919.000000 0.000000 FOR 8607919.000000 FOR S000002922 Centene Corporation 15135B101 05/14/2024 Election of Directors: Lori J. Robinson DIRECTOR ELECTIONS ISSUER 8607919.000000 0.000000 FOR 8607919.000000 FOR S000002922 Centene Corporation 15135B101 05/14/2024 Election of Directors: Theodore R. Samuels DIRECTOR ELECTIONS ISSUER 8607919.000000 0.000000 FOR 8607919.000000 FOR S000002922 Centene Corporation 15135B101 05/14/2024 Advisory Resolution To Approve Executive Compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 8607919.000000 0.000000 FOR 8607919.000000 FOR S000002922 Centene Corporation 15135B101 05/14/2024 Advisory Resolution To Approve Executive Compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 8607919.000000 0.000000 FOR 8607919.000000 FOR 1 S000002922 Centene Corporation 15135B101 05/14/2024 Ratification Of Appointment Of Kpmg Llp As Our Independent Public Accounting Firm For The Year Ending December 31, 2024. AUDIT-RELATED ISSUER 8607919.000000 0.000000 FOR 8607919.000000 FOR S000002922 Centene Corporation 15135B101 05/14/2024 Stockholder Proposal For Managing Climate Risk Through Science-Based Targets And Transition Planning. ENVIRONMENT OR CLIMATE SECURITY HOLDER 8607919.000000 0.000000 AGAINST 8607919.000000 FOR S000002922 Laboratory Corporation of America Holdings 50540R409 05/14/2024 Election of the members of the Company's Board of Directors: Kerrii B. Anderson DIRECTOR ELECTIONS ISSUER 1381908.000000 0.000000 AGAINST 1381908.000000 AGAINST S000002922 Laboratory Corporation of America Holdings 50540R409 05/14/2024 Election of the members of the Company's Board of Directors: Jeffrey A. Davis DIRECTOR ELECTIONS ISSUER 1381908.000000 0.000000 FOR 1381908.000000 FOR S000002922 Laboratory Corporation of America Holdings 50540R409 05/14/2024 Election of the members of the Company's Board of Directors: D. Gary Gilliland, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 1381908.000000 0.000000 FOR 1381908.000000 FOR S000002922 Laboratory Corporation of America Holdings 50540R409 05/14/2024 Election of the members of the Company's Board of Directors: Kirsten M. Kliphouse DIRECTOR ELECTIONS ISSUER 1381908.000000 0.000000 FOR 1381908.000000 FOR S000002922 Laboratory Corporation of America Holdings 50540R409 05/14/2024 Election of the members of the Company's Board of Directors: Garheng Kong, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 1381908.000000 0.000000 FOR 1381908.000000 FOR S000002922 Laboratory Corporation of America Holdings 50540R409 05/14/2024 Election of the members of the Company's Board of Directors: Peter M. Neupert DIRECTOR ELECTIONS ISSUER 1381908.000000 0.000000 FOR 1381908.000000 FOR S000002922 Laboratory Corporation of America Holdings 50540R409 05/14/2024 Election of the members of the Company's Board of Directors: Richelle P. Parham DIRECTOR ELECTIONS ISSUER 1381908.000000 0.000000 FOR 1381908.000000 FOR S000002922 Laboratory Corporation of America Holdings 50540R409 05/14/2024 Election of the members of the Company's Board of Directors: Paul B. Rothman, M.D. DIRECTOR ELECTIONS ISSUER 1381908.000000 0.000000 FOR 1381908.000000 FOR S000002922 Laboratory Corporation of America Holdings 50540R409 05/14/2024 Election of the members of the Company's Board of Directors: Adam H. Schechter DIRECTOR ELECTIONS ISSUER 1381908.000000 0.000000 FOR 1381908.000000 FOR S000002922 Laboratory Corporation of America Holdings 50540R409 05/14/2024 Election of the members of the Company's Board of Directors: Kathryn E. Wengel DIRECTOR ELECTIONS ISSUER 1381908.000000 0.000000 FOR 1381908.000000 FOR S000002922 Laboratory Corporation of America Holdings 50540R409 05/14/2024 To approve, by non-binding vote, the compensation of the Laboratory Corporation of America Holdings named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1381908.000000 0.000000 FOR 1381908.000000 FOR S000002922 Laboratory Corporation of America Holdings 50540R409 05/14/2024 To approve, by non-binding vote, the compensation of the Laboratory Corporation of America Holdings named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1381908.000000 0.000000 FOR 1381908.000000 FOR 1 S000002922 Laboratory Corporation of America Holdings 50540R409 05/14/2024 Ratification of the appointment of Deloitte and Touche LLP as Laboratory Corporation of America Holdings independent registered public accounting firm for the year ending December 31, 2024. AUDIT-RELATED ISSUER 1381908.000000 0.000000 FOR 1381908.000000 FOR S000002922 Laboratory Corporation of America Holdings 50540R409 05/14/2024 Shareholder proposal regarding shareholder opportunity to vote on excessive golden parachutes. COMPENSATION SECURITY HOLDER 1381908.000000 0.000000 AGAINST 1381908.000000 FOR S000002922 Laboratory Corporation of America Holdings 50540R409 05/14/2024 Shareholder proposal regarding a Board report on transport of nonhuman primates within the U.S. OTHER SOCIAL ISSUES SECURITY HOLDER 1381908.000000 0.000000 AGAINST 1381908.000000 FOR S000002922 Laboratory Corporation of America Holdings 50540R409 05/14/2024 Shareholder proposal regarding a Board report on risks of fulfilling information requests. OTHER SOCIAL ISSUES SECURITY HOLDER 1381908.000000 0.000000 AGAINST 1381908.000000 FOR S000002922 Prothena Corporation plc G72800108 05/14/2024 To elect, by separate resolutions, four directors to hold office until no later than the Annual General Meeting of the Company's Shareholders in 2027, unless they resign, are removed from office, or are otherwise disqualified from serving as directors of the Company: Richard T. Collier DIRECTOR ELECTIONS ISSUER 2394263.000000 0.000000 FOR 2394263.000000 FOR S000002922 Prothena Corporation plc G72800108 05/14/2024 To elect, by separate resolutions, four directors to hold office until no later than the Annual General Meeting of the Company's Shareholders in 2027, unless they resign, are removed from office, or are otherwise disqualified from serving as directors of the Company: Shane M. Cooke DIRECTOR ELECTIONS ISSUER 2394263.000000 0.000000 FOR 2394263.000000 FOR S000002922 Prothena Corporation plc G72800108 05/14/2024 To elect, by separate resolutions, four directors to hold office until no later than the Annual General Meeting of the Company's Shareholders in 2027, unless they resign, are removed from office, or are otherwise disqualified from serving as directors of the Company: William H. Dunn, Jr. DIRECTOR ELECTIONS ISSUER 2394263.000000 0.000000 FOR 2394263.000000 FOR S000002922 Prothena Corporation plc G72800108 05/14/2024 To elect, by separate resolutions, four directors to hold office until no later than the Annual General Meeting of the Company's Shareholders in 2027, unless they resign, are removed from office, or are otherwise disqualified from serving as directors of the Company: Daniel G. Welch DIRECTOR ELECTIONS ISSUER 2394263.000000 0.000000 AGAINST 2394263.000000 AGAINST S000002922 Prothena Corporation plc G72800108 05/14/2024 To ratify, in a non-binding vote, the appointment of KPMG LLP as the Company's independent registered public accounting firm for its fiscal year 2024 and to authorize, in a binding vote, the Company's Board of Directors, acting through its Audit Committee, to approve the remuneration of that auditor. AUDIT-RELATED ISSUER 2394263.000000 0.000000 FOR 2394263.000000 FOR S000002922 Prothena Corporation plc G72800108 05/14/2024 To approve, in a non-binding advisory vote, the compensation of the executive officers named in the Company's Proxy Statement for the Annual General Meeting. SECTION 14A SAY-ON-PAY VOTES ISSUER 2394263.000000 0.000000 FOR 2394263.000000 FOR S000002922 Prothena Corporation plc G72800108 05/14/2024 To approve, in a non-binding advisory vote, the compensation of the executive officers named in the Company's Proxy Statement for the Annual General Meeting. SECTION 14A SAY-ON-PAY VOTES ISSUER 2394263.000000 0.000000 FOR 2394263.000000 FOR 1 S000002922 Prothena Corporation plc G72800108 05/14/2024 To approve an amendment to the Company's 2018 Long Term Incentive Plan to increase the number of ordinary shares available for issuance under that Plan by 2,000,000 ordinary shares. COMPENSATION ISSUER 2394263.000000 0.000000 FOR 2394263.000000 FOR S000002922 Cytokinetics, Incorporated 23282W605 05/15/2024 Election Of Class II Director: Robert I. Blum DIRECTOR ELECTIONS ISSUER 1469555.000000 0.000000 FOR 1469555.000000 FOR S000002922 Cytokinetics, Incorporated 23282W605 05/15/2024 Election Of Class II Director: Robert A. Harrington, M.D. DIRECTOR ELECTIONS ISSUER 1469555.000000 0.000000 FOR 1469555.000000 FOR S000002922 Cytokinetics, Incorporated 23282W605 05/15/2024 To Approve The Amendment And Restatement Of The Company's Amended And Restated 2015 Employee Stock Purchase Plan To Increase The Number Of Authorized Shares Reserved For Issuance Under Such Plan By 300,000 Shares Of Common Stock. COMPENSATION ISSUER 1469555.000000 0.000000 FOR 1469555.000000 FOR S000002922 Cytokinetics, Incorporated 23282W605 05/15/2024 To Ratify The Appointment By The Audit Committee Of The Board Of Directors Of Ernst & Young LLP As The Company's Independent Registered Public Accounting Firm For The Fiscal Year Ending December 31, 2024. AUDIT-RELATED ISSUER 1469555.000000 0.000000 FOR 1469555.000000 FOR S000002922 Cytokinetics, Incorporated 23282W605 05/15/2024 To Approve, On An Advisory Basis, The Compensation Of The Company's Named Executive Officers, As Disclosed In The Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 1469555.000000 0.000000 FOR 1469555.000000 FOR S000002922 Cytokinetics, Incorporated 23282W605 05/15/2024 To Approve, On An Advisory Basis, The Compensation Of The Company's Named Executive Officers, As Disclosed In The Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 1469555.000000 0.000000 FOR 1469555.000000 FOR 1 S000002922 Elevance Health, Inc. 036752103 05/15/2024 Election Of Director: Lewis Hay, III DIRECTOR ELECTIONS ISSUER 2273986.000000 0.000000 FOR 2273986.000000 FOR S000002922 Elevance Health, Inc. 036752103 05/15/2024 Election Of Director: Antonio F. Neri DIRECTOR ELECTIONS ISSUER 2273986.000000 0.000000 FOR 2273986.000000 FOR S000002922 Elevance Health, Inc. 036752103 05/15/2024 Election Of Director: Ramiro G. Peru DIRECTOR ELECTIONS ISSUER 2273986.000000 0.000000 FOR 2273986.000000 FOR S000002922 Elevance Health, Inc. 036752103 05/15/2024 Advisory Vote To Approve The Compensation Of Our Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 2273986.000000 0.000000 FOR 2273986.000000 FOR S000002922 Elevance Health, Inc. 036752103 05/15/2024 Advisory Vote To Approve The Compensation Of Our Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 2273986.000000 0.000000 FOR 2273986.000000 FOR 1 S000002922 Elevance Health, Inc. 036752103 05/15/2024 To Ratify The Appointment Of Ernst & Young LLP As The Independent Registered Public Accounting Firm For 2024. AUDIT-RELATED ISSUER 2273986.000000 0.000000 FOR 2273986.000000 FOR S000002922 Elevance Health, Inc. 036752103 05/15/2024 Shareholder Proposal To Adopt A Policy To Require Certain Third-Party Organizations To Annually Report Political Activity Expenditures Prior To Elevance Health Donating To The Organizations. OTHER SOCIAL ISSUES SECURITY HOLDER 2273986.000000 0.000000 AGAINST 2273986.000000 FOR S000002922 Option Care Health, Inc. 68404L201 05/15/2024 Elect John J. Arlotta DIRECTOR ELECTIONS ISSUER 4107073.000000 0.000000 FOR 4107073.000000 FOR S000002922 Option Care Health, Inc. 68404L201 05/15/2024 Elect Elizabeth Q. Betten DIRECTOR ELECTIONS ISSUER 4107073.000000 0.000000 FOR 4107073.000000 FOR S000002922 Option Care Health, Inc. 68404L201 05/15/2024 Elect Elizabeth D. Bierbower DIRECTOR ELECTIONS ISSUER 4107073.000000 0.000000 FOR 4107073.000000 FOR S000002922 Option Care Health, Inc. 68404L201 05/15/2024 Elect Barbara W. Bodem DIRECTOR ELECTIONS ISSUER 4107073.000000 0.000000 FOR 4107073.000000 FOR S000002922 Option Care Health, Inc. 68404L201 05/15/2024 Elect Eric K. Brandt DIRECTOR ELECTIONS ISSUER 4107073.000000 0.000000 WITHHOLD 4107073.000000 AGAINST S000002922 Option Care Health, Inc. 68404L201 05/15/2024 Elect Natasha Deckmann DIRECTOR ELECTIONS ISSUER 4107073.000000 0.000000 FOR 4107073.000000 FOR S000002922 Option Care Health, Inc. 68404L201 05/15/2024 Elect David W. Golding DIRECTOR ELECTIONS ISSUER 4107073.000000 0.000000 FOR 4107073.000000 FOR S000002922 Option Care Health, Inc. 68404L201 05/15/2024 Elect Harry M. Jansen Kraemer, Jr. DIRECTOR ELECTIONS ISSUER 4107073.000000 0.000000 FOR 4107073.000000 FOR S000002922 Option Care Health, Inc. 68404L201 05/15/2024 Elect R. Carter Pate DIRECTOR ELECTIONS ISSUER 4107073.000000 0.000000 FOR 4107073.000000 FOR S000002922 Option Care Health, Inc. 68404L201 05/15/2024 Elect John C. Rademacher DIRECTOR ELECTIONS ISSUER 4107073.000000 0.000000 FOR 4107073.000000 FOR S000002922 Option Care Health, Inc. 68404L201 05/15/2024 Elect Timothy Sullivan DIRECTOR ELECTIONS ISSUER 4107073.000000 0.000000 FOR 4107073.000000 FOR S000002922 Option Care Health, Inc. 68404L201 05/15/2024 Elect Norman L. Wright DIRECTOR ELECTIONS ISSUER 4107073.000000 0.000000 FOR 4107073.000000 FOR S000002922 Option Care Health, Inc. 68404L201 05/15/2024 To Ratify The Appointment Of KMPG LLP As Our Independent Registered Public Accounting Firm For The Year Ending December 31, 2024. AUDIT-RELATED ISSUER 4107073.000000 0.000000 FOR 4107073.000000 FOR S000002922 Option Care Health, Inc. 68404L201 05/15/2024 To Approve, On A Non-Binding Advisory Basis, Our Executive Compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 4107073.000000 0.000000 FOR 4107073.000000 FOR S000002922 Option Care Health, Inc. 68404L201 05/15/2024 To Approve, On A Non-Binding Advisory Basis, Our Executive Compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 4107073.000000 0.000000 FOR 4107073.000000 FOR 1 S000002922 Option Care Health, Inc. 68404L201 05/15/2024 To Approve The Amended And Restated Option Care Health, Inc. 2018 Equity Incentive Plan. COMPENSATION ISSUER 4107073.000000 0.000000 FOR 4107073.000000 FOR S000002922 Syndax Pharmaceuticals, Inc. 87164F105 05/15/2024 Election Of Director: Martin H. Huber, M.D. DIRECTOR ELECTIONS ISSUER 4249352.000000 0.000000 FOR 4249352.000000 FOR S000002922 Syndax Pharmaceuticals, Inc. 87164F105 05/15/2024 Election Of Director: Jennifer Jarrett DIRECTOR ELECTIONS ISSUER 4249352.000000 0.000000 FOR 4249352.000000 FOR S000002922 Syndax Pharmaceuticals, Inc. 87164F105 05/15/2024 Election Of Director: William Meury DIRECTOR ELECTIONS ISSUER 4249352.000000 0.000000 FOR 4249352.000000 FOR S000002922 Syndax Pharmaceuticals, Inc. 87164F105 05/15/2024 To Approve, On An Advisory Basis, The Compensation Of The Company's Named Executive Officers, As Disclosed In The 2024 Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 4249352.000000 0.000000 AGAINST 4249352.000000 AGAINST S000002922 Syndax Pharmaceuticals, Inc. 87164F105 05/15/2024 To Approve, On An Advisory Basis, The Compensation Of The Company's Named Executive Officers, As Disclosed In The 2024 Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 4249352.000000 0.000000 AGAINST 4249352.000000 AGAINST 1 S000002922 Syndax Pharmaceuticals, Inc. 87164F105 05/15/2024 To Ratify The Selection Of Deloitte & Touche LLP As The Independent Registered Public Accounting Firm Of The Company For Its Fiscal Year Ending December 31, 2024. AUDIT-RELATED ISSUER 4249352.000000 0.000000 FOR 4249352.000000 FOR S000002922 Vertex Pharmaceuticals Incorporated 92532F100 05/15/2024 Election Of Director: Sangeeta Bhatia DIRECTOR ELECTIONS ISSUER 1802778.000000 0.000000 FOR 1802778.000000 FOR S000002922 Vertex Pharmaceuticals Incorporated 92532F100 05/15/2024 Election Of Director: Lloyd Carney DIRECTOR ELECTIONS ISSUER 1802778.000000 0.000000 AGAINST 1802778.000000 AGAINST S000002922 Vertex Pharmaceuticals Incorporated 92532F100 05/15/2024 Election Of Director: Alan Garber DIRECTOR ELECTIONS ISSUER 1802778.000000 0.000000 FOR 1802778.000000 FOR S000002922 Vertex Pharmaceuticals Incorporated 92532F100 05/15/2024 Election Of Director: Reshma Kewalramani DIRECTOR ELECTIONS ISSUER 1802778.000000 0.000000 FOR 1802778.000000 FOR S000002922 Vertex Pharmaceuticals Incorporated 92532F100 05/15/2024 Election Of Director: Michel Lagarde DIRECTOR ELECTIONS ISSUER 1802778.000000 0.000000 FOR 1802778.000000 FOR S000002922 Vertex Pharmaceuticals Incorporated 92532F100 05/15/2024 Election Of Director: Jeffrey Leiden DIRECTOR ELECTIONS ISSUER 1802778.000000 0.000000 FOR 1802778.000000 FOR S000002922 Vertex Pharmaceuticals Incorporated 92532F100 05/15/2024 Election Of Director: Diana Mckenzie DIRECTOR ELECTIONS ISSUER 1802778.000000 0.000000 FOR 1802778.000000 FOR S000002922 Vertex Pharmaceuticals Incorporated 92532F100 05/15/2024 Election Of Director: Bruce Sachs DIRECTOR ELECTIONS ISSUER 1802778.000000 0.000000 FOR 1802778.000000 FOR S000002922 Vertex Pharmaceuticals Incorporated 92532F100 05/15/2024 Election Of Director: Jennifer Schneider DIRECTOR ELECTIONS ISSUER 1802778.000000 0.000000 FOR 1802778.000000 FOR S000002922 Vertex Pharmaceuticals Incorporated 92532F100 05/15/2024 Election Of Director: Nancy Thornberry DIRECTOR ELECTIONS ISSUER 1802778.000000 0.000000 FOR 1802778.000000 FOR S000002922 Vertex Pharmaceuticals Incorporated 92532F100 05/15/2024 Election Of Director: Suketu Upadhyay DIRECTOR ELECTIONS ISSUER 1802778.000000 0.000000 FOR 1802778.000000 FOR S000002922 Vertex Pharmaceuticals Incorporated 92532F100 05/15/2024 Ratification Of Ernst & Young LLP As Independent Registered Public Accounting Firm For The Year Ending December 31, 2024. AUDIT-RELATED ISSUER 1802778.000000 0.000000 FOR 1802778.000000 FOR S000002922 Vertex Pharmaceuticals Incorporated 92532F100 05/15/2024 Advisory Vote To Approve Named Executive Office Compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 1802778.000000 0.000000 FOR 1802778.000000 FOR S000002922 Vertex Pharmaceuticals Incorporated 92532F100 05/15/2024 Advisory Vote To Approve Named Executive Office Compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 1802778.000000 0.000000 FOR 1802778.000000 FOR 1 S000002922 Vertex Pharmaceuticals Incorporated 92532F100 05/15/2024 Shareholder Proposal, If Properly Presented At The Meeting, Regarding Special Shareholder Meeting Improvement. SHAREHOLDER RIGHTS AND DEFENSES SECURITY HOLDER 1802778.000000 0.000000 FOR 1802778.000000 AGAINST S000002922 Vertex Pharmaceuticals Incorporated 92532F100 05/15/2024 Shareholder Proposal, If Properly Presented At The Meeting, Regarding A Report On Racial And Gender Pay Gaps. DIVERSITY, EQUITY, AND INCLUSION SECURITY HOLDER 1802778.000000 0.000000 AGAINST 1802778.000000 FOR S000002922 Alnylam Pharmaceuticals, Inc. 02043Q107 05/16/2024 Election Of Class II Director To Serve A Term Until 2027: Dennis A. Ausiello, M.D. DIRECTOR ELECTIONS ISSUER 5844018.000000 0.000000 FOR 5844018.000000 FOR S000002922 Alnylam Pharmaceuticals, Inc. 02043Q107 05/16/2024 Election Of Class II Director To Serve A Term Until 2027: Olivier Brandicourt, M.D. DIRECTOR ELECTIONS ISSUER 5844018.000000 0.000000 FOR 5844018.000000 FOR S000002922 Alnylam Pharmaceuticals, Inc. 02043Q107 05/16/2024 Election Of Class II Director To Serve A Term Until 2027: Peter N. Kellogg DIRECTOR ELECTIONS ISSUER 5844018.000000 0.000000 FOR 5844018.000000 FOR S000002922 Alnylam Pharmaceuticals, Inc. 02043Q107 05/16/2024 Election Of Class II Director To Serve A Term Until 2027: David E.I. Pyott DIRECTOR ELECTIONS ISSUER 5844018.000000 0.000000 FOR 5844018.000000 FOR S000002922 Alnylam Pharmaceuticals, Inc. 02043Q107 05/16/2024 To Approve, In A Non-Binding Advisory Vote, The Compensation Of Alnylam's Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 5844018.000000 0.000000 FOR 5844018.000000 FOR S000002922 Alnylam Pharmaceuticals, Inc. 02043Q107 05/16/2024 To Approve, In A Non-Binding Advisory Vote, The Compensation Of Alnylam's Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 5844018.000000 0.000000 FOR 5844018.000000 FOR 1 S000002922 Alnylam Pharmaceuticals, Inc. 02043Q107 05/16/2024 To Ratify The Appointment Of Pricewaterhousecoopers LLP, An Independent Registered Public Accounting Firm, As Alnylam's Independent Auditors For The Fiscal Year Ending December 31, 2024. AUDIT-RELATED ISSUER 5844018.000000 0.000000 FOR 5844018.000000 FOR S000002922 ConvaTec Group plc GB00BD3VFW73 05/16/2024 Accounts and Reports CORPORATE GOVERNANCE ISSUER 15436613.000000 0.000000 FOR 15436613.000000 FOR S000002922 ConvaTec Group plc GB00BD3VFW73 05/16/2024 Remuneration Report COMPENSATION ISSUER 15436613.000000 0.000000 FOR 15436613.000000 FOR S000002922 ConvaTec Group plc GB00BD3VFW73 05/16/2024 Final Dividend CAPITAL STRUCTURE ISSUER 15436613.000000 0.000000 FOR 15436613.000000 FOR S000002922 ConvaTec Group plc GB00BD3VFW73 05/16/2024 Elect John D. G. McAdam DIRECTOR ELECTIONS ISSUER 15436613.000000 0.000000 FOR 15436613.000000 FOR S000002922 ConvaTec Group plc GB00BD3VFW73 05/16/2024 Elect Karim Bitar DIRECTOR ELECTIONS ISSUER 15436613.000000 0.000000 FOR 15436613.000000 FOR S000002922 ConvaTec Group plc GB00BD3VFW73 05/16/2024 Elect Jonny Mason DIRECTOR ELECTIONS ISSUER 15436613.000000 0.000000 FOR 15436613.000000 FOR S000002922 ConvaTec Group plc GB00BD3VFW73 05/16/2024 Elect Margaret Ewing DIRECTOR ELECTIONS ISSUER 15436613.000000 0.000000 AGAINST 15436613.000000 AGAINST S000002922 ConvaTec Group plc GB00BD3VFW73 05/16/2024 Elect Brian May DIRECTOR ELECTIONS ISSUER 15436613.000000 0.000000 FOR 15436613.000000 FOR S000002922 ConvaTec Group plc GB00BD3VFW73 05/16/2024 Elect Constantin Coussios DIRECTOR ELECTIONS ISSUER 15436613.000000 0.000000 FOR 15436613.000000 FOR S000002922 ConvaTec Group plc GB00BD3VFW73 05/16/2024 Elect Heather L. Mason DIRECTOR ELECTIONS ISSUER 15436613.000000 0.000000 FOR 15436613.000000 FOR S000002922 ConvaTec Group plc GB00BD3VFW73 05/16/2024 Elect Kim Lody DIRECTOR ELECTIONS ISSUER 15436613.000000 0.000000 FOR 15436613.000000 FOR S000002922 ConvaTec Group plc GB00BD3VFW73 05/16/2024 Elect Sharon O'Keefe DIRECTOR ELECTIONS ISSUER 15436613.000000 0.000000 FOR 15436613.000000 FOR S000002922 ConvaTec Group plc GB00BD3VFW73 05/16/2024 Appointment of Auditor AUDIT-RELATED ISSUER 15436613.000000 0.000000 FOR 15436613.000000 FOR S000002922 ConvaTec Group plc GB00BD3VFW73 05/16/2024 Authority to Set Auditor's Fees AUDIT-RELATED ISSUER 15436613.000000 0.000000 FOR 15436613.000000 FOR S000002922 ConvaTec Group plc GB00BD3VFW73 05/16/2024 Amendment to Long-Term Incentive Plan COMPENSATION ISSUER 15436613.000000 0.000000 FOR 15436613.000000 FOR S000002922 ConvaTec Group plc GB00BD3VFW73 05/16/2024 Authorisation of Political Donations OTHER SOCIAL ISSUES ISSUER 15436613.000000 0.000000 FOR 15436613.000000 FOR S000002922 ConvaTec Group plc GB00BD3VFW73 05/16/2024 Authority to Issue Shares w/ Preemptive Rights CAPITAL STRUCTURE ISSUER 15436613.000000 0.000000 FOR 15436613.000000 FOR S000002922 ConvaTec Group plc GB00BD3VFW73 05/16/2024 Authority to Issue Shares w/o Preemptive Rights CAPITAL STRUCTURE ISSUER 15436613.000000 0.000000 FOR 15436613.000000 FOR S000002922 ConvaTec Group plc GB00BD3VFW73 05/16/2024 Authority to Issue Shares w/o Preemptive Rights (Specified Capital Investment) CAPITAL STRUCTURE ISSUER 15436613.000000 0.000000 FOR 15436613.000000 FOR S000002922 ConvaTec Group plc GB00BD3VFW73 05/16/2024 Authority to Repurchase Shares CAPITAL STRUCTURE ISSUER 15436613.000000 0.000000 FOR 15436613.000000 FOR S000002922 ConvaTec Group plc GB00BD3VFW73 05/16/2024 Authority to Set General Meeting Notice Period at 14 Days CORPORATE GOVERNANCE ISSUER 15436613.000000 0.000000 FOR 15436613.000000 FOR S000002922 Illumina, Inc. 452327109 05/16/2024 Election Of Director: Frances Arnold, Ph.D. DIRECTOR ELECTIONS ISSUER 1589864.000000 0.000000 FOR 1589864.000000 FOR S000002922 Illumina, Inc. 452327109 05/16/2024 Election Of Director: Caroline D. Dorsa DIRECTOR ELECTIONS ISSUER 1589864.000000 0.000000 AGAINST 1589864.000000 AGAINST S000002922 Illumina, Inc. 452327109 05/16/2024 Election Of Director: Robert S. Epstein, M.D. DIRECTOR ELECTIONS ISSUER 1589864.000000 0.000000 FOR 1589864.000000 FOR S000002922 Illumina, Inc. 452327109 05/16/2024 Election Of Director: Scott Gottlieb, M.D. DIRECTOR ELECTIONS ISSUER 1589864.000000 0.000000 FOR 1589864.000000 FOR S000002922 Illumina, Inc. 452327109 05/16/2024 Election Of Director: Gary S. Guthart, Ph.D. DIRECTOR ELECTIONS ISSUER 1589864.000000 0.000000 FOR 1589864.000000 FOR S000002922 Illumina, Inc. 452327109 05/16/2024 Election Of Director: Stephen P. Macmillan DIRECTOR ELECTIONS ISSUER 1589864.000000 0.000000 FOR 1589864.000000 FOR S000002922 Illumina, Inc. 452327109 05/16/2024 Election Of Director: Anna Richo DIRECTOR ELECTIONS ISSUER 1589864.000000 0.000000 FOR 1589864.000000 FOR S000002922 Illumina, Inc. 452327109 05/16/2024 Election Of Director: Philip W. Schiller DIRECTOR ELECTIONS ISSUER 1589864.000000 0.000000 FOR 1589864.000000 FOR S000002922 Illumina, Inc. 452327109 05/16/2024 Election Of Director: Susan E. Siegel DIRECTOR ELECTIONS ISSUER 1589864.000000 0.000000 FOR 1589864.000000 FOR S000002922 Illumina, Inc. 452327109 05/16/2024 Election Of Director: Jacob Thaysen, Ph.D. DIRECTOR ELECTIONS ISSUER 1589864.000000 0.000000 FOR 1589864.000000 FOR S000002922 Illumina, Inc. 452327109 05/16/2024 Election Of Director: Scott B. Ullem DIRECTOR ELECTIONS ISSUER 1589864.000000 0.000000 FOR 1589864.000000 FOR S000002922 Illumina, Inc. 452327109 05/16/2024 To Ratify The Appointment Of Ernst & Young LLP As Our Independent Registered Public Accounting Firm For The Fiscal Year Ending December 29, 2024. AUDIT-RELATED ISSUER 1589864.000000 0.000000 FOR 1589864.000000 FOR S000002922 Illumina, Inc. 452327109 05/16/2024 To Approve, On An Advisory Basis, The Compensation Of The Named Executive Officers As Disclosed In The Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 1589864.000000 0.000000 FOR 1589864.000000 FOR S000002922 Illumina, Inc. 452327109 05/16/2024 To Approve, On An Advisory Basis, The Compensation Of The Named Executive Officers As Disclosed In The Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 1589864.000000 0.000000 FOR 1589864.000000 FOR 1 S000002922 Align Technology, Inc. 016255101 05/22/2024 Election Of Director: Kevin T. Conroy DIRECTOR ELECTIONS ISSUER 634991.000000 0.000000 FOR 634991.000000 FOR S000002922 Align Technology, Inc. 016255101 05/22/2024 Election Of Director: Kevin J. Dallas DIRECTOR ELECTIONS ISSUER 634991.000000 0.000000 FOR 634991.000000 FOR S000002922 Align Technology, Inc. 016255101 05/22/2024 Election Of Director: Joseph M. Hogan DIRECTOR ELECTIONS ISSUER 634991.000000 0.000000 FOR 634991.000000 FOR S000002922 Align Technology, Inc. 016255101 05/22/2024 Election Of Director: Joseph Lacob DIRECTOR ELECTIONS ISSUER 634991.000000 0.000000 FOR 634991.000000 FOR S000002922 Align Technology, Inc. 016255101 05/22/2024 Election Of Director: C. Raymond Larkin, Jr DIRECTOR ELECTIONS ISSUER 634991.000000 0.000000 FOR 634991.000000 FOR S000002922 Align Technology, Inc. 016255101 05/22/2024 Election Of Director: George J. Morrow DIRECTOR ELECTIONS ISSUER 634991.000000 0.000000 FOR 634991.000000 FOR S000002922 Align Technology, Inc. 016255101 05/22/2024 Election Of Director: Anne M. Myong DIRECTOR ELECTIONS ISSUER 634991.000000 0.000000 FOR 634991.000000 FOR S000002922 Align Technology, Inc. 016255101 05/22/2024 Election Of Director: Mojdeh Poul DIRECTOR ELECTIONS ISSUER 634991.000000 0.000000 FOR 634991.000000 FOR S000002922 Align Technology, Inc. 016255101 05/22/2024 Election Of Director: Andrea L. Saia DIRECTOR ELECTIONS ISSUER 634991.000000 0.000000 FOR 634991.000000 FOR S000002922 Align Technology, Inc. 016255101 05/22/2024 Election Of Director: Susan E. Siegel DIRECTOR ELECTIONS ISSUER 634991.000000 0.000000 FOR 634991.000000 FOR S000002922 Align Technology, Inc. 016255101 05/22/2024 Ratification Of Appointment Of Independent Registered Public Accountants: Proposal To Ratify The Appointment Of Pricewaterhousecoopers LLP as Align Technology, Inc.'s Independent Registered Public Accountants For The Fiscal Year Ending December 31, 2024. AUDIT-RELATED ISSUER 634991.000000 0.000000 FOR 634991.000000 FOR S000002922 Align Technology, Inc. 016255101 05/22/2024 Advisory Vote On Named Executives Compensation: Consider An Advisory Vote To Approve The Compensation Of Our Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 634991.000000 0.000000 FOR 634991.000000 FOR S000002922 Align Technology, Inc. 016255101 05/22/2024 Advisory Vote On Named Executives Compensation: Consider An Advisory Vote To Approve The Compensation Of Our Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 634991.000000 0.000000 FOR 634991.000000 FOR 1 S000002922 Align Technology, Inc. 016255101 05/22/2024 Stockholder Proposal Regarding Simple Majority Vote. SHAREHOLDER RIGHTS AND DEFENSES SECURITY HOLDER 634991.000000 0.000000 FOR 634991.000000 AGAINST S000002922 Insulet Corporation 45784P101 05/22/2024 Elect Wayne A.I. Frederick DIRECTOR ELECTIONS ISSUER 1457112.000000 0.000000 FOR 1457112.000000 FOR S000002922 Insulet Corporation 45784P101 05/22/2024 Elect Flavia H. Pease DIRECTOR ELECTIONS ISSUER 1457112.000000 0.000000 FOR 1457112.000000 FOR S000002922 Insulet Corporation 45784P101 05/22/2024 Elect Timothy J. Scannell DIRECTOR ELECTIONS ISSUER 1457112.000000 0.000000 FOR 1457112.000000 FOR S000002922 Insulet Corporation 45784P101 05/22/2024 To Approve, On A Non-Binding, Advisory Basis, The Compensation Of Certain Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1457112.000000 0.000000 FOR 1457112.000000 FOR S000002922 Insulet Corporation 45784P101 05/22/2024 To Approve, On A Non-Binding, Advisory Basis, The Compensation Of Certain Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1457112.000000 0.000000 FOR 1457112.000000 FOR 1 S000002922 Insulet Corporation 45784P101 05/22/2024 To Ratify The Appointment Of Grant Thornton LLP As The Company's Independent Registered Public Accounting Firm For The Fiscal Year Ending December 31, 2024. AUDIT-RELATED ISSUER 1457112.000000 0.000000 FOR 1457112.000000 FOR S000002922 Privia Health Group, Inc. 74276R102 05/22/2024 Election Of Class II Director To Serve Until 2027 Annual Meeting And Until Their Respective Successors Have Been Duly Elected And Qualified: Thomas Mccarthy DIRECTOR ELECTIONS ISSUER 3229900.000000 0.000000 FOR 3229900.000000 FOR S000002922 Privia Health Group, Inc. 74276R102 05/22/2024 Election Of Class II Director To Serve Until 2027 Annual Meeting And Until Their Respective Successors Have Been Duly Elected And Qualified: Parth Mehrotra DIRECTOR ELECTIONS ISSUER 3229900.000000 0.000000 FOR 3229900.000000 FOR S000002922 Privia Health Group, Inc. 74276R102 05/22/2024 Election Of Class II Director To Serve Until 2027 Annual Meeting And Until Their Respective Successors Have Been Duly Elected And Qualified: Dr. Jaewon Ryu DIRECTOR ELECTIONS ISSUER 3229900.000000 0.000000 FOR 3229900.000000 FOR S000002922 Privia Health Group, Inc. 74276R102 05/22/2024 Election Of Class II Director To Serve Until 2027 Annual Meeting And Until Their Respective Successors Have Been Duly Elected And Qualified: William (Bill) Sullivan DIRECTOR ELECTIONS ISSUER 3229900.000000 0.000000 FOR 3229900.000000 FOR S000002922 Privia Health Group, Inc. 74276R102 05/22/2024 To Approve, On An Advisory (Non-Binding) Basis, The Compensation Of Our Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 3229900.000000 0.000000 FOR 3229900.000000 FOR S000002922 Privia Health Group, Inc. 74276R102 05/22/2024 To Approve, On An Advisory (Non-Binding) Basis, The Compensation Of Our Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 3229900.000000 0.000000 FOR 3229900.000000 FOR 1 S000002922 Privia Health Group, Inc. 74276R102 05/22/2024 To Ratify The Appointment Of Pricewaterhousecoopers LLP as Our Independent Registered Public Accounting Firm For The Year Ending December 31, 2024. AUDIT-RELATED ISSUER 3229900.000000 0.000000 FOR 3229900.000000 FOR S000002922 Privia Health Group, Inc. 74276R102 05/22/2024 To Amend And Restate Our Amended And Restated Certificate Of Incorporation (The Charter ) To Remove Supermajority Voting Standards. SHAREHOLDER RIGHTS AND DEFENSES ISSUER 3229900.000000 0.000000 FOR 3229900.000000 FOR S000002922 Privia Health Group, Inc. 74276R102 05/22/2024 To Amend And Restate Our Charter To Remove Or Limit The Personal Liability Of Officers To The Extent Permitted By Amendments To The Delaware General Corporation Law. CORPORATE GOVERNANCE ISSUER 3229900.000000 0.000000 FOR 3229900.000000 FOR S000002922 Stevanato Group S.p.A. T9224W109 05/22/2024 Approval Of The Financial Statements For The Financial Year Ended On December 31, 2023, And Acknowledgment Of The Related Statements And Reports. CORPORATE GOVERNANCE ISSUER 1642580.000000 0.000000 FOR 1642580.000000 FOR S000002922 Stevanato Group S.p.A. T9224W109 05/22/2024 Distribution Of A Gross Dividend In Cash Of Euro 0.053 For Each Outstanding Share, Net Of The Treasury Shares; Allocation Of The Residual Net Profits To The Reserves And Related Resolutions. CAPITAL STRUCTURE ISSUER 1642580.000000 0.000000 FOR 1642580.000000 FOR S000002922 Stevanato Group S.p.A. T9224W109 05/22/2024 Appointment Of The Individuals Included In The Slate Of Candidates Submitted By Stevanato Holding S.R.L. On April 23, 2024 As Members Of The Board Of Directors For The Period Elapsing From May 22, 2024 To The Date Of Approval Of The Financial Statements For The Financial Year Ending On December 31, 2024; Appointment Of Mr. Franco Stevanato As Chairman Of The Board Of Directors. DIRECTOR ELECTIONS ISSUER 1642580.000000 0.000000 AGAINST 1642580.000000 NONE S000002922 Stevanato Group S.p.A. T9224W109 05/22/2024 Granting To Each Director (Except For Mr. Franco Moro) Of The Yearly Gross Total Compensation Of Euro 148,000, To Be Paid Partly In Cash And Partly In Shares. COMPENSATION ISSUER 1642580.000000 0.000000 FOR 1642580.000000 FOR S000002922 Stevanato Group S.p.A. T9224W109 05/22/2024 Adjustment Of The Compensation Granted To The External Auditor Pricewaterhousecoopers S.P.A. For Each Of The Financial Years 2023-2025. AUDIT-RELATED ISSUER 1642580.000000 0.000000 FOR 1642580.000000 FOR S000002922 Stevanato Group S.p.A. T9224W109 05/22/2024 Granting The Board Of Directors With The Authority To Purchase, And Dispose Of, Treasury Shares Within Certain Limitations For The Period Elapsing From May 22, 2024 To The Date Of Approval Of The Financial Statements For The Financial Year Ending On December 31, 2024. CAPITAL STRUCTURE ISSUER 1642580.000000 0.000000 FOR 1642580.000000 FOR S000002922 Thermo Fisher Scientific Inc. 883556102 05/22/2024 Election Of Director: Marc N. Casper DIRECTOR ELECTIONS ISSUER 2108134.000000 0.000000 FOR 2108134.000000 FOR S000002922 Thermo Fisher Scientific Inc. 883556102 05/22/2024 Election Of Director: Nelson J. Chai DIRECTOR ELECTIONS ISSUER 2108134.000000 0.000000 FOR 2108134.000000 FOR S000002922 Thermo Fisher Scientific Inc. 883556102 05/22/2024 Election Of Director: Ruby R. Chandy DIRECTOR ELECTIONS ISSUER 2108134.000000 0.000000 FOR 2108134.000000 FOR S000002922 Thermo Fisher Scientific Inc. 883556102 05/22/2024 Election Of Director: C. Martin Harris DIRECTOR ELECTIONS ISSUER 2108134.000000 0.000000 FOR 2108134.000000 FOR S000002922 Thermo Fisher Scientific Inc. 883556102 05/22/2024 Election Of Director: Tyler Jacks DIRECTOR ELECTIONS ISSUER 2108134.000000 0.000000 FOR 2108134.000000 FOR S000002922 Thermo Fisher Scientific Inc. 883556102 05/22/2024 Election Of Director: Jennifer M. Johnson DIRECTOR ELECTIONS ISSUER 2108134.000000 0.000000 FOR 2108134.000000 FOR S000002922 Thermo Fisher Scientific Inc. 883556102 05/22/2024 Election Of Director: R. Alexandra Keith DIRECTOR ELECTIONS ISSUER 2108134.000000 0.000000 FOR 2108134.000000 FOR S000002922 Thermo Fisher Scientific Inc. 883556102 05/22/2024 Election Of Director: James C. Mullen DIRECTOR ELECTIONS ISSUER 2108134.000000 0.000000 FOR 2108134.000000 FOR S000002922 Thermo Fisher Scientific Inc. 883556102 05/22/2024 Election Of Director: Debora L. Spar DIRECTOR ELECTIONS ISSUER 2108134.000000 0.000000 FOR 2108134.000000 FOR S000002922 Thermo Fisher Scientific Inc. 883556102 05/22/2024 Election Of Director: Scott M. Sperling DIRECTOR ELECTIONS ISSUER 2108134.000000 0.000000 FOR 2108134.000000 FOR S000002922 Thermo Fisher Scientific Inc. 883556102 05/22/2024 Election Of Director: Dion J. Weisler DIRECTOR ELECTIONS ISSUER 2108134.000000 0.000000 FOR 2108134.000000 FOR S000002922 Thermo Fisher Scientific Inc. 883556102 05/22/2024 An Advisory Vote To Approve Named Executive Officer Compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 2108134.000000 0.000000 FOR 2108134.000000 FOR S000002922 Thermo Fisher Scientific Inc. 883556102 05/22/2024 An Advisory Vote To Approve Named Executive Officer Compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 2108134.000000 0.000000 FOR 2108134.000000 FOR 1 S000002922 Thermo Fisher Scientific Inc. 883556102 05/22/2024 Ratification Of The Audit Committee's Selection Of Pricewaterhousecoopers LLP as The Company's Independent Auditors For 2024. AUDIT-RELATED ISSUER 2108134.000000 0.000000 FOR 2108134.000000 FOR S000002922 Thermo Fisher Scientific Inc. 883556102 05/22/2024 Shareholder Proposal: Simple Majority Vote. SHAREHOLDER RIGHTS AND DEFENSES SECURITY HOLDER 2108134.000000 0.000000 AGAINST 2108134.000000 FOR S000002922 Zoetis Inc. 98978V103 05/22/2024 Election Of Director: Paul M. Bisaro DIRECTOR ELECTIONS ISSUER 4179325.000000 0.000000 FOR 4179325.000000 FOR S000002922 Zoetis Inc. 98978V103 05/22/2024 Election Of Director: Vanessa Broadhurst DIRECTOR ELECTIONS ISSUER 4179325.000000 0.000000 FOR 4179325.000000 FOR S000002922 Zoetis Inc. 98978V103 05/22/2024 Election Of Director: Frank A. D Amelio DIRECTOR ELECTIONS ISSUER 4179325.000000 0.000000 FOR 4179325.000000 FOR S000002922 Zoetis Inc. 98978V103 05/22/2024 Election Of Director: Gavin D.K. Hattersley DIRECTOR ELECTIONS ISSUER 4179325.000000 0.000000 FOR 4179325.000000 FOR S000002922 Zoetis Inc. 98978V103 05/22/2024 Election Of Director: Sanjay Khosla DIRECTOR ELECTIONS ISSUER 4179325.000000 0.000000 FOR 4179325.000000 FOR S000002922 Zoetis Inc. 98978V103 05/22/2024 Election Of Director: Antoinette R. Leatherberry DIRECTOR ELECTIONS ISSUER 4179325.000000 0.000000 FOR 4179325.000000 FOR S000002922 Zoetis Inc. 98978V103 05/22/2024 Election Of Director: Michael B. Mccallister DIRECTOR ELECTIONS ISSUER 4179325.000000 0.000000 FOR 4179325.000000 FOR S000002922 Zoetis Inc. 98978V103 05/22/2024 Election Of Director: Gregory Norden DIRECTOR ELECTIONS ISSUER 4179325.000000 0.000000 FOR 4179325.000000 FOR S000002922 Zoetis Inc. 98978V103 05/22/2024 Election Of Director: Louise M. Parent DIRECTOR ELECTIONS ISSUER 4179325.000000 0.000000 FOR 4179325.000000 FOR S000002922 Zoetis Inc. 98978V103 05/22/2024 Election Of Director: Kristin C. Peck DIRECTOR ELECTIONS ISSUER 4179325.000000 0.000000 FOR 4179325.000000 FOR S000002922 Zoetis Inc. 98978V103 05/22/2024 Election Of Director: Willie M. Reed DIRECTOR ELECTIONS ISSUER 4179325.000000 0.000000 FOR 4179325.000000 FOR S000002922 Zoetis Inc. 98978V103 05/22/2024 Election Of Director: Robert W. Scully DIRECTOR ELECTIONS ISSUER 4179325.000000 0.000000 FOR 4179325.000000 FOR S000002922 Zoetis Inc. 98978V103 05/22/2024 Advisory Vote To Approve Our Executive Compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 4179325.000000 0.000000 FOR 4179325.000000 FOR S000002922 Zoetis Inc. 98978V103 05/22/2024 Advisory Vote To Approve Our Executive Compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 4179325.000000 0.000000 FOR 4179325.000000 FOR 1 S000002922 Zoetis Inc. 98978V103 05/22/2024 Ratification Of Appointment Of KMPG LLP As Our Independent Registered Public Accounting Firm For 2024. AUDIT-RELATED ISSUER 4179325.000000 0.000000 FOR 4179325.000000 FOR S000002922 Zoetis Inc. 98978V103 05/22/2024 Approval Of An Amendment To Our Restated Certificate Of Incorporation To Provide For Exculpation Of Officers As Permitted By The Delaware General Corporation Law. CORPORATE GOVERNANCE ISSUER 4179325.000000 0.000000 FOR 4179325.000000 FOR S000002922 Zoetis Inc. 98978V103 05/22/2024 Shareholder Proposal Regarding An Improvement To Our Director Resignation Policy. SHAREHOLDER RIGHTS AND DEFENSES SECURITY HOLDER 4179325.000000 0.000000 AGAINST 4179325.000000 FOR S000002922 Acadia Healthcare Company, Inc. 00404A109 05/23/2024 Election of Directors: E. Perot Bissell DIRECTOR ELECTIONS ISSUER 3658046.000000 0.000000 FOR 3658046.000000 FOR S000002922 Acadia Healthcare Company, Inc. 00404A109 05/23/2024 Election of Directors: Vicky B. Gregg DIRECTOR ELECTIONS ISSUER 3658046.000000 0.000000 FOR 3658046.000000 FOR S000002922 Acadia Healthcare Company, Inc. 00404A109 05/23/2024 Election of Directors: Christopher H. Hunter DIRECTOR ELECTIONS ISSUER 3658046.000000 0.000000 FOR 3658046.000000 FOR S000002922 Acadia Healthcare Company, Inc. 00404A109 05/23/2024 Approve an amendment to the Certificate of Incorporation to declassify the Board of Directors. SHAREHOLDER RIGHTS AND DEFENSES ISSUER 3658046.000000 0.000000 FOR 3658046.000000 FOR S000002922 Acadia Healthcare Company, Inc. 00404A109 05/23/2024 Advisory vote on the compensation of the Company's named executive officers as presented in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 3658046.000000 0.000000 FOR 3658046.000000 FOR S000002922 Acadia Healthcare Company, Inc. 00404A109 05/23/2024 Advisory vote on the compensation of the Company's named executive officers as presented in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 3658046.000000 0.000000 FOR 3658046.000000 FOR 1 S000002922 Acadia Healthcare Company, Inc. 00404A109 05/23/2024 Ratify the appointment of Ernst & Young LLP as the Company 's independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 3658046.000000 0.000000 FOR 3658046.000000 FOR S000002922 Immunocore Holdings plc 45258D105 05/23/2024 To re-appoint as a director Bahija Jallal, Ph.D., who retires in accordance with the articles of association. DIRECTOR ELECTIONS ISSUER 2897598.000000 0.000000 FOR 2897598.000000 FOR S000002922 Immunocore Holdings plc 45258D105 05/23/2024 To re-appoint as a director Professor Sir John Bell, who retires in accordance with the articles of association. DIRECTOR ELECTIONS ISSUER 2897598.000000 0.000000 FOR 2897598.000000 FOR S000002922 Immunocore Holdings plc 45258D105 05/23/2024 To approve, on advisory basis, the compensation of Company's named executive officers, as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 2897598.000000 0.000000 FOR 2897598.000000 FOR S000002922 Immunocore Holdings plc 45258D105 05/23/2024 To approve, on advisory basis, the compensation of Company's named executive officers, as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 2897598.000000 0.000000 FOR 2897598.000000 FOR 1 S000002922 Immunocore Holdings plc 45258D105 05/23/2024 To indicate, on an advisory basis, the preferred frequency of shareholder advisory votes on the compensation of Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 2897598.000000 0.000000 ONE YEAR 2897598.000000 FOR S000002922 Immunocore Holdings plc 45258D105 05/23/2024 To indicate, on an advisory basis, the preferred frequency of shareholder advisory votes on the compensation of Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 2897598.000000 0.000000 ONE YEAR 2897598.000000 FOR 1 S000002922 Immunocore Holdings plc 45258D105 05/23/2024 To ratify the appointment of Deloitte LLP, a limited liability partnership organized under the laws of England, as the Company's U.S. independent registered public accounting firm for the year ending December 31, 2024. AUDIT-RELATED ISSUER 2897598.000000 0.000000 FOR 2897598.000000 FOR S000002922 Immunocore Holdings plc 45258D105 05/23/2024 To re-appoint Deloitte LLP, a limited liability partnership organized under the laws of England, as the Company's U.K. statutory auditors, to hold office until the conclusion of our next annual general meeting of shareholders. AUDIT-RELATED ISSUER 2897598.000000 0.000000 FOR 2897598.000000 FOR S000002922 Immunocore Holdings plc 45258D105 05/23/2024 To authorize the directors to determine our U.K. statutory auditors' remuneration for the year ending December 31, 2024. AUDIT-RELATED ISSUER 2897598.000000 0.000000 FOR 2897598.000000 FOR S000002922 Immunocore Holdings plc 45258D105 05/23/2024 To receive and adopt our U.K. statutory annual accounts and reports for the year ended December 31, 2023 (the "2023 U.K. Annual Report"). CORPORATE GOVERNANCE ISSUER 2897598.000000 0.000000 FOR 2897598.000000 FOR S000002922 Immunocore Holdings plc 45258D105 05/23/2024 To approve our directors remuneration report for the year ended December 31, 2023, which is set forth as Annex A to the attached proxy statement and on pages 20 to 47 (inclusive) of the 2023 U.K. Annual Report. COMPENSATION ISSUER 2897598.000000 0.000000 FOR 2897598.000000 FOR S000002922 Immunocore Holdings plc 45258D105 05/23/2024 To authorize the Company to make political donations/incur political expenditure. OTHER SOCIAL ISSUES ISSUER 2897598.000000 0.000000 FOR 2897598.000000 FOR S000002922 Immunocore Holdings plc 45258D105 05/23/2024 That, with effect from the conclusion of the AGM, the draft articles of association produced to the AGM and, for the purpose of identification, initialed by the Chairman, be adopted as the articles of association of the Company in substitution for, and to the exclusion of, the Company's existing articles of association. CORPORATE GOVERNANCE ISSUER 2897598.000000 0.000000 FOR 2897598.000000 FOR S000002922 Waters Corporation 941848103 05/23/2024 To elect directors to serve for the ensuing year and until their successors are elected: Dr. Flemming Ornskov, M.D., M.P.H. DIRECTOR ELECTIONS ISSUER 666877.000000 0.000000 FOR 666877.000000 FOR S000002922 Waters Corporation 941848103 05/23/2024 To elect directors to serve for the ensuing year and until their successors are elected: Linda Baddour DIRECTOR ELECTIONS ISSUER 666877.000000 0.000000 FOR 666877.000000 FOR S000002922 Waters Corporation 941848103 05/23/2024 To elect directors to serve for the ensuing year and until their successors are elected: Udit Batra, Ph.D. DIRECTOR ELECTIONS ISSUER 666877.000000 0.000000 FOR 666877.000000 FOR S000002922 Waters Corporation 941848103 05/23/2024 To elect directors to serve for the ensuing year and until their successors are elected: Dan Brennan DIRECTOR ELECTIONS ISSUER 666877.000000 0.000000 FOR 666877.000000 FOR S000002922 Waters Corporation 941848103 05/23/2024 To elect directors to serve for the ensuing year and until their successors are elected: Richard Fearon DIRECTOR ELECTIONS ISSUER 666877.000000 0.000000 FOR 666877.000000 FOR S000002922 Waters Corporation 941848103 05/23/2024 To elect directors to serve for the ensuing year and until their successors are elected: Pearl S. Huang, Ph.D. DIRECTOR ELECTIONS ISSUER 666877.000000 0.000000 FOR 666877.000000 FOR S000002922 Waters Corporation 941848103 05/23/2024 To elect directors to serve for the ensuing year and until their successors are elected: Wei Jiang DIRECTOR ELECTIONS ISSUER 666877.000000 0.000000 FOR 666877.000000 FOR S000002922 Waters Corporation 941848103 05/23/2024 To elect directors to serve for the ensuing year and until their successors are elected: Christopher A. Kuebler DIRECTOR ELECTIONS ISSUER 666877.000000 0.000000 FOR 666877.000000 FOR S000002922 Waters Corporation 941848103 05/23/2024 To elect directors to serve for the ensuing year and until their successors are elected: Mark Vergnano DIRECTOR ELECTIONS ISSUER 666877.000000 0.000000 FOR 666877.000000 FOR S000002922 Waters Corporation 941848103 05/23/2024 To ratify the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 666877.000000 0.000000 FOR 666877.000000 FOR S000002922 Waters Corporation 941848103 05/23/2024 To approve, by non-binding vote, executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 666877.000000 0.000000 FOR 666877.000000 FOR S000002922 Waters Corporation 941848103 05/23/2024 To approve, by non-binding vote, executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 666877.000000 0.000000 FOR 666877.000000 FOR 1 S000002922 Waters Corporation 941848103 05/23/2024 To amend the Company's certificate of incorporation to provide for exculpation of certain officers of the Company as permitted by recent amendments to Delaware law. CORPORATE GOVERNANCE ISSUER 666877.000000 0.000000 FOR 666877.000000 FOR S000002922 Merck & Co., Inc. 58933Y105 05/28/2024 Election of Director: Douglas M. Baker, Jr. DIRECTOR ELECTIONS ISSUER 20479587.000000 0.000000 FOR 20479587.000000 FOR S000002922 Merck & Co., Inc. 58933Y105 05/28/2024 Election of Director: Mary Ellen Coe DIRECTOR ELECTIONS ISSUER 20479587.000000 0.000000 FOR 20479587.000000 FOR S000002922 Merck & Co., Inc. 58933Y105 05/28/2024 Election of Director: Pamela J. Craig DIRECTOR ELECTIONS ISSUER 20479587.000000 0.000000 FOR 20479587.000000 FOR S000002922 Merck & Co., Inc. 58933Y105 05/28/2024 Election of Director: Robert M. Davis DIRECTOR ELECTIONS ISSUER 20479587.000000 0.000000 FOR 20479587.000000 FOR S000002922 Merck & Co., Inc. 58933Y105 05/28/2024 Election of Director: Thomas H. Glocer DIRECTOR ELECTIONS ISSUER 20479587.000000 0.000000 FOR 20479587.000000 FOR S000002922 Merck & Co., Inc. 58933Y105 05/28/2024 Election of Director: Risa J. Lavizzo-Mourey, M.D. DIRECTOR ELECTIONS ISSUER 20479587.000000 0.000000 FOR 20479587.000000 FOR S000002922 Merck & Co., Inc. 58933Y105 05/28/2024 Election of Director: Stephen L. Mayo, Ph.D. DIRECTOR ELECTIONS ISSUER 20479587.000000 0.000000 FOR 20479587.000000 FOR S000002922 Merck & Co., Inc. 58933Y105 05/28/2024 Election of Director: Paul B. Rothman, M.D. DIRECTOR ELECTIONS ISSUER 20479587.000000 0.000000 FOR 20479587.000000 FOR S000002922 Merck & Co., Inc. 58933Y105 05/28/2024 Election of Director: Patricia F. Russo DIRECTOR ELECTIONS ISSUER 20479587.000000 0.000000 AGAINST 20479587.000000 AGAINST S000002922 Merck & Co., Inc. 58933Y105 05/28/2024 Election of Director: Christine E. Seidman, M.D. DIRECTOR ELECTIONS ISSUER 20479587.000000 0.000000 FOR 20479587.000000 FOR S000002922 Merck & Co., Inc. 58933Y105 05/28/2024 Election of Director: Inge G. Thulin DIRECTOR ELECTIONS ISSUER 20479587.000000 0.000000 FOR 20479587.000000 FOR S000002922 Merck & Co., Inc. 58933Y105 05/28/2024 Election of Director: Kathy J. Warden DIRECTOR ELECTIONS ISSUER 20479587.000000 0.000000 FOR 20479587.000000 FOR S000002922 Merck & Co., Inc. 58933Y105 05/28/2024 Non-binding advisory vote to approve the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 20479587.000000 0.000000 FOR 20479587.000000 FOR S000002922 Merck & Co., Inc. 58933Y105 05/28/2024 Non-binding advisory vote to approve the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 20479587.000000 0.000000 FOR 20479587.000000 FOR 1 S000002922 Merck & Co., Inc. 58933Y105 05/28/2024 Ratification of the appointment of the Company s independent registered public accounting firm for 2024. AUDIT-RELATED ISSUER 20479587.000000 0.000000 FOR 20479587.000000 FOR S000002922 Merck & Co., Inc. 58933Y105 05/28/2024 Shareholder proposal regarding a shareholder right to act by written consent. SHAREHOLDER RIGHTS AND DEFENSES SECURITY HOLDER 20479587.000000 0.000000 AGAINST 20479587.000000 FOR S000002922 Merck & Co., Inc. 58933Y105 05/28/2024 Shareholder proposal regarding a government censorship transparency report. OTHER SOCIAL ISSUES SECURITY HOLDER 20479587.000000 0.000000 AGAINST 20479587.000000 FOR S000002922 Merck & Co., Inc. 58933Y105 05/28/2024 Shareholder proposal regarding a report on respecting workforce civil liberties. DIVERSITY, EQUITY, AND INCLUSION SECURITY HOLDER 20479587.000000 0.000000 AGAINST 20479587.000000 FOR S000002922 Shandong Weigao Group Medical Polymer Company Limited CNE100000171 05/28/2024 Accounts and Reports CORPORATE GOVERNANCE ISSUER 77092000.000000 0.000000 FOR 77092000.000000 FOR S000002922 Shandong Weigao Group Medical Polymer Company Limited CNE100000171 05/28/2024 Directors' Report CORPORATE GOVERNANCE ISSUER 77092000.000000 0.000000 FOR 77092000.000000 FOR S000002922 Shandong Weigao Group Medical Polymer Company Limited CNE100000171 05/28/2024 Supervisors' Report CORPORATE GOVERNANCE ISSUER 77092000.000000 0.000000 FOR 77092000.000000 FOR S000002922 Shandong Weigao Group Medical Polymer Company Limited CNE100000171 05/28/2024 Allocation of Profits/Dividends CAPITAL STRUCTURE ISSUER 77092000.000000 0.000000 FOR 77092000.000000 FOR S000002922 Shandong Weigao Group Medical Polymer Company Limited CNE100000171 05/28/2024 Appointment of Auditor and Authority to Set Fees AUDIT-RELATED ISSUER 77092000.000000 0.000000 FOR 77092000.000000 FOR S000002922 Shandong Weigao Group Medical Polymer Company Limited CNE100000171 05/28/2024 Elect CONG Rinan DIRECTOR ELECTIONS ISSUER 77092000.000000 0.000000 FOR 77092000.000000 FOR S000002922 Shandong Weigao Group Medical Polymer Company Limited CNE100000171 05/28/2024 Elect TANG Zhengpeng DIRECTOR ELECTIONS ISSUER 77092000.000000 0.000000 FOR 77092000.000000 FOR S000002922 Shandong Weigao Group Medical Polymer Company Limited CNE100000171 05/28/2024 Elect CHEN Lin DIRECTOR ELECTIONS ISSUER 77092000.000000 0.000000 FOR 77092000.000000 FOR S000002922 Shandong Weigao Group Medical Polymer Company Limited CNE100000171 05/28/2024 Elect WANG Daoming DIRECTOR ELECTIONS ISSUER 77092000.000000 0.000000 FOR 77092000.000000 FOR S000002922 Shandong Weigao Group Medical Polymer Company Limited CNE100000171 05/28/2024 Elect YAN Xia DIRECTOR ELECTIONS ISSUER 77092000.000000 0.000000 FOR 77092000.000000 FOR S000002922 Shandong Weigao Group Medical Polymer Company Limited CNE100000171 05/28/2024 Elect SUN Heng DIRECTOR ELECTIONS ISSUER 77092000.000000 0.000000 FOR 77092000.000000 FOR S000002922 Shandong Weigao Group Medical Polymer Company Limited CNE100000171 05/28/2024 Elect GU Mei Jun as Supervisor DIRECTOR ELECTIONS ISSUER 77092000.000000 0.000000 FOR 77092000.000000 FOR S000002922 Shandong Weigao Group Medical Polymer Company Limited CNE100000171 05/28/2024 Directors' Fees COMPENSATION ISSUER 77092000.000000 0.000000 FOR 77092000.000000 FOR S000002922 Shandong Weigao Group Medical Polymer Company Limited CNE100000171 05/28/2024 Authority to Issue H and Non-Listed Domestic Shares w/o Preemptive Rights CAPITAL STRUCTURE ISSUER 77092000.000000 0.000000 FOR 77092000.000000 FOR S000002922 Shandong Weigao Group Medical Polymer Company Limited CNE100000171 05/28/2024 Authority to Repurchase H Shares CAPITAL STRUCTURE ISSUER 77092000.000000 0.000000 FOR 77092000.000000 FOR S000002922 Shandong Weigao Group Medical Polymer Company Limited CNE100000171 05/28/2024 Amendments to Articles CORPORATE GOVERNANCE ISSUER 77092000.000000 0.000000 FOR 77092000.000000 FOR S000002922 agilon health, inc. 00857U107 05/29/2024 Election of Class III Directors: Ravi Sachdev DIRECTOR ELECTIONS ISSUER 34720760.000000 0.000000 FOR 34720760.000000 FOR S000002922 agilon health, inc. 00857U107 05/29/2024 Election of Class III Directors: Steven J. Sell DIRECTOR ELECTIONS ISSUER 34720760.000000 0.000000 FOR 34720760.000000 FOR S000002922 agilon health, inc. 00857U107 05/29/2024 Election of Class III Directors: William Wulf, M.D. DIRECTOR ELECTIONS ISSUER 34720760.000000 0.000000 FOR 34720760.000000 FOR S000002922 agilon health, inc. 00857U107 05/29/2024 Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2024. AUDIT-RELATED ISSUER 34720760.000000 0.000000 FOR 34720760.000000 FOR S000002922 agilon health, inc. 00857U107 05/29/2024 To approve, by advisory vote, the compensation paid to the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 34720760.000000 0.000000 FOR 34720760.000000 FOR S000002922 agilon health, inc. 00857U107 05/29/2024 To approve, by advisory vote, the compensation paid to the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 34720760.000000 0.000000 FOR 34720760.000000 FOR 1 S000002922 Ascendis Pharma A/S 04351P101 05/30/2024 Election of attorney-at-law Lars Luthjohan as chairman of the general meeting. CORPORATE GOVERNANCE ISSUER 1809494.000000 13187.000000 FOR 1809494.000000 FOR S000002922 Ascendis Pharma A/S 04351P101 05/30/2024 Report on the Companys Activities during the Past Year CORPORATE GOVERNANCE ISSUER 1809494.000000 13187.000000 FOR 1809494.000000 FOR S000002922 Ascendis Pharma A/S 04351P101 05/30/2024 Presentation of Audited Annual Report with Auditors Statement for Approval and Discharge of the Board of Directors and Management CORPORATE GOVERNANCE ISSUER 1809494.000000 13187.000000 FOR 1809494.000000 FOR S000002922 Ascendis Pharma A/S 04351P101 05/30/2024 Resolution on Application of Profits or Covering of Losses as per the Adopted Annual Report CAPITAL STRUCTURE ISSUER 1809494.000000 13187.000000 FOR 1809494.000000 FOR S000002922 Ascendis Pharma A/S 04351P101 05/30/2024 Election of Board Members: Albert Cha (re-election for Class II) DIRECTOR ELECTIONS ISSUER 1809494.000000 13187.000000 FOR 1809494.000000 FOR S000002922 Ascendis Pharma A/S 04351P101 05/30/2024 Election of Board Members: Lars Holtug (re-election for Class II) DIRECTOR ELECTIONS ISSUER 1809494.000000 13187.000000 FOR 1809494.000000 FOR S000002922 Ascendis Pharma A/S 04351P101 05/30/2024 Election of State-authorized Public Auditor. AUDIT-RELATED ISSUER 1809494.000000 13187.000000 FOR 1809494.000000 FOR S000002922 Ascendis Pharma A/S 04351P101 05/30/2024 The Board of Directors proposes that the existing structure with two classes of members of the Board of Directors is discontinued and is replaced with a simpler structure under which all members of the board of directors are elected for one year and are up for election at each annual general meeting in accordance with the Recommendations on Corporate Governance issued by the Danis Committee on Corporate Governance. SHAREHOLDER RIGHTS AND DEFENSES ISSUER 1809494.000000 13187.000000 FOR 1809494.000000 FOR S000002922 Ascendis Pharma A/S 04351P101 05/30/2024 The currently existing authorization contained in article 4 d (1) to the Board of Directors to increase the Company s share capital with pre-emptive subscription rights for the Company s expires 28 May 2024. The Board of Directors proposes that a renewed authorization until 29 May 2029 is adopted. CAPITAL STRUCTURE ISSUER 1809494.000000 13187.000000 FOR 1809494.000000 FOR S000002922 Ascendis Pharma A/S 04351P101 05/30/2024 The Board of Directors proposes to amend the Articles of Association by adopting an authorization to the Board of Directors during the period until 29 May 2029 to issue up to 1,000,000 warrants to executive management and employees, advisors and consultants. The exercise price for the warrants shall at least be equal to the market price of the shares at the time of issuance. CAPITAL STRUCTURE ISSUER 1809494.000000 13187.000000 FOR 1809494.000000 FOR S000002922 Alkermes plc G01767105 05/31/2024 To elect as directors to serve a one-year term until the Company's 2025 annual general meeting of shareholders: Emily Peterson Alva DIRECTOR ELECTIONS ISSUER 8601892.000000 0.000000 FOR 8601892.000000 FOR S000002922 Alkermes plc G01767105 05/31/2024 To elect as directors to serve a one-year term until the Company's 2025 annual general meeting of shareholders: Shane M. Cooke DIRECTOR ELECTIONS ISSUER 8601892.000000 0.000000 FOR 8601892.000000 FOR S000002922 Alkermes plc G01767105 05/31/2024 To elect as directors to serve a one-year term until the Company's 2025 annual general meeting of shareholders: David A. Daglio, Jr. DIRECTOR ELECTIONS ISSUER 8601892.000000 0.000000 FOR 8601892.000000 FOR S000002922 Alkermes plc G01767105 05/31/2024 To elect as directors to serve a one-year term until the Company's 2025 annual general meeting of shareholders: Richard B. Gaynor, M.D. DIRECTOR ELECTIONS ISSUER 8601892.000000 0.000000 FOR 8601892.000000 FOR S000002922 Alkermes plc G01767105 05/31/2024 To elect as directors to serve a one-year term until the Company's 2025 annual general meeting of shareholders: Cato T. Laurencin, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 8601892.000000 0.000000 FOR 8601892.000000 FOR S000002922 Alkermes plc G01767105 05/31/2024 To elect as directors to serve a one-year term until the Company's 2025 annual general meeting of shareholders: Nancy S. Lurker DIRECTOR ELECTIONS ISSUER 8601892.000000 0.000000 FOR 8601892.000000 FOR S000002922 Alkermes plc G01767105 05/31/2024 To elect as directors to serve a one-year term until the Company's 2025 annual general meeting of shareholders: Brian P. McKeon DIRECTOR ELECTIONS ISSUER 8601892.000000 0.000000 FOR 8601892.000000 FOR S000002922 Alkermes plc G01767105 05/31/2024 To elect as directors to serve a one-year term until the Company's 2025 annual general meeting of shareholders: Richard F. Pops DIRECTOR ELECTIONS ISSUER 8601892.000000 0.000000 FOR 8601892.000000 FOR S000002922 Alkermes plc G01767105 05/31/2024 To elect as directors to serve a one-year term until the Company's 2025 annual general meeting of shareholders: Nancy L. Snyderman, M.D. DIRECTOR ELECTIONS ISSUER 8601892.000000 0.000000 FOR 8601892.000000 FOR S000002922 Alkermes plc G01767105 05/31/2024 To elect as directors to serve a one-year term until the Company's 2025 annual general meeting of shareholders: Frank Anders Wilson DIRECTOR ELECTIONS ISSUER 8601892.000000 0.000000 FOR 8601892.000000 FOR S000002922 Alkermes plc G01767105 05/31/2024 To elect as directors to serve a one-year term until the Company's 2025 annual general meeting of shareholders: Christopher I. Wright, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 8601892.000000 0.000000 FOR 8601892.000000 FOR S000002922 Alkermes plc G01767105 05/31/2024 To approve, in a non-binding, advisory vote, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 8601892.000000 0.000000 FOR 8601892.000000 FOR S000002922 Alkermes plc G01767105 05/31/2024 To approve, in a non-binding, advisory vote, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 8601892.000000 0.000000 FOR 8601892.000000 FOR 1 S000002922 Alkermes plc G01767105 05/31/2024 To approve, in a non-binding, advisory vote, the frequency of future advisory votes on the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 8601892.000000 0.000000 ONE YEAR 8601892.000000 FOR S000002922 Alkermes plc G01767105 05/31/2024 To approve, in a non-binding, advisory vote, the frequency of future advisory votes on the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 8601892.000000 0.000000 ONE YEAR 8601892.000000 FOR 1 S000002922 Alkermes plc G01767105 05/31/2024 To ratify, in a non-binding vote, the appointment of PricewaterhouseCoopers LLP as the independent auditor and accounting firm of the Company and to authorize, in a binding vote, the Audit and Risk Committee of the Board to set the independent auditor and accounting firm's remuneration. AUDIT-RELATED ISSUER 8601892.000000 0.000000 FOR 8601892.000000 FOR S000002922 Alkermes plc G01767105 05/31/2024 To approve the Alkermes plc 2018 Stock Option and Incentive Plan, as amended. COMPENSATION ISSUER 8601892.000000 0.000000 FOR 8601892.000000 FOR S000002922 Alkermes plc G01767105 05/31/2024 To renew Board authority to allot and issue shares under Irish law. CAPITAL STRUCTURE ISSUER 8601892.000000 0.000000 FOR 8601892.000000 FOR S000002922 Alkermes plc G01767105 05/31/2024 To renew Board authority to disapply the statutory pre-emption rights that would otherwise apply under Irish law. CAPITAL STRUCTURE ISSUER 8601892.000000 0.000000 FOR 8601892.000000 FOR S000002922 Denali Therapeutics Inc 24823R105 05/31/2024 Elect Jay T. Flatley DIRECTOR ELECTIONS ISSUER 6242434.000000 0.000000 FOR 6242434.000000 FOR S000002922 Denali Therapeutics Inc 24823R105 05/31/2024 Elect Marc Tessier-Lavigne DIRECTOR ELECTIONS ISSUER 6242434.000000 0.000000 FOR 6242434.000000 FOR S000002922 Denali Therapeutics Inc 24823R105 05/31/2024 Elect Nancy A. Thornberry DIRECTOR ELECTIONS ISSUER 6242434.000000 0.000000 FOR 6242434.000000 FOR S000002922 Denali Therapeutics Inc 24823R105 05/31/2024 Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 6242434.000000 0.000000 FOR 6242434.000000 FOR S000002922 Denali Therapeutics Inc 24823R105 05/31/2024 Advisory vote on executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 6242434.000000 0.000000 FOR 6242434.000000 FOR S000002922 Denali Therapeutics Inc 24823R105 05/31/2024 Advisory vote on executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 6242434.000000 0.000000 FOR 6242434.000000 FOR 1 S000002922 UnitedHealth Group Incorporated 91324P102 06/03/2024 Election of Director: Charles Baker DIRECTOR ELECTIONS ISSUER 6293482.000000 0.000000 FOR 6293482.000000 FOR S000002922 UnitedHealth Group Incorporated 91324P102 06/03/2024 Election of Director: Timothy Flynn DIRECTOR ELECTIONS ISSUER 6293482.000000 0.000000 FOR 6293482.000000 FOR S000002922 UnitedHealth Group Incorporated 91324P102 06/03/2024 Election of Director: Paul Garcia DIRECTOR ELECTIONS ISSUER 6293482.000000 0.000000 FOR 6293482.000000 FOR S000002922 UnitedHealth Group Incorporated 91324P102 06/03/2024 Election of Director: Kristen Gil DIRECTOR ELECTIONS ISSUER 6293482.000000 0.000000 FOR 6293482.000000 FOR S000002922 UnitedHealth Group Incorporated 91324P102 06/03/2024 Election of Director: Stephen Hemsley DIRECTOR ELECTIONS ISSUER 6293482.000000 0.000000 FOR 6293482.000000 FOR S000002922 UnitedHealth Group Incorporated 91324P102 06/03/2024 Election of Director: Michele Hooper DIRECTOR ELECTIONS ISSUER 6293482.000000 0.000000 FOR 6293482.000000 FOR S000002922 UnitedHealth Group Incorporated 91324P102 06/03/2024 Election of Director: F. William McNabb III DIRECTOR ELECTIONS ISSUER 6293482.000000 0.000000 FOR 6293482.000000 FOR S000002922 UnitedHealth Group Incorporated 91324P102 06/03/2024 Election of Director: Valerie Montgomery Rice, M.D. DIRECTOR ELECTIONS ISSUER 6293482.000000 0.000000 FOR 6293482.000000 FOR S000002922 UnitedHealth Group Incorporated 91324P102 06/03/2024 Election of Director: John Noseworthy, M.D. DIRECTOR ELECTIONS ISSUER 6293482.000000 0.000000 FOR 6293482.000000 FOR S000002922 UnitedHealth Group Incorporated 91324P102 06/03/2024 Election of Director: Andrew Witty DIRECTOR ELECTIONS ISSUER 6293482.000000 0.000000 FOR 6293482.000000 FOR S000002922 UnitedHealth Group Incorporated 91324P102 06/03/2024 Advisory approval of the Company s executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 6293482.000000 0.000000 FOR 6293482.000000 FOR S000002922 UnitedHealth Group Incorporated 91324P102 06/03/2024 Advisory approval of the Company s executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 6293482.000000 0.000000 FOR 6293482.000000 FOR 1 S000002922 UnitedHealth Group Incorporated 91324P102 06/03/2024 Ratification of the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for the Company for the year ending December 31, 2024. AUDIT-RELATED ISSUER 6293482.000000 0.000000 FOR 6293482.000000 FOR S000002922 UnitedHealth Group Incorporated 91324P102 06/03/2024 If properly presented at the 2024 Annual Meeting of Shareholders, the shareholder proposal requiring a political contributions congruency report. OTHER SOCIAL ISSUES SECURITY HOLDER 6293482.000000 0.000000 AGAINST 6293482.000000 FOR S000002922 Morphic Holding, Inc. 61775R105 06/04/2024 Elect Gustav Christensen DIRECTOR ELECTIONS ISSUER 1927084.000000 0.000000 FOR 1927084.000000 FOR S000002922 Morphic Holding, Inc. 61775R105 06/04/2024 Elect Susannah Gray DIRECTOR ELECTIONS ISSUER 1927084.000000 0.000000 FOR 1927084.000000 FOR S000002922 Morphic Holding, Inc. 61775R105 06/04/2024 Elect Amir H. Nashat DIRECTOR ELECTIONS ISSUER 1927084.000000 0.000000 FOR 1927084.000000 FOR S000002922 Morphic Holding, Inc. 61775R105 06/04/2024 Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 1927084.000000 0.000000 FOR 1927084.000000 FOR S000002922 Morphic Holding, Inc. 61775R105 06/04/2024 To approve, on a non-binding advisory basis, the compensation paid to the Company's Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1927084.000000 0.000000 FOR 1927084.000000 FOR S000002922 Morphic Holding, Inc. 61775R105 06/04/2024 To approve, on a non-binding advisory basis, the compensation paid to the Company's Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1927084.000000 0.000000 FOR 1927084.000000 FOR 1 S000002922 Xenon Pharmaceuticals Inc. 98420N105 06/04/2024 Election of Directors: Dawn Svoronos DIRECTOR ELECTIONS ISSUER 2542337.000000 0.000000 FOR 2542337.000000 FOR S000002922 Xenon Pharmaceuticals Inc. 98420N105 06/04/2024 Election of Directors: Gillian Cannon DIRECTOR ELECTIONS ISSUER 2542337.000000 0.000000 FOR 2542337.000000 FOR S000002922 Xenon Pharmaceuticals Inc. 98420N105 06/04/2024 Election of Directors: Steven Gannon DIRECTOR ELECTIONS ISSUER 2542337.000000 0.000000 FOR 2542337.000000 FOR S000002922 Xenon Pharmaceuticals Inc. 98420N105 06/04/2024 Election of Directors: Elizabeth Garofalo DIRECTOR ELECTIONS ISSUER 2542337.000000 0.000000 FOR 2542337.000000 FOR S000002922 Xenon Pharmaceuticals Inc. 98420N105 06/04/2024 Election of Directors: Justin Gover DIRECTOR ELECTIONS ISSUER 2542337.000000 0.000000 FOR 2542337.000000 FOR S000002922 Xenon Pharmaceuticals Inc. 98420N105 06/04/2024 Election of Directors: Pat Machado DIRECTOR ELECTIONS ISSUER 2542337.000000 0.000000 FOR 2542337.000000 FOR S000002922 Xenon Pharmaceuticals Inc. 98420N105 06/04/2024 Election of Directors: Ian Mortimer DIRECTOR ELECTIONS ISSUER 2542337.000000 0.000000 FOR 2542337.000000 FOR S000002922 Xenon Pharmaceuticals Inc. 98420N105 06/04/2024 Election of Directors: Gary Patou DIRECTOR ELECTIONS ISSUER 2542337.000000 0.000000 FOR 2542337.000000 FOR S000002922 Xenon Pharmaceuticals Inc. 98420N105 06/04/2024 Compensation of Named Executive Officers: Approve, on an advisory basis, the compensation of the Corporations named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 2542337.000000 0.000000 FOR 2542337.000000 FOR S000002922 Xenon Pharmaceuticals Inc. 98420N105 06/04/2024 Compensation of Named Executive Officers: Approve, on an advisory basis, the compensation of the Corporations named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 2542337.000000 0.000000 FOR 2542337.000000 FOR 1 S000002922 Xenon Pharmaceuticals Inc. 98420N105 06/04/2024 Amendment to the Amended and Restated 2014 Plan: Approve certain amendments to the Amended and Restated 2014 Equity Incentive Plan, including to increase the maximum number of Common Shares available for issuance thereunder by 5,200,000 COMPENSATION ISSUER 2542337.000000 0.000000 FOR 2542337.000000 FOR S000002922 Xenon Pharmaceuticals Inc. 98420N105 06/04/2024 Appointment of Auditor: Appoint KPMG LLP as the Corporation's auditor to hold office until the next annual meeting of the Corporation or until their successors are duly elected AUDIT-RELATED ISSUER 2542337.000000 0.000000 FOR 2542337.000000 FOR S000002922 Xenon Pharmaceuticals Inc. 98420N105 06/04/2024 Remuneration of Auditor: Authorize the Audit Committee of the board of directors of the Corporation to fix the remuneration to be paid to the auditor of the Corporation AUDIT-RELATED ISSUER 2542337.000000 0.000000 FOR 2542337.000000 FOR S000002922 Apellis Pharmaceuticals, Inc. 03753U106 06/05/2024 Election of two Class I directors to hold office until the 2027 annual meeting of stockholders: Paul Fonteyne DIRECTOR ELECTIONS ISSUER 9503375.000000 0.000000 FOR 9503375.000000 FOR S000002922 Apellis Pharmaceuticals, Inc. 03753U106 06/05/2024 Election of two Class I directors to hold office until the 2027 annual meeting of stockholders: Stephanie Monaghan O Brien DIRECTOR ELECTIONS ISSUER 9503375.000000 0.000000 FOR 9503375.000000 FOR S000002922 Apellis Pharmaceuticals, Inc. 03753U106 06/05/2024 Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 9503375.000000 0.000000 FOR 9503375.000000 FOR S000002922 Apellis Pharmaceuticals, Inc. 03753U106 06/05/2024 Approval of an advisory vote on executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 9503375.000000 0.000000 FOR 9503375.000000 FOR S000002922 Apellis Pharmaceuticals, Inc. 03753U106 06/05/2024 Approval of an advisory vote on executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 9503375.000000 0.000000 FOR 9503375.000000 FOR 1 S000002922 Apogee Therapeutics, Inc. 03770N101 06/05/2024 Elect Andrew Gottesdiener DIRECTOR ELECTIONS ISSUER 1135110.000000 0.000000 FOR 1135110.000000 FOR S000002922 Apogee Therapeutics, Inc. 03770N101 06/05/2024 Elect Peter Harwin DIRECTOR ELECTIONS ISSUER 1135110.000000 0.000000 FOR 1135110.000000 FOR S000002922 Apogee Therapeutics, Inc. 03770N101 06/05/2024 Elect Michael Henderson DIRECTOR ELECTIONS ISSUER 1135110.000000 0.000000 FOR 1135110.000000 FOR S000002922 Apogee Therapeutics, Inc. 03770N101 06/05/2024 Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2024. AUDIT-RELATED ISSUER 1135110.000000 0.000000 FOR 1135110.000000 FOR S000002922 Apogee Therapeutics, Inc. 03770N101 06/05/2024 Approval of the grant of options to purchase 100,000 shares of the Company's common stock to a director, Mark C. McKenna. COMPENSATION ISSUER 1135110.000000 0.000000 FOR 1135110.000000 FOR S000002922 Amicus Therapeutics, Inc. 03152W109 06/06/2024 Elect Eiry W. Roberts DIRECTOR ELECTIONS ISSUER 13772376.000000 0.000000 FOR 13772376.000000 FOR S000002922 Amicus Therapeutics, Inc. 03152W109 06/06/2024 Elect Craig A. Wheeler DIRECTOR ELECTIONS ISSUER 13772376.000000 0.000000 FOR 13772376.000000 FOR S000002922 Amicus Therapeutics, Inc. 03152W109 06/06/2024 Elect Burke W. Whitman DIRECTOR ELECTIONS ISSUER 13772376.000000 0.000000 FOR 13772376.000000 FOR S000002922 Amicus Therapeutics, Inc. 03152W109 06/06/2024 Approval of the Amended and Restated 2007 Equity Incentive Plan to add 7,000,000 shares to the equity pool. COMPENSATION ISSUER 13772376.000000 0.000000 FOR 13772376.000000 FOR S000002922 Amicus Therapeutics, Inc. 03152W109 06/06/2024 Ratify the appointment of Ernst & Young LLP as the Company s independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 13772376.000000 0.000000 FOR 13772376.000000 FOR S000002922 Amicus Therapeutics, Inc. 03152W109 06/06/2024 Approval, on an advisory basis, the Company s executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 13772376.000000 0.000000 FOR 13772376.000000 FOR S000002922 Amicus Therapeutics, Inc. 03152W109 06/06/2024 Approval, on an advisory basis, the Company s executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 13772376.000000 0.000000 FOR 13772376.000000 FOR 1 S000002922 Evolent Health, Inc. 30050B101 06/06/2024 Election of Director: Toyin Ajayi, MD DIRECTOR ELECTIONS ISSUER 3351619.000000 0.000000 FOR 3351619.000000 FOR S000002922 Evolent Health, Inc. 30050B101 06/06/2024 Election of Director: Craig Barbarosh DIRECTOR ELECTIONS ISSUER 3351619.000000 0.000000 FOR 3351619.000000 FOR S000002922 Evolent Health, Inc. 30050B101 06/06/2024 Election of Director: Seth Blackley DIRECTOR ELECTIONS ISSUER 3351619.000000 0.000000 FOR 3351619.000000 FOR S000002922 Evolent Health, Inc. 30050B101 06/06/2024 Election of Director: M. Bridget Duffy, MD DIRECTOR ELECTIONS ISSUER 3351619.000000 0.000000 FOR 3351619.000000 FOR S000002922 Evolent Health, Inc. 30050B101 06/06/2024 Election of Director: Russell Glass DIRECTOR ELECTIONS ISSUER 3351619.000000 0.000000 FOR 3351619.000000 FOR S000002922 Evolent Health, Inc. 30050B101 06/06/2024 Election of Director: Peter Grua DIRECTOR ELECTIONS ISSUER 3351619.000000 0.000000 FOR 3351619.000000 FOR S000002922 Evolent Health, Inc. 30050B101 06/06/2024 Election of Director: Diane Holder DIRECTOR ELECTIONS ISSUER 3351619.000000 0.000000 FOR 3351619.000000 FOR S000002922 Evolent Health, Inc. 30050B101 06/06/2024 Election of Director: Richard Jelinek DIRECTOR ELECTIONS ISSUER 3351619.000000 0.000000 FOR 3351619.000000 FOR S000002922 Evolent Health, Inc. 30050B101 06/06/2024 Election of Director: Kim Keck DIRECTOR ELECTIONS ISSUER 3351619.000000 0.000000 FOR 3351619.000000 FOR S000002922 Evolent Health, Inc. 30050B101 06/06/2024 Election of Director: Cheryl Scott DIRECTOR ELECTIONS ISSUER 3351619.000000 0.000000 FOR 3351619.000000 FOR S000002922 Evolent Health, Inc. 30050B101 06/06/2024 Proposal to ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 3351619.000000 0.000000 FOR 3351619.000000 FOR S000002922 Evolent Health, Inc. 30050B101 06/06/2024 Proposal to approve the compensation of our named executive officers for 2023 on an advisory basis. SECTION 14A SAY-ON-PAY VOTES ISSUER 3351619.000000 0.000000 FOR 3351619.000000 FOR S000002922 Evolent Health, Inc. 30050B101 06/06/2024 Proposal to approve the compensation of our named executive officers for 2023 on an advisory basis. SECTION 14A SAY-ON-PAY VOTES ISSUER 3351619.000000 0.000000 FOR 3351619.000000 FOR 1 S000002922 Evolent Health, Inc. 30050B101 06/06/2024 Proposal to approve the selection of the frequency of future advisory votes on executive compensation on an advisory basis. SECTION 14A SAY-ON-PAY VOTES ISSUER 3351619.000000 0.000000 ONE YEAR 3351619.000000 FOR S000002922 Evolent Health, Inc. 30050B101 06/06/2024 Proposal to approve the selection of the frequency of future advisory votes on executive compensation on an advisory basis. SECTION 14A SAY-ON-PAY VOTES ISSUER 3351619.000000 0.000000 ONE YEAR 3351619.000000 FOR 1 S000002922 Ionis Pharmaceuticals, Inc. 462222100 06/06/2024 Election of Director: Brett P. Monia DIRECTOR ELECTIONS ISSUER 3591680.000000 0.000000 FOR 3591680.000000 FOR S000002922 Ionis Pharmaceuticals, Inc. 462222100 06/06/2024 Election of Director: Michael Yang DIRECTOR ELECTIONS ISSUER 3591680.000000 0.000000 FOR 3591680.000000 FOR S000002922 Ionis Pharmaceuticals, Inc. 462222100 06/06/2024 To make an advisory vote on executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 3591680.000000 0.000000 FOR 3591680.000000 FOR S000002922 Ionis Pharmaceuticals, Inc. 462222100 06/06/2024 To make an advisory vote on executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 3591680.000000 0.000000 FOR 3591680.000000 FOR 1 S000002922 Ionis Pharmaceuticals, Inc. 462222100 06/06/2024 To approve an amendment of the Ionis Pharmaceuticals, Inc. 2011 Equity Incentive Plan to increase the aggregate number of shares of common stock authorized for issuance under such plan by 3,300,000 shares to an aggregate of 38,500,000 shares and to prohibit certain share recycling on full value awards. COMPENSATION ISSUER 3591680.000000 0.000000 FOR 3591680.000000 FOR S000002922 Ionis Pharmaceuticals, Inc. 462222100 06/06/2024 To ratify the Audit Committee s selection of Ernst & Young LLP as independent auditors for the 2024 fiscal year. AUDIT-RELATED ISSUER 3591680.000000 0.000000 FOR 3591680.000000 FOR S000002922 Sarepta Therapeutics, Inc. 803607100 06/06/2024 Election of Class I Director to hold office until the 2026 annual meeting of stockholders, or until their successors are earlier elected: Douglas S. Ingram DIRECTOR ELECTIONS ISSUER 1914236.000000 0.000000 FOR 1914236.000000 FOR S000002922 Sarepta Therapeutics, Inc. 803607100 06/06/2024 Election of Class I Director to hold office until the 2026 annual meeting of stockholders, or until their successors are earlier elected: Hans Wigzell, M.D. Ph.D. DIRECTOR ELECTIONS ISSUER 1914236.000000 0.000000 FOR 1914236.000000 FOR S000002922 Sarepta Therapeutics, Inc. 803607100 06/06/2024 Election of Class I Director to hold office until the 2026 annual meeting of stockholders, or until their successors are earlier elected: Kathryn J. Boor, Ph.D. DIRECTOR ELECTIONS ISSUER 1914236.000000 0.000000 FOR 1914236.000000 FOR S000002922 Sarepta Therapeutics, Inc. 803607100 06/06/2024 Election of Class I Director to hold office until the 2026 annual meeting of stockholders, or until their successors are earlier elected: Michael Chambers DIRECTOR ELECTIONS ISSUER 1914236.000000 0.000000 FOR 1914236.000000 FOR S000002922 Sarepta Therapeutics, Inc. 803607100 06/06/2024 Advisory vote to approve, on a non-binding basis, named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 1914236.000000 0.000000 FOR 1914236.000000 FOR S000002922 Sarepta Therapeutics, Inc. 803607100 06/06/2024 Advisory vote to approve, on a non-binding basis, named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 1914236.000000 0.000000 FOR 1914236.000000 FOR 1 S000002922 Sarepta Therapeutics, Inc. 803607100 06/06/2024 Ratify the selection of KPMG LLP as the Company s independent registered public accounting firm for the current year ending December 31, 2024. AUDIT-RELATED ISSUER 1914236.000000 0.000000 FOR 1914236.000000 FOR S000002922 Surgery Partners 86881A100 06/06/2024 Election of Class III Director: Clifford G. Adlerz DIRECTOR ELECTIONS ISSUER 3609838.000000 0.000000 FOR 3609838.000000 FOR S000002922 Surgery Partners 86881A100 06/06/2024 Election of Class III Director: J. Eric Evans DIRECTOR ELECTIONS ISSUER 3609838.000000 0.000000 FOR 3609838.000000 FOR S000002922 Surgery Partners 86881A100 06/06/2024 Election of Class III Director: Blair E. Hendrix DIRECTOR ELECTIONS ISSUER 3609838.000000 0.000000 FOR 3609838.000000 FOR S000002922 Surgery Partners 86881A100 06/06/2024 Election of Class III Director: Andrew T. Kaplan DIRECTOR ELECTIONS ISSUER 3609838.000000 0.000000 FOR 3609838.000000 FOR S000002922 Surgery Partners 86881A100 06/06/2024 Approval, on an advisory basis, of the compensation paid by the Company to its named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 3609838.000000 0.000000 FOR 3609838.000000 FOR S000002922 Surgery Partners 86881A100 06/06/2024 Approval, on an advisory basis, of the compensation paid by the Company to its named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 3609838.000000 0.000000 FOR 3609838.000000 FOR 1 S000002922 Surgery Partners 86881A100 06/06/2024 Approval of the Surgery Partners, Inc. Employee Stock Purchase Plan. COMPENSATION ISSUER 3609838.000000 0.000000 FOR 3609838.000000 FOR S000002922 Surgery Partners 86881A100 06/06/2024 Ratification of the appointment of Deloitte & Touche LLP as the Company s independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 3609838.000000 0.000000 FOR 3609838.000000 FOR S000002922 Vaxcyte, Inc. 92243G108 06/06/2024 Elect Annie Drapeau DIRECTOR ELECTIONS ISSUER 2633933.000000 0.000000 FOR 2633933.000000 FOR S000002922 Vaxcyte, Inc. 92243G108 06/06/2024 Elect Teri Loxam DIRECTOR ELECTIONS ISSUER 2633933.000000 0.000000 FOR 2633933.000000 FOR S000002922 Vaxcyte, Inc. 92243G108 06/06/2024 Elect Carlos Paya DIRECTOR ELECTIONS ISSUER 2633933.000000 0.000000 FOR 2633933.000000 FOR S000002922 Vaxcyte, Inc. 92243G108 06/06/2024 Ratification of the appointment of Deloitte & Touche LLP as the Company s independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 2633933.000000 0.000000 FOR 2633933.000000 FOR S000002922 Vaxcyte, Inc. 92243G108 06/06/2024 Approval, on a non-binding, advisory basis, of the compensation of the Company s named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 2633933.000000 0.000000 FOR 2633933.000000 FOR S000002922 Vaxcyte, Inc. 92243G108 06/06/2024 Approval, on a non-binding, advisory basis, of the compensation of the Company s named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 2633933.000000 0.000000 FOR 2633933.000000 FOR 1 S000002922 Akero Therapeutics, Inc. 00973Y108 06/07/2024 Elect Seth L. Harrison DIRECTOR ELECTIONS ISSUER 1543035.000000 0.000000 WITHHOLD 1543035.000000 AGAINST S000002922 Akero Therapeutics, Inc. 00973Y108 06/07/2024 Elect Graham Walmsley DIRECTOR ELECTIONS ISSUER 1543035.000000 0.000000 FOR 1543035.000000 FOR S000002922 Akero Therapeutics, Inc. 00973Y108 06/07/2024 Elect Yuan Xu DIRECTOR ELECTIONS ISSUER 1543035.000000 0.000000 WITHHOLD 1543035.000000 AGAINST S000002922 Akero Therapeutics, Inc. 00973Y108 06/07/2024 To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 1543035.000000 0.000000 FOR 1543035.000000 FOR S000002922 Akero Therapeutics, Inc. 00973Y108 06/07/2024 To consider and act upon a non-binding, advisory vote to approve the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1543035.000000 0.000000 FOR 1543035.000000 FOR S000002922 Akero Therapeutics, Inc. 00973Y108 06/07/2024 To consider and act upon a non-binding, advisory vote to approve the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1543035.000000 0.000000 FOR 1543035.000000 FOR 1 S000002922 Akero Therapeutics, Inc. 00973Y108 06/07/2024 To approve an Amendment to our Fourth Amended and Restated Certificate of Incorporation, to limit the liability of certain officers of Akero Therapeutics, Inc., as permitted by recent amendments to Delaware law. CORPORATE GOVERNANCE ISSUER 1543035.000000 0.000000 FOR 1543035.000000 FOR S000002922 Sage Therapeutics, Inc. 78667J108 06/10/2024 Elect Elizabeth Barrett DIRECTOR ELECTIONS ISSUER 4079009.000000 0.000000 FOR 4079009.000000 FOR S000002922 Sage Therapeutics, Inc. 78667J108 06/10/2024 Elect Geno Germano DIRECTOR ELECTIONS ISSUER 4079009.000000 0.000000 FOR 4079009.000000 FOR S000002922 Sage Therapeutics, Inc. 78667J108 06/10/2024 To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024 AUDIT-RELATED ISSUER 4079009.000000 0.000000 FOR 4079009.000000 FOR S000002922 Sage Therapeutics, Inc. 78667J108 06/10/2024 To hold a non-binding advisory vote to approve the compensation paid to our named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 4079009.000000 0.000000 FOR 4079009.000000 FOR S000002922 Sage Therapeutics, Inc. 78667J108 06/10/2024 To hold a non-binding advisory vote to approve the compensation paid to our named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 4079009.000000 0.000000 FOR 4079009.000000 FOR 1 S000002922 Sage Therapeutics, Inc. 78667J108 06/10/2024 To approve the Sage Therapeutics, Inc. 2024 Equity Incentive Plan COMPENSATION ISSUER 4079009.000000 0.000000 FOR 4079009.000000 FOR S000002922 Blueprint Medicines Corporation 09627Y109 06/12/2024 Elect Daniella Beckman DIRECTOR ELECTIONS ISSUER 2149647.000000 0.000000 FOR 2149647.000000 FOR S000002922 Blueprint Medicines Corporation 09627Y109 06/12/2024 Elect Habib J. Dable DIRECTOR ELECTIONS ISSUER 2149647.000000 0.000000 FOR 2149647.000000 FOR S000002922 Blueprint Medicines Corporation 09627Y109 06/12/2024 Elect Lynn Seely DIRECTOR ELECTIONS ISSUER 2149647.000000 0.000000 FOR 2149647.000000 FOR S000002922 Blueprint Medicines Corporation 09627Y109 06/12/2024 Approval of a non-binding advisory vote on the frequency of future advisory votes on the compensation paid to our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 2149647.000000 0.000000 ONE YEAR 2149647.000000 FOR S000002922 Blueprint Medicines Corporation 09627Y109 06/12/2024 Approval of a non-binding advisory vote on the frequency of future advisory votes on the compensation paid to our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 2149647.000000 0.000000 ONE YEAR 2149647.000000 FOR 1 S000002922 Blueprint Medicines Corporation 09627Y109 06/12/2024 Approval of a non-binding advisory vote on the compensation paid to our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 2149647.000000 0.000000 FOR 2149647.000000 FOR S000002922 Blueprint Medicines Corporation 09627Y109 06/12/2024 Approval of a non-binding advisory vote on the compensation paid to our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 2149647.000000 0.000000 FOR 2149647.000000 FOR 1 S000002922 Blueprint Medicines Corporation 09627Y109 06/12/2024 Approval of the Blueprint Medicines Corporation 2024 Stock Incentive Plan. COMPENSATION ISSUER 2149647.000000 0.000000 FOR 2149647.000000 FOR S000002922 Blueprint Medicines Corporation 09627Y109 06/12/2024 Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 2149647.000000 0.000000 FOR 2149647.000000 FOR S000002922 Intellia Therapeutics, Inc. 45826J105 06/12/2024 Elect Fred E. Cohen DIRECTOR ELECTIONS ISSUER 3296787.000000 0.000000 FOR 3296787.000000 FOR S000002922 Intellia Therapeutics, Inc. 45826J105 06/12/2024 Elect Frank Verwiel DIRECTOR ELECTIONS ISSUER 3296787.000000 0.000000 FOR 3296787.000000 FOR S000002922 Intellia Therapeutics, Inc. 45826J105 06/12/2024 Ratification of the appointment of Deloitte & Touche LLP as Intellia s independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 3296787.000000 0.000000 FOR 3296787.000000 FOR S000002922 Intellia Therapeutics, Inc. 45826J105 06/12/2024 Approve, on a non-binding advisory basis, the compensation of the named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 3296787.000000 0.000000 FOR 3296787.000000 FOR S000002922 Intellia Therapeutics, Inc. 45826J105 06/12/2024 Approve, on a non-binding advisory basis, the compensation of the named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 3296787.000000 0.000000 FOR 3296787.000000 FOR 1 S000002922 Intellia Therapeutics, Inc. 45826J105 06/12/2024 Approval of a second amendment to our Second Amended and Restated Certificate of Incorporation, as amended, to limit the liability of certain officers of the Company as permitted by recent amendments to the Delaware General Corporation Law. CORPORATE GOVERNANCE ISSUER 3296787.000000 0.000000 FOR 3296787.000000 FOR S000002922 Celldex Therapeutics, Inc. 15117B202 06/13/2024 Election of Directors: Karen L. Shoos DIRECTOR ELECTIONS ISSUER 3369316.000000 0.000000 FOR 3369316.000000 FOR S000002922 Celldex Therapeutics, Inc. 15117B202 06/13/2024 Election of Directors: Anthony S. Marucci DIRECTOR ELECTIONS ISSUER 3369316.000000 0.000000 FOR 3369316.000000 FOR S000002922 Celldex Therapeutics, Inc. 15117B202 06/13/2024 Election of Directors: Keith L. Brownlie DIRECTOR ELECTIONS ISSUER 3369316.000000 0.000000 FOR 3369316.000000 FOR S000002922 Celldex Therapeutics, Inc. 15117B202 06/13/2024 Election of Directors: Cheryl L. Cohen DIRECTOR ELECTIONS ISSUER 3369316.000000 0.000000 FOR 3369316.000000 FOR S000002922 Celldex Therapeutics, Inc. 15117B202 06/13/2024 Election of Directors: Herbert J. Conrad DIRECTOR ELECTIONS ISSUER 3369316.000000 0.000000 FOR 3369316.000000 FOR S000002922 Celldex Therapeutics, Inc. 15117B202 06/13/2024 Election of Directors: Rita I. Jain, M.D. DIRECTOR ELECTIONS ISSUER 3369316.000000 0.000000 FOR 3369316.000000 FOR S000002922 Celldex Therapeutics, Inc. 15117B202 06/13/2024 Election of Directors: James J. Marino DIRECTOR ELECTIONS ISSUER 3369316.000000 0.000000 FOR 3369316.000000 FOR S000002922 Celldex Therapeutics, Inc. 15117B202 06/13/2024 Election of Directors: Garry A. Neil, M.D. DIRECTOR ELECTIONS ISSUER 3369316.000000 0.000000 FOR 3369316.000000 FOR S000002922 Celldex Therapeutics, Inc. 15117B202 06/13/2024 Election of Directors: Harry H. Penner, Jr. DIRECTOR ELECTIONS ISSUER 3369316.000000 0.000000 FOR 3369316.000000 FOR S000002922 Celldex Therapeutics, Inc. 15117B202 06/13/2024 To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the year ending December 31, 2024. AUDIT-RELATED ISSUER 3369316.000000 0.000000 FOR 3369316.000000 FOR S000002922 Celldex Therapeutics, Inc. 15117B202 06/13/2024 To approve an amendment to our 2021 Omnibus Equity Incentive Plan, including an increase in the number of shares reserved for issuance thereunder by 3,200,000 shares to 7,500,000 shares. COMPENSATION ISSUER 3369316.000000 0.000000 FOR 3369316.000000 FOR S000002922 Celldex Therapeutics, Inc. 15117B202 06/13/2024 To approve, on an advisory basis, the compensation of the Company's Named Executive Officers as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 3369316.000000 0.000000 FOR 3369316.000000 FOR S000002922 Celldex Therapeutics, Inc. 15117B202 06/13/2024 To approve, on an advisory basis, the compensation of the Company's Named Executive Officers as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 3369316.000000 0.000000 FOR 3369316.000000 FOR 1 S000002922 Exact Sciences Corporation 30063P105 06/13/2024 To elect three members of the Board of Directors to serve for one-year terms as Class III Directors: Michael Barber DIRECTOR ELECTIONS ISSUER 2657237.000000 0.000000 FOR 2657237.000000 FOR S000002922 Exact Sciences Corporation 30063P105 06/13/2024 To elect three members of the Board of Directors to serve for one-year terms as Class III Directors: Paul Clancy DIRECTOR ELECTIONS ISSUER 2657237.000000 0.000000 FOR 2657237.000000 FOR S000002922 Exact Sciences Corporation 30063P105 06/13/2024 To elect three members of the Board of Directors to serve for one-year terms as Class III Directors: Daniel Levangie DIRECTOR ELECTIONS ISSUER 2657237.000000 0.000000 FOR 2657237.000000 FOR S000002922 Exact Sciences Corporation 30063P105 06/13/2024 To ratify the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for 2024. AUDIT-RELATED ISSUER 2657237.000000 0.000000 FOR 2657237.000000 FOR S000002922 Exact Sciences Corporation 30063P105 06/13/2024 To approve, on an advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 2657237.000000 0.000000 FOR 2657237.000000 FOR S000002922 Exact Sciences Corporation 30063P105 06/13/2024 To approve, on an advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 2657237.000000 0.000000 FOR 2657237.000000 FOR 1 S000002922 Rocket Pharmaceuticals, Inc. 77313F106 06/13/2024 Election of Directors: Roderick Wong, M.D. DIRECTOR ELECTIONS ISSUER 4913120.000000 0.000000 FOR 4913120.000000 FOR S000002922 Rocket Pharmaceuticals, Inc. 77313F106 06/13/2024 Election of Directors: Elisabeth Bjork, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 4913120.000000 0.000000 FOR 4913120.000000 FOR S000002922 Rocket Pharmaceuticals, Inc. 77313F106 06/13/2024 Election of Directors: Carsten Boess DIRECTOR ELECTIONS ISSUER 4913120.000000 0.000000 FOR 4913120.000000 FOR S000002922 Rocket Pharmaceuticals, Inc. 77313F106 06/13/2024 Election of Directors: Pedro Granadillo DIRECTOR ELECTIONS ISSUER 4913120.000000 0.000000 FOR 4913120.000000 FOR S000002922 Rocket Pharmaceuticals, Inc. 77313F106 06/13/2024 Election of Directors: Gotham Makker, M.D. DIRECTOR ELECTIONS ISSUER 4913120.000000 0.000000 FOR 4913120.000000 FOR S000002922 Rocket Pharmaceuticals, Inc. 77313F106 06/13/2024 Election of Directors: Fady Malik, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 4913120.000000 0.000000 FOR 4913120.000000 FOR S000002922 Rocket Pharmaceuticals, Inc. 77313F106 06/13/2024 Election of Directors: Gaurav Shah, M.D. DIRECTOR ELECTIONS ISSUER 4913120.000000 0.000000 FOR 4913120.000000 FOR S000002922 Rocket Pharmaceuticals, Inc. 77313F106 06/13/2024 Election of Directors: David P. Southwell DIRECTOR ELECTIONS ISSUER 4913120.000000 0.000000 FOR 4913120.000000 FOR S000002922 Rocket Pharmaceuticals, Inc. 77313F106 06/13/2024 Election of Directors: R. Keith Woods DIRECTOR ELECTIONS ISSUER 4913120.000000 0.000000 FOR 4913120.000000 FOR S000002922 Rocket Pharmaceuticals, Inc. 77313F106 06/13/2024 Election of Directors: Naveen Yalamanchi, M.D. DIRECTOR ELECTIONS ISSUER 4913120.000000 0.000000 FOR 4913120.000000 FOR S000002922 Rocket Pharmaceuticals, Inc. 77313F106 06/13/2024 Ratification of the appointment of EisnerAmper LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 4913120.000000 0.000000 FOR 4913120.000000 FOR S000002922 Rocket Pharmaceuticals, Inc. 77313F106 06/13/2024 Approval of the compensation of the Company's named executive officers, on a non-binding, advisory basis. SECTION 14A SAY-ON-PAY VOTES ISSUER 4913120.000000 0.000000 FOR 4913120.000000 FOR S000002922 Rocket Pharmaceuticals, Inc. 77313F106 06/13/2024 Approval of the compensation of the Company's named executive officers, on a non-binding, advisory basis. SECTION 14A SAY-ON-PAY VOTES ISSUER 4913120.000000 0.000000 FOR 4913120.000000 FOR 1 S000002922 Rocket Pharmaceuticals, Inc. 77313F106 06/13/2024 Approval of an amendment to the Company's Seventh Amended and Restated Certificate of Incorporation to increase the number of authorized shares of common stock. CAPITAL STRUCTURE ISSUER 4913120.000000 0.000000 FOR 4913120.000000 FOR S000002922 Eisai Co., Ltd. JP3160400002 06/14/2024 Elect Haruo Naito DIRECTOR ELECTIONS ISSUER 19123817.000000 0.000000 FOR 19123817.000000 FOR S000002922 Eisai Co., Ltd. JP3160400002 06/14/2024 Elect Yumiko Miwa @ Yumiko Shibata DIRECTOR ELECTIONS ISSUER 19123817.000000 0.000000 FOR 19123817.000000 FOR S000002922 Eisai Co., Ltd. JP3160400002 06/14/2024 Elect Fumihiko Ike DIRECTOR ELECTIONS ISSUER 19123817.000000 0.000000 FOR 19123817.000000 FOR S000002922 Eisai Co., Ltd. JP3160400002 06/14/2024 Elect Yoshiteru Kato DIRECTOR ELECTIONS ISSUER 19123817.000000 0.000000 FOR 19123817.000000 FOR S000002922 Eisai Co., Ltd. JP3160400002 06/14/2024 Elect Ryota Miura DIRECTOR ELECTIONS ISSUER 19123817.000000 0.000000 FOR 19123817.000000 FOR S000002922 Eisai Co., Ltd. JP3160400002 06/14/2024 Elect Hiroyuki Kato DIRECTOR ELECTIONS ISSUER 19123817.000000 0.000000 FOR 19123817.000000 FOR S000002922 Eisai Co., Ltd. JP3160400002 06/14/2024 Elect Richard Thornley DIRECTOR ELECTIONS ISSUER 19123817.000000 0.000000 FOR 19123817.000000 FOR S000002922 Eisai Co., Ltd. JP3160400002 06/14/2024 Elect Toru Moriyama DIRECTOR ELECTIONS ISSUER 19123817.000000 0.000000 FOR 19123817.000000 FOR S000002922 Eisai Co., Ltd. JP3160400002 06/14/2024 Elect Yuko Yasuda DIRECTOR ELECTIONS ISSUER 19123817.000000 0.000000 FOR 19123817.000000 FOR S000002922 Eisai Co., Ltd. JP3160400002 06/14/2024 Elect Takuji Kanai DIRECTOR ELECTIONS ISSUER 19123817.000000 0.000000 FOR 19123817.000000 FOR S000002922 Eisai Co., Ltd. JP3160400002 06/14/2024 Elect Kenta Takahashi DIRECTOR ELECTIONS ISSUER 19123817.000000 0.000000 FOR 19123817.000000 FOR S000002922 Regeneron Pharmaceuticals, Inc. 75886F107 06/14/2024 Election of Director: N. Anthony Coles, M.D. DIRECTOR ELECTIONS ISSUER 675638.000000 0.000000 FOR 675638.000000 FOR S000002922 Regeneron Pharmaceuticals, Inc. 75886F107 06/14/2024 Election of Director: Kathryn Guarini, Ph.D. DIRECTOR ELECTIONS ISSUER 675638.000000 0.000000 FOR 675638.000000 FOR S000002922 Regeneron Pharmaceuticals, Inc. 75886F107 06/14/2024 Election of Director: Arthur F. Ryan DIRECTOR ELECTIONS ISSUER 675638.000000 0.000000 FOR 675638.000000 FOR S000002922 Regeneron Pharmaceuticals, Inc. 75886F107 06/14/2024 Election of Director: David P. Schenkein, M.D. DIRECTOR ELECTIONS ISSUER 675638.000000 0.000000 FOR 675638.000000 FOR S000002922 Regeneron Pharmaceuticals, Inc. 75886F107 06/14/2024 Election of Director: George L. Sing DIRECTOR ELECTIONS ISSUER 675638.000000 0.000000 FOR 675638.000000 FOR S000002922 Regeneron Pharmaceuticals, Inc. 75886F107 06/14/2024 Ratification of the appointment of PricewaterhouseCoopers LLP as the Company s independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 675638.000000 0.000000 FOR 675638.000000 FOR S000002922 Regeneron Pharmaceuticals, Inc. 75886F107 06/14/2024 Proposal to approve, on an advisory basis, executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 675638.000000 0.000000 FOR 675638.000000 FOR S000002922 Regeneron Pharmaceuticals, Inc. 75886F107 06/14/2024 Proposal to approve, on an advisory basis, executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 675638.000000 0.000000 FOR 675638.000000 FOR 1 S000002922 Regeneron Pharmaceuticals, Inc. 75886F107 06/14/2024 Non-binding shareholder proposal requesting simple majority voting requirements, if properly presented. SHAREHOLDER RIGHTS AND DEFENSES SECURITY HOLDER 675638.000000 0.000000 FOR 675638.000000 AGAINST S000002922 TG Therapeutics, Inc. 88322Q108 06/14/2024 Elect Laurence N. Charney DIRECTOR ELECTIONS ISSUER 3066304.000000 0.000000 FOR 3066304.000000 FOR S000002922 TG Therapeutics, Inc. 88322Q108 06/14/2024 Elect Yann Echelard DIRECTOR ELECTIONS ISSUER 3066304.000000 0.000000 FOR 3066304.000000 FOR S000002922 TG Therapeutics, Inc. 88322Q108 06/14/2024 Elect Kenneth Hoberman DIRECTOR ELECTIONS ISSUER 3066304.000000 0.000000 FOR 3066304.000000 FOR S000002922 TG Therapeutics, Inc. 88322Q108 06/14/2024 Elect Daniel Hume DIRECTOR ELECTIONS ISSUER 3066304.000000 0.000000 FOR 3066304.000000 FOR S000002922 TG Therapeutics, Inc. 88322Q108 06/14/2024 Elect Sagar Lonial DIRECTOR ELECTIONS ISSUER 3066304.000000 0.000000 FOR 3066304.000000 FOR S000002922 TG Therapeutics, Inc. 88322Q108 06/14/2024 Elect Michael S. Weiss DIRECTOR ELECTIONS ISSUER 3066304.000000 0.000000 FOR 3066304.000000 FOR S000002922 TG Therapeutics, Inc. 88322Q108 06/14/2024 To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the year ending December 31, 2024. AUDIT-RELATED ISSUER 3066304.000000 0.000000 FOR 3066304.000000 FOR S000002922 TG Therapeutics, Inc. 88322Q108 06/14/2024 An advisory vote to approve the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 3066304.000000 0.000000 AGAINST 3066304.000000 AGAINST S000002922 TG Therapeutics, Inc. 88322Q108 06/14/2024 An advisory vote to approve the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 3066304.000000 0.000000 AGAINST 3066304.000000 AGAINST 1 S000002922 TG Therapeutics, Inc. 88322Q108 06/14/2024 To approve an amendment to our Certificate of Incorporation to increase the number of authorized shares of common stock from 175,000,000 to 190,000,000. CAPITAL STRUCTURE ISSUER 3066304.000000 0.000000 FOR 3066304.000000 FOR S000002922 TG Therapeutics, Inc. 88322Q108 06/14/2024 To approve an amendment to the Company s 2022 Incentive Plan to remove the full-value awards limit. COMPENSATION ISSUER 3066304.000000 0.000000 FOR 3066304.000000 FOR S000002922 DAIICHI SANKYO COMPANY, LIMITED JP3475350009 06/17/2024 Allocation of Profits/Dividends CAPITAL STRUCTURE ISSUER 40320290.000000 0.000000 FOR 40320290.000000 FOR S000002922 DAIICHI SANKYO COMPANY, LIMITED JP3475350009 06/17/2024 Elect Sunao Manabe DIRECTOR ELECTIONS ISSUER 40320290.000000 0.000000 FOR 40320290.000000 FOR S000002922 DAIICHI SANKYO COMPANY, LIMITED JP3475350009 06/17/2024 Elect Hiroyuki Okuzawa DIRECTOR ELECTIONS ISSUER 40320290.000000 0.000000 FOR 40320290.000000 FOR S000002922 DAIICHI SANKYO COMPANY, LIMITED JP3475350009 06/17/2024 Elect Shoji Hirashima DIRECTOR ELECTIONS ISSUER 40320290.000000 0.000000 FOR 40320290.000000 FOR S000002922 DAIICHI SANKYO COMPANY, LIMITED JP3475350009 06/17/2024 Elect Takashi Fukuoka DIRECTOR ELECTIONS ISSUER 40320290.000000 0.000000 FOR 40320290.000000 FOR S000002922 DAIICHI SANKYO COMPANY, LIMITED JP3475350009 06/17/2024 Elect Kazuaki Kama DIRECTOR ELECTIONS ISSUER 40320290.000000 0.000000 FOR 40320290.000000 FOR S000002922 DAIICHI SANKYO COMPANY, LIMITED JP3475350009 06/17/2024 Elect Sawako Nohara DIRECTOR ELECTIONS ISSUER 40320290.000000 0.000000 FOR 40320290.000000 FOR S000002922 DAIICHI SANKYO COMPANY, LIMITED JP3475350009 06/17/2024 Elect Yasuhiro Komatsu DIRECTOR ELECTIONS ISSUER 40320290.000000 0.000000 FOR 40320290.000000 FOR S000002922 DAIICHI SANKYO COMPANY, LIMITED JP3475350009 06/17/2024 Elect Takaaki Nishii DIRECTOR ELECTIONS ISSUER 40320290.000000 0.000000 FOR 40320290.000000 FOR S000002922 DAIICHI SANKYO COMPANY, LIMITED JP3475350009 06/17/2024 Elect Takashi Matsumoto DIRECTOR ELECTIONS ISSUER 40320290.000000 0.000000 FOR 40320290.000000 FOR S000002922 DAIICHI SANKYO COMPANY, LIMITED JP3475350009 06/17/2024 Elect Yo Honma DIRECTOR ELECTIONS ISSUER 40320290.000000 0.000000 FOR 40320290.000000 FOR S000002922 Kymera Therapeutics, Inc. 501575104 06/18/2024 Elect Pamela Esposito DIRECTOR ELECTIONS ISSUER 1446764.000000 0.000000 FOR 1446764.000000 FOR S000002922 Kymera Therapeutics, Inc. 501575104 06/18/2024 Elect Gorjan Hrustanovic DIRECTOR ELECTIONS ISSUER 1446764.000000 0.000000 FOR 1446764.000000 FOR S000002922 Kymera Therapeutics, Inc. 501575104 06/18/2024 Elect Victor Sandor DIRECTOR ELECTIONS ISSUER 1446764.000000 0.000000 FOR 1446764.000000 FOR S000002922 Kymera Therapeutics, Inc. 501575104 06/18/2024 To approve, on a non-binding advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1446764.000000 0.000000 FOR 1446764.000000 FOR S000002922 Kymera Therapeutics, Inc. 501575104 06/18/2024 To approve, on a non-binding advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1446764.000000 0.000000 FOR 1446764.000000 FOR 1 S000002922 Kymera Therapeutics, Inc. 501575104 06/18/2024 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 1446764.000000 0.000000 FOR 1446764.000000 FOR S000002922 Kymera Therapeutics, Inc. 501575104 06/18/2024 To approve an amendment to the Kymera Therapeutics, Inc. 2020 Stock Option and Incentive Plan. COMPENSATION ISSUER 1446764.000000 0.000000 FOR 1446764.000000 FOR S000002922 PTC Therapeutics, Inc. 69366J200 06/18/2024 Elect Emma Reeve DIRECTOR ELECTIONS ISSUER 3393863.000000 0.000000 FOR 3393863.000000 FOR S000002922 PTC Therapeutics, Inc. 69366J200 06/18/2024 Elect Michael Schmertzler DIRECTOR ELECTIONS ISSUER 3393863.000000 0.000000 FOR 3393863.000000 FOR S000002922 PTC Therapeutics, Inc. 69366J200 06/18/2024 Elect Mary Smith DIRECTOR ELECTIONS ISSUER 3393863.000000 0.000000 FOR 3393863.000000 FOR S000002922 PTC Therapeutics, Inc. 69366J200 06/18/2024 Elect Glenn D. Steele, Jr. DIRECTOR ELECTIONS ISSUER 3393863.000000 0.000000 FOR 3393863.000000 FOR S000002922 PTC Therapeutics, Inc. 69366J200 06/18/2024 Ratification of the appointment of Ernst & Young LLP as the Company s independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 3393863.000000 0.000000 FOR 3393863.000000 FOR S000002922 PTC Therapeutics, Inc. 69366J200 06/18/2024 Approval on a non-binding, advisory basis, of the Company s named executive officer compensation as described in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 3393863.000000 0.000000 FOR 3393863.000000 FOR S000002922 PTC Therapeutics, Inc. 69366J200 06/18/2024 Approval on a non-binding, advisory basis, of the Company s named executive officer compensation as described in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 3393863.000000 0.000000 FOR 3393863.000000 FOR 1 S000002922 Zai Lab Limited 98887Q104 06/18/2024 Re-election of Director to serve until the 2025 annual general meeting of shareholders: Samantha (Ying) Du DIRECTOR ELECTIONS ISSUER 2597074.000000 216980.000000 FOR 2597074.000000 FOR S000002922 Zai Lab Limited 98887Q104 06/18/2024 Re-election of Director to serve until the 2025 annual general meeting of shareholders: Kai-Xian Chen DIRECTOR ELECTIONS ISSUER 2597074.000000 216980.000000 AGAINST 2597074.000000 AGAINST S000002922 Zai Lab Limited 98887Q104 06/18/2024 Re-election of Director to serve until the 2025 annual general meeting of shareholders: John D. Diekman DIRECTOR ELECTIONS ISSUER 2597074.000000 216980.000000 FOR 2597074.000000 FOR S000002922 Zai Lab Limited 98887Q104 06/18/2024 Re-election of Director to serve until the 2025 annual general meeting of shareholders: Richard Gaynor DIRECTOR ELECTIONS ISSUER 2597074.000000 216980.000000 FOR 2597074.000000 FOR S000002922 Zai Lab Limited 98887Q104 06/18/2024 Re-election of Director to serve until the 2025 annual general meeting of shareholders: Nisa Leung DIRECTOR ELECTIONS ISSUER 2597074.000000 216980.000000 FOR 2597074.000000 FOR S000002922 Zai Lab Limited 98887Q104 06/18/2024 Re-election of Director to serve until the 2025 annual general meeting of shareholders: William Lis DIRECTOR ELECTIONS ISSUER 2597074.000000 216980.000000 FOR 2597074.000000 FOR S000002922 Zai Lab Limited 98887Q104 06/18/2024 Re-election of Director to serve until the 2025 annual general meeting of shareholders: Scott Morrison DIRECTOR ELECTIONS ISSUER 2597074.000000 216980.000000 AGAINST 2597074.000000 AGAINST S000002922 Zai Lab Limited 98887Q104 06/18/2024 Re-election of Director to serve until the 2025 annual general meeting of shareholders: Leon O. Moulder, Jr. DIRECTOR ELECTIONS ISSUER 2597074.000000 216980.000000 FOR 2597074.000000 FOR S000002922 Zai Lab Limited 98887Q104 06/18/2024 Re-election of Director to serve until the 2025 annual general meeting of shareholders: Michel Vounatsos DIRECTOR ELECTIONS ISSUER 2597074.000000 216980.000000 FOR 2597074.000000 FOR S000002922 Zai Lab Limited 98887Q104 06/18/2024 Re-election of Director to serve until the 2025 annual general meeting of shareholders: Peter Wirth DIRECTOR ELECTIONS ISSUER 2597074.000000 216980.000000 FOR 2597074.000000 FOR S000002922 Zai Lab Limited 98887Q104 06/18/2024 THAT, the appointment of KPMG LLP and KPMG as the Company s independent registered public accounting firms and auditors to audit the Company s consolidated financial statements to be filed with the U.S. Securities and Exchange Commission and The Stock Exchange of Hong Kong Limited for the year ending December 31, 2024, respectively, is hereby approved. AUDIT-RELATED ISSUER 2597074.000000 216980.000000 FOR 2597074.000000 FOR S000002922 Zai Lab Limited 98887Q104 06/18/2024 THAT, the authority of the Board of Directors to fix the auditor compensation for 2024, is hereby approved. AUDIT-RELATED ISSUER 2597074.000000 216980.000000 FOR 2597074.000000 FOR S000002922 Zai Lab Limited 98887Q104 06/18/2024 THAT, on an advisory basis, the compensation of the Company s named executive officers, as disclosed in this proxy statement, is hereby approved. SECTION 14A SAY-ON-PAY VOTES ISSUER 2597074.000000 216980.000000 AGAINST 2597074.000000 AGAINST S000002922 Zai Lab Limited 98887Q104 06/18/2024 THAT, on an advisory basis, the compensation of the Company s named executive officers, as disclosed in this proxy statement, is hereby approved. SECTION 14A SAY-ON-PAY VOTES ISSUER 2597074.000000 216980.000000 AGAINST 2597074.000000 AGAINST 1 S000002922 Zai Lab Limited 98887Q104 06/18/2024 THAT, a general mandate to the Board of Directors to allot and issue ordinary shares and/or ADSs and/or resell treasury shares of up to 20% of the total number of issued ordinary shares of the Company (excluding treasury shares) as of the date of the Annual Meeting until the 2025 annual general meeting of shareholders is hereby approved. CAPITAL STRUCTURE ISSUER 2597074.000000 216980.000000 AGAINST 2597074.000000 AGAINST S000002922 Zai Lab Limited 98887Q104 06/18/2024 THAT, if Ordinary Resolution 14 is not approved, a general mandate to the Board of Directors to allot and issue ordinary shares and/or ADSs and/or resell treasury shares of up to 10% of the total number of issued ordinary shares of the Company (excluding treasury shares) as of the date of the Annual Meeting until the 2025 annual general meeting of shareholders is hereby approved. CAPITAL STRUCTURE ISSUER 2597074.000000 216980.000000 AGAINST 2597074.000000 AGAINST S000002922 Zai Lab Limited 98887Q104 06/18/2024 THAT, a general mandate to repurchase ordinary shares and/or ADSs of up to 10% of the total number of issued ordinary shares of the Company (excluding treasury shares) as of the date of the Annual Meeting until the 2025 annual general meeting of shareholders is hereby approved. CAPITAL STRUCTURE ISSUER 2597074.000000 216980.000000 AGAINST 2597074.000000 AGAINST S000002922 Zai Lab Limited 98887Q104 06/18/2024 THAT, an ordinary resolution to approve the Zai Lab Limited 2024 Equity Incentive Plan is hereby approved. COMPENSATION ISSUER 2597074.000000 216980.000000 FOR 2597074.000000 FOR S000002922 Zai Lab Limited KYG9887T1168 06/18/2024 To re-elect Samantha (Ying) Du to serve as a director DIRECTOR ELECTIONS ISSUER 16916600.000000 0.000000 FOR 16916600.000000 FOR S000002922 Zai Lab Limited KYG9887T1168 06/18/2024 To re-elect Kai-Xian Chen to serve as a director DIRECTOR ELECTIONS ISSUER 16916600.000000 0.000000 AGAINST 16916600.000000 AGAINST S000002922 Zai Lab Limited KYG9887T1168 06/18/2024 To re-elect John D. Diekman to serve as a director DIRECTOR ELECTIONS ISSUER 16916600.000000 0.000000 FOR 16916600.000000 FOR S000002922 Zai Lab Limited KYG9887T1168 06/18/2024 To re-elect Richard Gaynor to serve as a director DIRECTOR ELECTIONS ISSUER 16916600.000000 0.000000 FOR 16916600.000000 FOR S000002922 Zai Lab Limited KYG9887T1168 06/18/2024 To re-elect Nisa Leung to serve as a director DIRECTOR ELECTIONS ISSUER 16916600.000000 0.000000 FOR 16916600.000000 FOR S000002922 Zai Lab Limited KYG9887T1168 06/18/2024 To re-elect William Lis to serve as a director DIRECTOR ELECTIONS ISSUER 16916600.000000 0.000000 FOR 16916600.000000 FOR S000002922 Zai Lab Limited KYG9887T1168 06/18/2024 To re-elect Scott Morrison to serve as a director DIRECTOR ELECTIONS ISSUER 16916600.000000 0.000000 AGAINST 16916600.000000 AGAINST S000002922 Zai Lab Limited KYG9887T1168 06/18/2024 To re-elect Leon O. Moulder, Jr. to serve as a director DIRECTOR ELECTIONS ISSUER 16916600.000000 0.000000 FOR 16916600.000000 FOR S000002922 Zai Lab Limited KYG9887T1168 06/18/2024 To re-elect Michel Vounatsos to serve as a director DIRECTOR ELECTIONS ISSUER 16916600.000000 0.000000 FOR 16916600.000000 FOR S000002922 Zai Lab Limited KYG9887T1168 06/18/2024 To re-elect Peter Wirth to serve as a director DIRECTOR ELECTIONS ISSUER 16916600.000000 0.000000 FOR 16916600.000000 FOR S000002922 Zai Lab Limited KYG9887T1168 06/18/2024 To approve the appointment of KPMG LLP and the company's independent registered public accounting firms and auditors to audit our consolidated financial statements to be filed with the U.S. securities and exchange commission (SEC) and the Hong Kong Stock Exchange for the year ending December 31, 2024, respectively. AUDIT-RELATED ISSUER 16916600.000000 0.000000 FOR 16916600.000000 FOR S000002922 Zai Lab Limited KYG9887T1168 06/18/2024 To authorize the board of directors to fix auditor compensation for 2024. AUDIT-RELATED ISSUER 16916600.000000 0.000000 FOR 16916600.000000 FOR S000002922 Zai Lab Limited KYG9887T1168 06/18/2024 To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in this proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 16916600.000000 0.000000 AGAINST 16916600.000000 AGAINST S000002922 Zai Lab Limited KYG9887T1168 06/18/2024 To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in this proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 16916600.000000 0.000000 AGAINST 16916600.000000 AGAINST 1 S000002922 Zai Lab Limited KYG9887T1168 06/18/2024 To approve a general mandate to the board of directors to allot and issue ordinary shares and/or adss and/or resell treasury shares pf up to 20% of the total number of issued ordinary shares of the company (excluding treasury shares) as of the date the annual meeting until the 2025 annual general meeting of shareholders. CAPITAL STRUCTURE ISSUER 16916600.000000 0.000000 AGAINST 16916600.000000 AGAINST S000002922 Zai Lab Limited KYG9887T1168 06/18/2024 To approve a general mandate to the board of directors to allot and issue orfinary shares and/or adss and/or resell treasury shares up to 10% of the total number of issued ordinary shares of the company (excluding treasury shares) as of the date of the annual meeting until the 2025 annual general meeting of shareholders. CAPITAL STRUCTURE ISSUER 16916600.000000 0.000000 AGAINST 16916600.000000 AGAINST S000002922 Zai Lab Limited KYG9887T1168 06/18/2024 To approve a general mandate to repurchase ordinary shares and/or adss of up to 10% of the total number of issued ordinary shares of the company (excluding treasury shares) as of the date of the annual meeting until the 2025 annual general meeting of shareholders. CAPITAL STRUCTURE ISSUER 16916600.000000 0.000000 FOR 16916600.000000 FOR S000002922 Zai Lab Limited KYG9887T1168 06/18/2024 To approve the Zai Lab Limited 2024 Equity Incentive Plan. COMPENSATION ISSUER 16916600.000000 0.000000 FOR 16916600.000000 FOR S000002922 Biogen Inc. 09062X103 06/20/2024 Election of Directors. To elect the 9 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one year term extending until our 2025 annual meeting of stockholders and their successors are duly elected and qualified: Caroline D. Dorsa DIRECTOR ELECTIONS ISSUER 4558453.000000 0.000000 AGAINST 4558453.000000 AGAINST S000002922 Biogen Inc. 09062X103 06/20/2024 Election of Directors. To elect the 9 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one year term extending until our 2025 annual meeting of stockholders and their successors are duly elected and qualified: Maria C. Freire DIRECTOR ELECTIONS ISSUER 4558453.000000 0.000000 FOR 4558453.000000 FOR S000002922 Biogen Inc. 09062X103 06/20/2024 Election of Directors. To elect the 9 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one year term extending until our 2025 annual meeting of stockholders and their successors are duly elected and qualified: William A. Hawkins DIRECTOR ELECTIONS ISSUER 4558453.000000 0.000000 AGAINST 4558453.000000 AGAINST S000002922 Biogen Inc. 09062X103 06/20/2024 Election of Directors. To elect the 9 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one year term extending until our 2025 annual meeting of stockholders and their successors are duly elected and qualified: Susan K. Langer DIRECTOR ELECTIONS ISSUER 4558453.000000 0.000000 AGAINST 4558453.000000 AGAINST S000002922 Biogen Inc. 09062X103 06/20/2024 Election of Directors. To elect the 9 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one year term extending until our 2025 annual meeting of stockholders and their successors are duly elected and qualified: Jesus B. Mantas DIRECTOR ELECTIONS ISSUER 4558453.000000 0.000000 FOR 4558453.000000 FOR S000002922 Biogen Inc. 09062X103 06/20/2024 Election of Directors. To elect the 9 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one year term extending until our 2025 annual meeting of stockholders and their successors are duly elected and qualified: Monish Patolawala DIRECTOR ELECTIONS ISSUER 4558453.000000 0.000000 FOR 4558453.000000 FOR S000002922 Biogen Inc. 09062X103 06/20/2024 Election of Directors. To elect the 9 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one year term extending until our 2025 annual meeting of stockholders and their successors are duly elected and qualified: Eric K. Rowinsky DIRECTOR ELECTIONS ISSUER 4558453.000000 0.000000 FOR 4558453.000000 FOR S000002922 Biogen Inc. 09062X103 06/20/2024 Election of Directors. To elect the 9 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one year term extending until our 2025 annual meeting of stockholders and their successors are duly elected and qualified: Stephen A. Sherwin DIRECTOR ELECTIONS ISSUER 4558453.000000 0.000000 FOR 4558453.000000 FOR S000002922 Biogen Inc. 09062X103 06/20/2024 Election of Directors. To elect the 9 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one year term extending until our 2025 annual meeting of stockholders and their successors are duly elected and qualified: Christopher A. Viehbacher DIRECTOR ELECTIONS ISSUER 4558453.000000 0.000000 FOR 4558453.000000 FOR S000002922 Biogen Inc. 09062X103 06/20/2024 To ratify the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 4558453.000000 0.000000 FOR 4558453.000000 FOR S000002922 Biogen Inc. 09062X103 06/20/2024 Say on Pay - To hold an advisory vote on executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 4558453.000000 0.000000 FOR 4558453.000000 FOR S000002922 Biogen Inc. 09062X103 06/20/2024 Say on Pay - To hold an advisory vote on executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 4558453.000000 0.000000 FOR 4558453.000000 FOR 1 S000002922 Biogen Inc. 09062X103 06/20/2024 To approve an amendment to Biogen s Amended and Restated Certificate of Incorporation, as amended, to add an officer exculpation provision. CORPORATE GOVERNANCE ISSUER 4558453.000000 0.000000 FOR 4558453.000000 FOR S000002922 Biogen Inc. 09062X103 06/20/2024 To approve the Biogen Inc. 2024 Omnibus Plan. COMPENSATION ISSUER 4558453.000000 0.000000 FOR 4558453.000000 FOR S000002922 Biogen Inc. 09062X103 06/20/2024 To approve the Biogen Inc. 2024 Employee Stock Purchase Plan. COMPENSATION ISSUER 4558453.000000 0.000000 FOR 4558453.000000 FOR S000002922 Hapvida Participacoes Investimento SA BRHAPVACNOR4 06/20/2024 Accounts and Reports CORPORATE GOVERNANCE ISSUER 8909471.000000 0.000000 FOR 8909471.000000 FOR S000002922 Revolution Medicines, Inc. 76155X100 06/20/2024 Elect Elizabeth McKee Anderson DIRECTOR ELECTIONS ISSUER 6540577.000000 0.000000 FOR 6540577.000000 FOR S000002922 Revolution Medicines, Inc. 76155X100 06/20/2024 Elect Flavia Borellini DIRECTOR ELECTIONS ISSUER 6540577.000000 0.000000 FOR 6540577.000000 FOR S000002922 Revolution Medicines, Inc. 76155X100 06/20/2024 Elect Lorence H. Kim DIRECTOR ELECTIONS ISSUER 6540577.000000 0.000000 FOR 6540577.000000 FOR S000002922 Revolution Medicines, Inc. 76155X100 06/20/2024 To ratify the appointment, by the Audit Committee of the Company s Board of Directors, of PricewaterhouseCoopers LLP, as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 6540577.000000 0.000000 FOR 6540577.000000 FOR S000002922 Revolution Medicines, Inc. 76155X100 06/20/2024 To approve, on a non-binding, advisory basis, the compensation of the Company s named executive officers as disclosed in the Proxy Statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission ( Say-on-Pay ). SECTION 14A SAY-ON-PAY VOTES ISSUER 6540577.000000 0.000000 FOR 6540577.000000 FOR S000002922 Revolution Medicines, Inc. 76155X100 06/20/2024 To approve, on a non-binding, advisory basis, the compensation of the Company s named executive officers as disclosed in the Proxy Statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission ( Say-on-Pay ). SECTION 14A SAY-ON-PAY VOTES ISSUER 6540577.000000 0.000000 FOR 6540577.000000 FOR 1 S000002922 QIAGEN N.V. N72482149 06/21/2024 Proposal to adopt the Annual Accounts for the year ended December 31, 2023 ( Calendar Year 2023 ). CORPORATE GOVERNANCE ISSUER 1086762.000000 0.000000 FOR 1086762.000000 NONE S000002922 QIAGEN N.V. N72482149 06/21/2024 Proposal to cast a favorable non-binding advisory vote in respect of the Remuneration Report 2023. CORPORATE GOVERNANCE ISSUER 1086762.000000 0.000000 FOR 1086762.000000 NONE S000002922 QIAGEN N.V. N72482149 06/21/2024 Proposal to discharge from liability the Managing Directors for the performance of their duties during Calendar Year 2023. CORPORATE GOVERNANCE ISSUER 1086762.000000 0.000000 FOR 1086762.000000 FOR S000002922 QIAGEN N.V. N72482149 06/21/2024 Proposal to discharge from liability the Supervisory Directors for the performance of their duties during Calendar Year 2023. CORPORATE GOVERNANCE ISSUER 1086762.000000 0.000000 FOR 1086762.000000 FOR S000002922 QIAGEN N.V. N72482149 06/21/2024 Reappointment of the Supervisory Director: Dr. Metin Colpan DIRECTOR ELECTIONS ISSUER 1086762.000000 0.000000 FOR 1086762.000000 FOR S000002922 QIAGEN N.V. N72482149 06/21/2024 Reappointment of the Supervisory Director: Dr. Toralf Haag DIRECTOR ELECTIONS ISSUER 1086762.000000 0.000000 FOR 1086762.000000 FOR S000002922 QIAGEN N.V. N72482149 06/21/2024 Reappointment of the Supervisory Director: Prof. Dr. Ross L. Levine DIRECTOR ELECTIONS ISSUER 1086762.000000 0.000000 FOR 1086762.000000 FOR S000002922 QIAGEN N.V. N72482149 06/21/2024 Reappointment of the Supervisory Director: Prof. Dr. Elaine Mardis DIRECTOR ELECTIONS ISSUER 1086762.000000 0.000000 FOR 1086762.000000 FOR S000002922 QIAGEN N.V. N72482149 06/21/2024 Reappointment of the Supervisory Director: Dr. Eva Pisa DIRECTOR ELECTIONS ISSUER 1086762.000000 0.000000 FOR 1086762.000000 FOR S000002922 QIAGEN N.V. N72482149 06/21/2024 Reappointment of the Supervisory Director: Mr. Lawrence A. Rosen DIRECTOR ELECTIONS ISSUER 1086762.000000 0.000000 FOR 1086762.000000 FOR S000002922 QIAGEN N.V. N72482149 06/21/2024 Reappointment of the Supervisory Director: Mr. Stephen H. Rusckowski DIRECTOR ELECTIONS ISSUER 1086762.000000 0.000000 FOR 1086762.000000 FOR S000002922 QIAGEN N.V. N72482149 06/21/2024 Reappointment of the Supervisory Director: Ms. Elizabeth E. Tallett DIRECTOR ELECTIONS ISSUER 1086762.000000 0.000000 AGAINST 1086762.000000 AGAINST S000002922 QIAGEN N.V. N72482149 06/21/2024 Reappointment of the Supervisory Director: Mr. Bert van Meurs DIRECTOR ELECTIONS ISSUER 1086762.000000 0.000000 FOR 1086762.000000 FOR S000002922 QIAGEN N.V. N72482149 06/21/2024 Reappointment of the Supervisory Director: Ms. Eva van Pelt DIRECTOR ELECTIONS ISSUER 1086762.000000 0.000000 FOR 1086762.000000 FOR S000002922 QIAGEN N.V. N72482149 06/21/2024 Reappointment of the Managing Director: Mr. Thierry Bernard DIRECTOR ELECTIONS ISSUER 1086762.000000 0.000000 FOR 1086762.000000 FOR S000002922 QIAGEN N.V. N72482149 06/21/2024 Reappointment of the Managing Director: Mr. Roland Sackers DIRECTOR ELECTIONS ISSUER 1086762.000000 0.000000 FOR 1086762.000000 FOR S000002922 QIAGEN N.V. N72482149 06/21/2024 Proposal to adopt the Remuneration Policy with respect to the Supervisory Board. COMPENSATION ISSUER 1086762.000000 0.000000 FOR 1086762.000000 FOR S000002922 QIAGEN N.V. N72482149 06/21/2024 Proposal to determine the remuneration of the members of the Supervisory Board. COMPENSATION ISSUER 1086762.000000 0.000000 FOR 1086762.000000 FOR S000002922 QIAGEN N.V. N72482149 06/21/2024 Proposal to reappoint KPMG Accountants N.V. as auditors of the Company for the calendar year ending December 31, 2024. AUDIT-RELATED ISSUER 1086762.000000 0.000000 FOR 1086762.000000 FOR S000002922 QIAGEN N.V. N72482149 06/21/2024 Proposal to appoint Ernst & Young Accountants LLP as auditors of the Company for the calendar year ending December 31, 2025. AUDIT-RELATED ISSUER 1086762.000000 0.000000 FOR 1086762.000000 FOR S000002922 QIAGEN N.V. N72482149 06/21/2024 Proposal to authorize the Supervisory Board, until December 21, 2025 to: issue a number of ordinary shares and financing preference shares and grant rights to subscribe for such shares of up to 50% of the aggregate par value of all shares issued and outstanding. CAPITAL STRUCTURE ISSUER 1086762.000000 0.000000 AGAINST 1086762.000000 AGAINST S000002922 QIAGEN N.V. N72482149 06/21/2024 Proposal to authorize the Supervisory Board, until December 21, 2025 to: restrict or exclude the pre-emptive rights with respect to issuing ordinary shares or granting subscription rights of up to 10% of the aggregate par value of all shares issued and outstanding. CAPITAL STRUCTURE ISSUER 1086762.000000 0.000000 FOR 1086762.000000 FOR S000002922 QIAGEN N.V. N72482149 06/21/2024 Proposal to authorize the Managing Board, until December 21, 2025, to acquire shares in the Company s own share capital. CAPITAL STRUCTURE ISSUER 1086762.000000 0.000000 FOR 1086762.000000 FOR S000002922 QIAGEN N.V. N72482149 06/21/2024 Proposal to approve discretionary rights for the Managing Board to implement a capital repayment by means of a synthetic share repurchase. CAPITAL STRUCTURE ISSUER 1086762.000000 0.000000 FOR 1086762.000000 FOR S000002922 QIAGEN N.V. N72482149 06/21/2024 Proposal to approve the cancellation of fractional ordinary shares held by the Company. CAPITAL STRUCTURE ISSUER 1086762.000000 0.000000 FOR 1086762.000000 FOR S000002922 Structure Therapeutics Inc. 86366E106 06/25/2024 Election of the nomiees for Class I director named below to serve until the 2027 annual general meeting of shareholders and until her successor is duly elected and qualified, or until her earlier death, resignation or removal: Sharon Tetlow DIRECTOR ELECTIONS ISSUER 2624515.000000 328500.000000 FOR 2624515.000000 FOR S000002922 Structure Therapeutics Inc. 86366E106 06/25/2024 To ratify the appointment by the Audit Committee of the Board of Directors of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 2624515.000000 328500.000000 FOR 2624515.000000 FOR S000002922 TERUMO CORPORATION JP3546800008 06/26/2024 Allocation of Profits/Dividends CAPITAL STRUCTURE ISSUER 6976400.000000 0.000000 FOR 6976400.000000 FOR S000002922 TERUMO CORPORATION JP3546800008 06/26/2024 Elect Toshiaki Takagi DIRECTOR ELECTIONS ISSUER 6976400.000000 0.000000 FOR 6976400.000000 FOR S000002922 TERUMO CORPORATION JP3546800008 06/26/2024 Elect Hikaru Samejima DIRECTOR ELECTIONS ISSUER 6976400.000000 0.000000 FOR 6976400.000000 FOR S000002922 TERUMO CORPORATION JP3546800008 06/26/2024 Elect Toshihiko Osada DIRECTOR ELECTIONS ISSUER 6976400.000000 0.000000 FOR 6976400.000000 FOR S000002922 TERUMO CORPORATION JP3546800008 06/26/2024 Elect Kazunori Hirose DIRECTOR ELECTIONS ISSUER 6976400.000000 0.000000 FOR 6976400.000000 FOR S000002922 TERUMO CORPORATION JP3546800008 06/26/2024 Elect Norimasa Kunimoto DIRECTOR ELECTIONS ISSUER 6976400.000000 0.000000 FOR 6976400.000000 FOR S000002922 TERUMO CORPORATION JP3546800008 06/26/2024 Elect Hidenori Nishi DIRECTOR ELECTIONS ISSUER 6976400.000000 0.000000 FOR 6976400.000000 FOR S000002922 TERUMO CORPORATION JP3546800008 06/26/2024 Elect Keiya Ozawa DIRECTOR ELECTIONS ISSUER 6976400.000000 0.000000 FOR 6976400.000000 FOR S000002922 TERUMO CORPORATION JP3546800008 06/26/2024 Elect Mari Kogiso DIRECTOR ELECTIONS ISSUER 6976400.000000 0.000000 FOR 6976400.000000 FOR S000002922 TERUMO CORPORATION JP3546800008 06/26/2024 Elect Koichi Sakaguchi DIRECTOR ELECTIONS ISSUER 6976400.000000 0.000000 FOR 6976400.000000 FOR S000002922 TERUMO CORPORATION JP3546800008 06/26/2024 Elect Hiroaki Kosugi DIRECTOR ELECTIONS ISSUER 6976400.000000 0.000000 FOR 6976400.000000 FOR S000002922 United Therapeutics Corporation 91307C102 06/26/2024 Election of Director: Christopher Causey DIRECTOR ELECTIONS ISSUER 842593.000000 0.000000 FOR 842593.000000 FOR S000002922 United Therapeutics Corporation 91307C102 06/26/2024 Election of Director: Raymond Dwek DIRECTOR ELECTIONS ISSUER 842593.000000 0.000000 FOR 842593.000000 FOR S000002922 United Therapeutics Corporation 91307C102 06/26/2024 Election of Director: Richard Giltner DIRECTOR ELECTIONS ISSUER 842593.000000 0.000000 FOR 842593.000000 FOR S000002922 United Therapeutics Corporation 91307C102 06/26/2024 Election of Director: Ray Kurzweil DIRECTOR ELECTIONS ISSUER 842593.000000 0.000000 FOR 842593.000000 FOR S000002922 United Therapeutics Corporation 91307C102 06/26/2024 Election of Director: Jan Malcolm DIRECTOR ELECTIONS ISSUER 842593.000000 0.000000 FOR 842593.000000 FOR S000002922 United Therapeutics Corporation 91307C102 06/26/2024 Election of Director: Linda Maxwell DIRECTOR ELECTIONS ISSUER 842593.000000 0.000000 FOR 842593.000000 FOR S000002922 United Therapeutics Corporation 91307C102 06/26/2024 Election of Director: Nilda Mesa DIRECTOR ELECTIONS ISSUER 842593.000000 0.000000 FOR 842593.000000 FOR S000002922 United Therapeutics Corporation 91307C102 06/26/2024 Election of Director: Judy Olian DIRECTOR ELECTIONS ISSUER 842593.000000 0.000000 FOR 842593.000000 FOR S000002922 United Therapeutics Corporation 91307C102 06/26/2024 Election of Director: Christopher Patusky DIRECTOR ELECTIONS ISSUER 842593.000000 0.000000 FOR 842593.000000 FOR S000002922 United Therapeutics Corporation 91307C102 06/26/2024 Election of Director: Martine Rothblatt DIRECTOR ELECTIONS ISSUER 842593.000000 0.000000 FOR 842593.000000 FOR S000002922 United Therapeutics Corporation 91307C102 06/26/2024 Election of Director: Louis Sullivan DIRECTOR ELECTIONS ISSUER 842593.000000 0.000000 FOR 842593.000000 FOR S000002922 United Therapeutics Corporation 91307C102 06/26/2024 Election of Director: Tommy Thompson DIRECTOR ELECTIONS ISSUER 842593.000000 0.000000 FOR 842593.000000 FOR S000002922 United Therapeutics Corporation 91307C102 06/26/2024 Advisory resolution to approve executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 842593.000000 0.000000 FOR 842593.000000 FOR S000002922 United Therapeutics Corporation 91307C102 06/26/2024 Advisory resolution to approve executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 842593.000000 0.000000 FOR 842593.000000 FOR 1 S000002922 United Therapeutics Corporation 91307C102 06/26/2024 Approval of the amendment and restatement of the United Therapeutics Corporation Amended and Restated 2015 Stock Incentive Plan. COMPENSATION ISSUER 842593.000000 0.000000 FOR 842593.000000 FOR S000002922 United Therapeutics Corporation 91307C102 06/26/2024 Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for 2024. AUDIT-RELATED ISSUER 842593.000000 0.000000 FOR 842593.000000 FOR S000002922 Autolus Therapeutics plc 05280R100 06/28/2024 To receive and adopt the Company s accounts for the financial year ended 31 December 2023 and the associated reports of the Directors and auditors (the 2023 Annual Report and Accounts ). CORPORATE GOVERNANCE ISSUER 13541015.000000 0.000000 FOR 13541015.000000 FOR S000002922 Autolus Therapeutics plc 05280R100 06/28/2024 To approve the Directors remuneration report set out on pages 18 to 44 (inclusive) of the 2023 Annual Report and Accounts. COMPENSATION ISSUER 13541015.000000 0.000000 FOR 13541015.000000 FOR S000002922 Autolus Therapeutics plc 05280R100 06/28/2024 To re-appoint Ernst & Young LLP as auditors of the Company and to authorise the Directors to determine the auditors remuneration. AUDIT-RELATED ISSUER 13541015.000000 0.000000 FOR 13541015.000000 FOR S000002922 Autolus Therapeutics plc 05280R100 06/28/2024 To re-elect Ms. L Bain as a Director. DIRECTOR ELECTIONS ISSUER 13541015.000000 0.000000 FOR 13541015.000000 FOR S000002922 Autolus Therapeutics plc 05280R100 06/28/2024 To re-elect Ms. C Butitta as a Director. DIRECTOR ELECTIONS ISSUER 13541015.000000 0.000000 FOR 13541015.000000 FOR S000002922 Autolus Therapeutics plc 05280R100 06/28/2024 To re-elect Dr. C Itin as a Director. DIRECTOR ELECTIONS ISSUER 13541015.000000 0.000000 FOR 13541015.000000 FOR S000002922 Autolus Therapeutics plc 05280R100 06/28/2024 To re-elect Dr. W Young as a Director. DIRECTOR ELECTIONS ISSUER 13541015.000000 0.000000 FOR 13541015.000000 FOR S000002922 Autolus Therapeutics plc 05280R100 06/28/2024 To authorise the Board, generally and unconditionally for the purpose of section 551 of the Companies Act 2006 to allot shares in the Company or to grant rights to subscribe for or to convert any security into shares in the Company up to a maximum aggregate nominal amount of $8,400. CAPITAL STRUCTURE ISSUER 13541015.000000 0.000000 FOR 13541015.000000 FOR S000002922 Autolus Therapeutics plc 05280R100 06/28/2024 Subject to the passing of Resolution 8, to empower the Board generally pursuant to section 570(1) and section 573 of the Companies Act to allot equity securities (as defined in section 560 of the Companies Act) for cash pursuant to the general authority conferred on them by Resolution 8 as if section 561(1) of the Companies Act did not apply to that allotment. (Special Resolution) CAPITAL STRUCTURE ISSUER 13541015.000000 0.000000 FOR 13541015.000000 FOR S000002922